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RSV   respiratory syncytial virus 
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Summary 
 
Asthma and chronic obstructive pulmonary disease (COPD) are respiratory disorders 
characterized by shortness of breath, mucus production and cough. Over the last decades, 
the incidence and severity of both diseases has increased continuously, especially in the 
industrialized West. Although genetic predisposition is a fundamental factor underlying both 
disorders, the observed increase in prevalence has occurred too rapidly to be explained by 
genetic variations alone, implicating a role for environmental factors. 
 
The strongest predictive factor for the development of asthma is the sensitization to house 
dust mite (HDM) allergens. Additionally, epidemiological studies have demonstrated that 
cigarette smoke (CS) exposure is a considerable risk factor for the development or 
progression of allergic asthma. To better understand the impact of CS exposure on 
immunological responses towards allergens, we took advantage of a previously established 
mouse model in which CS breaks inhalation tolerance to the “surrogate” allergen ovalbumin. 
Investigating the impact of CS inhalation on key aspects of airway dendritic cells (DCs), 
revealed enhanced DC recruitment and maturation in mice concomitantly exposures to CS 
and ovalbumin for 3 weeks. Prolonged CS inhalation further amplified the DC-mediated 
transport of inhaled ovalbumin to the draining lymph nodes. In order to unravel the 
underlying mechanisms leading to a Th2-oriented immune response, we hypothesized a role 
for the endotoxin-like effects of CS in facilitating allergic sensitization by triggering the 
endotoxin-recognition receptor TLR4 on epithelial cells or DCs. Surprisingly, neither TLR4 
deficient mice, nor the adaptor protein MyD88 knockout mice were protected against CS-
induced facilitated Th2 immunity, suggesting that other pathways are involved. 
 
Importantly, the differences in biochemical and immunogenic characteristics of the 
surrogate allergen ovalbumin and real-life allergens (e.g. HDM) may have a profound impact 
on the mechanisms behind the elicited allergic response. Accordingly, we established a novel 
mouse model with improved clinical relevance, using HDM as real-life allergen, together 
with CS as indoor pollutant. We provided biological proof that CS indeed favours HDM-
driven asthma development, as illustrated by increased characteristics of asthma, such as 
enhanced eosinophilia, elevated production of Th2-related cytokines, increased airway 
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hyperresponsiveness and HDM-specific serum IgG1. Furthermore, we demonstrated that CS 
inhalation during the sensitization phase is sufficient to induce asthma development in mice. 
We found that only a few days of CS inhalation during the initial allergen contact already 
enhanced DC recruitment, activation and migration to the lymph nodes, supporting the local 
induction of HDM-specific Th2 immunity. Finally, using IL1RI deficient mice, we 
demonstrated IL1RI to be necessary to prime local Th2 responses in the lymph nodes. 
 
Chronic CS inhalation is an important risk factor for the development of COPD. In addition, 
repeated CS exposure may compromise the epithelial barrier function against invading 
pathogens, making COPD patients more prone to develop acute exacerbations with 
aggravation of symptoms. The discovery of specific IgE antibodies directed against 
Staphylococcus aureus enterotoxins in patients with COPD, provides indications that these 
antigens may act as potential aggravating factors of COPD pathophysiology. To focus on the 
disease-aggravating role of bacterial superantigens, we designed a novel mouse model of 
concomitant exposure to CS and Staphylococcus aureus enterotoxin B. Simultaneous 
exposure to both stimuli resulted in a significant aggravation of hallmark features of CS-
induced pulmonary inflammation, such as a marked increase in CD8+ T lymphocytes and 
neutrophils, enhanced goblet cell hyperplasia and the formation of dense lymphoid 
aggregates in the lung. 
 
In conclusion, we demonstrated a role for environmental factors in the induction, 
progression or aggravation of asthma and COPD, using mouse models of combined 
exposures to natural and anthropogenic environmental stimuli. 
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Samenvatting 
 
Astma en chronisch obstructief longlijden (COPD) zijn veel voorkomende respiratoire 
ziekten, met klachten als kortademigheid, chronisch hoesten en slijm. De laatste jaren is de 
prevalentie en de ernst van beide ziekten, vooral in de geïndustrialiseerde landen, sterk 
toegenomen. Niettegenstaande de genetische achtergrond een belangrijke risicofactor kan 
zijn in het ontstaan van astma en COPD, worden vooral omgevingsfactoren verantwoor-
delijk geacht voor de snel toegenomen prevalentie. 
 
De belangrijkste predictieve factor voor het ontstaan van astma, is de sensibilisatie ten 
opzichte van huisstofmijt (HSM) allergenen. Uit epidemiologische studies blijkt dat 
sigarettenrook (SR) eveneens een belangrijke trigger is in het ontstaan en de progressie van 
de ziekte. Om inzichten te verwerven in de moleculaire mechanismen verantwoordelijk voor 
SR-geïnduceerd astma, werd initieel gebruik gemaakt van een reeds bestaand muismodel 
waar SR de normale inhalatietolerantie ten opzichte van het “surrogaat” allergeen 
ovalbumine verstoort. Onderzoek naar het effect van SR op het gedrag van pulmonaire 
dendritische cellen (DCs), de belangrijkste immuunsensors in de long, onthulde een 
verhoogde rekrutering en maturatie van DCs in muizen die 3 weken werden blootgesteld aan 
een combinatie van SR en ovalbumine. Langdurige SR inhalatie amplificeerde eveneens het 
DC-gemedieerde transport van dit antigen naar de drainerende lymfeknopen. Een belangrijk 
mechanisme, verantwoordelijk voor de DC activatie en de ontwikkeling van Th2 responsen in 
de long, is de TLR4 – endotoxine pathway. Daarom werden TLR4 deficiënte muizen, alsook 
adaptor eiwit MyD88 knock-out muizen blootgesteld aan sigarettenrook in combinatie met 
OVA aerosol. De deficiënte muizen bleken echter op even efficiënte wijze als de wildtypes 
allergische inflammatie te genereren in de luchtwegen, wat doet vermoeden dat 
alternatieve mechanismen betrokken zijn in de ontwikkeling van SR-geïnduceerd astma.  
 
Het verschil in biochemisch en immunogeen karakter tussen het surrogaat allergeen 
ovalbumine en werkelijke allergenen (vb. HSM) kan echter de onderliggende mechanismen 
van een allergische respons in sterke mate beïnvloeden. Bijgevolg werd een nieuw 
muismodel ontwikkeld, gebruik makend van HSM als klinisch relevant allergeen, 
gecombineerd met SR als omgevingspolluent. Gebruik makend van dit model kon biologisch 
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bewijs geleverd worden dat SR inderdaad de ontwikkeling van HSM-geïnduceerd astma kan 
beïnvloeden, wat zich vertaalde in een toegenomen astma fenotype, zoals een stijging in 
eosinofilie, verhoogde productie van Th2-gerelateerde cytokines, toegenomen luchtweg 
hyperreactiviteit en HSM-specifiek serum IgG1. Verder bleek de blootstelling aan SR tijdens 
de sensitisatie fase reeds voldoende om astma te ontwikkelen. Meer nog, een kortstondige 
SR blootstelling van slechts enkele dagen, tijdens de eerste contacten met het allergeen, was 
reeds voldoende om DCs in verhoogde mate te activeren en te rekruteren naar de long, 
alsook hun migratie naar de lymfeknopen te stimuleren en zó HSM-specifieke Th2 
immuniteit te induceren. Finaal kon, gebruik makend van IL1RI deficiënte muizen, 
aangetoond worden dat IL1RI noodzakelijk is voor de inductie van deze Th2 responsen in de 
lymfeknopen. 
 
De chronische blootstelling aan SR is een belangrijke risicofactor voor de ontwikkeling van 
COPD. Aangezien SR de mucosale weerstand tegen invasieve pathogenen verzwakt, kan dit 
COPD patiënten gevoeliger maken voor de ontwikkeling van acute exacerbaties met 
versterkte symptomen tot gevolg. De ontdekking van specifieke immunoglobulines in COPD 
patiënten, gericht tegen de virulente enterotoxines afkomstig van Staphylococcus aureus, 
doet vermoeden dat deze antigenen mogelijks een rol spelen in de aggravatie van COPD 
pathofysiologie. Om dit te onderzoeken, ontwikkelden we een nieuw muismodel van 
gecombineerde blootstelling aan SR en Staphylococcus aureus enterotoxine B. Gelijktijdige 
blootstelling aan beide stimuli resulteerde in een significante aggravatie van typische 
kenmerken van CS-geïnduceerde pulmonaire inflammatie, zoals een verhoogde toename 
van CD8+ T lymfocyten en neutrofielen, toegenomen slijmbeker hyperplasie en de vorming 
van compacte lymfoide aggregaten in de long. 
 
In conclusie, gebruik makend van muismodellen waarin de blootstelling aan natuurlijke en 
antropogene omgevingsstimuli werden gecombineerd, hebben we aangetoond dat 
omgevingsfactoren een belangrijke rol kunnen spelen in de inductie, progressie en 
aggravatie van astma en COPD. 
 
 
10
 
11 
  
 
 
 
 
 
 
 
 
 
 
PART I: INTRODUCTION 
 
In the following 3 chapters, we will highlight different aspects of asthma and COPD 
pathogenesis, which will be addressed in the thesis further on.
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CHAPTER 1: ANCIENT MEETS NOVEL: PULMONARY INNATE 
IMMUNITY AND THE RISE OF ANTHROPOGENIC STIMULI 
1 
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1.1. Pulmonary innate immunity 
 
The innate immune system of the lung is one of the most critical homeostatic systems of the 
body.  Life-threatening damage to the delicate gas-exchange structures can occur either by 
failure to rapidly detect and clear inhaled airborne pathogens, or as a result of an unbridled 
inflammatory response. Hence, the integrity of the lung must be protected at all times.   
 
Despite their structural vulnerability, the lungs defend themselves effectively through a 
combination of mechanical, humoral (adaptive immunity) and cellular mechanisms 1,2. The 
airway epithelial lining, composed of ciliated and mucous-secreting cells, provide the first 
line of defense against invading pathogens 3,4. Beating of the cilia moves a continuous 
stream of mucus, trapping and ejecting inhaled pathogens from the lung. Antimicrobial 
peptides and pulmonary surfactant proteins, synthesized by the epithelium of the deeper 
alveolar zones, further constitute an additional immediate mechanism of defense 5. 
Phagocytic cells, like alveolar macrophages and neutrophils, complete the picture by 
neutralizing persistent pathogens that broke through. Other important sensors of innate 
immunity are invariant natural killer (iNK) T cells and pulmonary dendritic cells (DCs). 
Pulmonary DCs are a heterogenous population of antigen-presenting cells (APC) with the 
unique ability to initiate appropriate adaptive immune responses in the lung 6. They reside in 
tissues in close contact to the external environment and form an extensive network 
immediately above and beneath the basement membrane and within the interalveolar 
septa. Their specialized surface receptors (e.g. C-type lectin receptors, Toll-like receptors 
(TLRs)) recognize highly conserved pathogen-associated molecular patterns or PAMPs 7. 
Inhalation of invading pathogens unveils the innate character of airway DC dynamics, 
reflected by their fast and massive recruitment into the airways and lungs 8. Capture of 
inhaled antigens leads to DC activation and migration to the T cell zones of draining thoracic 
lymph nodes and depending on the nature of the antigen, DCs will selectively promote Th1, 
Th2 or Th17 immunity 9. 
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 1.2. The rise of anthropogenic stimuli # 
 
Throughout evolution, innate immunity had to co-evolve constantly in order to remain 
effective. Dating back millions of years ago, the explosive colonization of the land by a 
myriad of organisms characteristic for that time, must have brought a constant selection 
pressure on the very first airway innate immune defenses, especially with the development 
of the first vertebrate lungs 360 million years ago 10,11. Seen on this time-scale, human 
evolution is an extremely recent event. 
 
Since prehistoric times, and boosted by the first industrial revolution, human activity has 
resulted in the ever increasing release of airborne xenobiotic compounds, most of them 
derived from the combustion of fossil fuels (e.g. diesel, charcoal) 12 or tobacco 13.  
Xenobiotics (Greek xenos = foreigner, stranger) are chemically synthesized compounds that 
do not exist naturally and are thus ‘foreign to the body’ 14. Carbonaceous particles (e.g. 
diesel exhaust particles), as well as a broad array of volatile compounds (carbon monoxide 
(CO), nitrogen oxides (NOx), sulphur dioxides (SO2)) and the more carcinogenic polycyclic 
aromatic hydrocarbons (PAHs) are all important classes of pollutants with ‘unnatural’ 
effects. Because of their small size (< 10 μm PM10, < 2.5 μm PM2.5, < 0.1 μm PM0.1), airborne 
particulates can be easily inhaled and absorbed into the bloodstream or deposited in the 
deeper zones of the lung, causing adverse respiratory and cardiac effects 15-17. 
Furthermore, due to socioeconomic changes, higher levels of combustion products have 
been reached since the widespread use of tobacco. Emerging evidence suggests a prominent 
role for cigarette smoke (CS) as indoor risk factor for the development of respiratory 
diseases 18. Cigarette smoke is a major and entirely preventable cause of disease in middle- 
and high-income countries and kills nearly 6 million people each year. Unless urgent action is 
taken, the annual death toll can rise to more than eight million by 2030 19. 
 
The question arises how the immune system of the lung deals with these evolutionary 
recent anthropogenic stimuli. It can be assumed that confrontation of un-evolved airway 
DCs with these modern agents induces aberrant immune responses in the lung, giving a new 
view on the pathogenesis of several chronic inflammatory pulmonary diseases, like asthma 
and chronic obstructive pulmonary disease (COPD). 
# Based on: ‘A new danger in the air: how pulmonary innate immunity copes with man-made airborne 
xenobiotics.’ Lanckacker EA, Robays LJ, Joos GF, Vermaelen KY. J Innate Immun. 2010;2(2):96-106. 
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CHAPTER 2: ALLERGIC ASTHMA 2 
17
 
18 
 
19 
2.1. Introduction 
 
Asthma is a chronic inflammatory disease, characterized by recurrent episodes of wheezing, 
breathlessness, chest tightness and cough. The symptoms are usually associated with 
increased airway hyperresponsiveness and variable airflow obstruction, which is often 
reversible, either spontaneously or after treatment 20.  
Extensive work has been done to understand the complex aetiology of the asthmatic 
disease. Most asthmatic patients are atopic or genetically predisposed to produce 
immunoglobulin (Ig)E antibodies to common environmental allergens, like house dust mites 
(HDMs), molds, grass pollen or animal dander. More than 50% of all asthma cases are 
attributed to atopic (allergic) Th2-high eosinophilic asthma, however an important part is 
non-Th2 prone 21,22. Non-Th2-related asthma is often associated with severe asthmatic 
disease and characterized by a mixed Th1/Th2 phenotype and neutrophilic airway 
inflammation 23. The introductory part of this thesis will especially focus on atopic Th2-prone 
allergic asthma. For more information about different asthma phenotypes, we refer to the 
review of Wenzel et al. 23. 
 
Allergic asthma results from aberrant immune responses towards inhaled aeroallergens and 
originates from allergic sensitization, followed by repetitive and persistent re-exposure to 
the same allergen. Typical for allergic asthma is the chronic inflammatory response, 
accountable for almost all the cardinal features of asthma pathophysiology. The persistence 
and nature of the inflammation, largely determines the severity of the disease, which can 
vary from intermittent to mild, moderate or severe persistent asthma or can even be fatal 24. 
 
2.1.1.  Inhalation tolerance 
 
DCs play a crucial role in determining the outcome of an immune response upon mucosal 
antigen encounter. The mucosal environment itself instructs DCs to induce an immune 
response that is either tolerogenic or immunogenic. In steady state or in the absence of any 
‘danger’ signal, tissue resident immature DCs express low levels of co-stimulatory molecules 
on their cell surface. DCs will take-up harmless environmental compounds and present them 
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in the lymph nodes, inducing regulatory T cells 
(Tregs) who will further maintain the 
homeostasis in the lung (Figure 1). 
In healthy individuals, immune tolerance is the 
normal functional outcome upon allergen 
exposure. Failure of these endogenous 
tolerance mechanisms are thought to be 
responsible for allergen sensitization and the 
development of an aberrant immune 
response. 
 
2.1.2.  Mucosal allergic sensitization towards aeroallergens 
 
The strongest predictive factor for the development of asthma, is the sensitization to 
aeroallergens. Allergic sensitization is defined as the phase between the initial encounter of 
the allergen in the body and the development of increased IgE sensitivity, however without 
causing any allergic symptoms yet. Sensitization generally begins in early childhood and may 
last a few days, several months or even years. 
 
The airway DCs are the key regulators of allergic sensitization in the lung. They form an 
extensive network immediately above and beneath the airway basement membrane and 
project their dendrites in between the epithelial cells to sample the incoming air without 
breaking the epithelial integrity 25. DCs have to sense (exogenous) danger signals to get 
properly activated. This danger signal can originate directly from the allergen itself or from 
the local tissue environment and determines the nature of the subsequent immune 
response. Especially the release of Th2-skewing mediators from the airway epithelium are 
important (see Chapter 2.2). Once activated, DCs take up the encountered allergens, process 
them into small peptides and present them, in the context of major histocompatibility 
complex (MHC) II molecules, to naïve CD4+ T cells in the lymph nodes (Figure 2). During their 
migration to the lymph nodes, DCs differentiate into professional antigen presenting cells, 
expressing costimulatory molecules (CD80, CD86) that favour the differentiation and clonal 
expansion of allergen-specific T helper 2 (Th2) effector cells 26. Moreover, the differentiation 
Figure 1: Allergen exposure in healthy  individual. 
Arrow:               migration;             differentiation. Figure by 
Lanckacker EA 
20
 
21 
Figure 2: Mucosal sensitization in atopic patients. 
Arrow:               migration;              differentiation. Figure by 
Lanckacker EA, based on Galli et al. Nature. 2008 Jul 24;454(7203):445-54 
towards the Th2 phenotype seems to 
be dependent on the so-called ‘early 
IL-4’, probably released by basophils 
as primary source 27. The induction of 
a Th2 immune response results in the 
further release of interleukin (IL)-4 
and IL-13. These cytokines will sti-
mulate allergen-specific B cells to 
undergo immunoglobulin class 
switch recombination from IgM to 
IgE 28. Allergen-specific IgE binds the 
high affinity IgE receptor FcεRI expressed on mast cells and basophils and remains there until 
re-exposure of the same allergen occurs (Figure 2). Once initiated, the IgE response can be 
further amplified by basophils, mast cells and activated eosinophils. From now on, the 
subject is sensitized, allergen re-exposure may result in a rapid allergic reaction.  
 
2.1.3.  Allergic inflammation and asthma development 
 
In sensitized individuals, re-introduction of the allergen will crosslink adjacent IgE molecules 
on mast cells and basophils, activating them to release the content of their granules into the 
surrounding fluids (Figure 3). The rapid release of preformed and newly synthesized proin-
flammatory mediators contributes to the acute signs and symptoms of the allergic 
inflammatory response. The early phase of an allergic reaction typically occurs within 
minutes or even seconds following allergen exposure. The local release of proinflammatory 
mediators such as histamine, eicosanoids (e.g. leukotriene (LT) B4, prostaglandin (PG) D2) 
and proteases (e.g. tryptase) induces vasodilation, bronchoconstriction and excessive mucus 
production. During the late phase reaction, other mast cell mediators such as 
multifunctional cytokines (e.g. IL-8, CC chemokine ligand (CCL)-2, tumor necrosis factor 
(TNF)-α) and growth factors (e.g. granulocyte macrophage colony-stimulating factor (GM-
CSF)) further induce chemotactic recruitment and activation of eosinophils, neutrophils and 
Th2 effector cells. The late phase reaction takes place 2 to 6 hours after allergen rechallenge 
and may even persist a few days. The local recruitment of Th2 cells implies the production of 
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Th2-cytokines which account for the complex features of asthma. The infiltration of 
eosinophils in the lungs, is mediated by IL-5 in concert with CC chemokine receptor (CCR)3 
chemokines, such as eotaxin. IL-5 is also important for the proliferation, activation and 
survival of eosinophils. The IgE antibody production requires the release of IL-4 and IL-13. In 
addition, these cytokines will be responsible for the up-regulation of vascular cell adhesion 
molecule (VCAM)-1 on endothelial cells, facilitating transendothelial migration of very late 
antigen (VLA)-4 positive inflammatory cells. Furthermore, IL-13 together with IL-9 can 
change the excitability of bronchial smooth muscle cells, inducing airway 
hyperresponsiveness and goblet cell hyperplasia. IL-9 is also identified as potent mast cell 
growth and differentiation factor (Figure 3) 24.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.4. Chronic allergic inflammation  
 
Continuous or repetitive allergen exposure results in a persistent inflammatory response. In 
the beginning, the inflammation is largely restricted to the conducting airways. However, as 
Figure 3: Early and late phase response after allergen rechallenge. The early phase response is characterized by 
mast cell activation through cross-linking of allergen-specific IgE and results in bronchoconstriction, increased 
vascular permeability and mucus production. The late phase reaction is characterized by infiltration of the airway 
wall with eosinophils and lymphocytes. Arrow:            functional consequences of mast cell mediator release. 
Figure by Lanckacker EA, based on Galli et al. Nature. 2008 Jul 24;454(7203):445-54. 
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the disease becomes more chronic, cellular infiltrates (eosinophils, lymphocytes, 
neutrophils) disperse to the trachea and the smaller airways and finally, take up residence in 
the tissues. Especially the presence of eosinophils is characteristic for chronic allergic airway 
inflammation. Eosinophils are thought to be major contributors to tissue damage, as 
activated eosinophils release potential tissue damaging superoxides, eicosanoids, major 
basic protein (MBP) and a range of cytokines and chemokines 29. Interestingly, eosinophilic 
inflammation and airway remodeling, have been reported in biopsies from young children, 
suggesting that these changes might be initiated, unexpectedly, early in life 30. Repetitive 
tissue damage due to chronic airway inflammation is associated with substantial thickening 
of the airway wall and may account for severe airflow obstruction and decline in lung 
function, as observed in established asthma. Airway wall remodeling includes epithelial 
fragility, goblet cell metaplasia and submucosal gland enlargement, increased deposition of 
extracellular matrix proteins (tenascin, fibronectin, and type I, III and V collagen) and 
increased smooth muscle mass index 31. In addition, the mitotic activity of the airway 
epithelium, required for restoration of the denuded place, may be suppressed in patients 
with asthma and may explain the abnormal repair response to injury 32. 
 
2.2. Role of the airway epithelium 
 
Airway epithelial cells make up the first line of defense against various particles and 
aeroallergens. The physical barrier function of the epithelium depends on the coordinate 
expression of tight junction (e.g. claudins, occludin, zonula occludens (ZO)-1, 2, 3) and 
adherens junction proteins (E-cadherin, β-catenin) 33. Most of the clinically relevant allergens 
have protease activity, degrading these transmembrane proteins to promote allergen access 
to the DC network underneath. Loss of E-cadherin for example has been described in 
biopsies from patients with asthma 34 and may facilitate allergic sensitization by modulating 
DC biology 35. 
The airway epithelium is pivotal in the development of immune responses in the lung (Figure 
4A). The unique interplay between epithelial cells and DCs is crucial for the induction of 
inflammatory disorders, such as asthma 36. Epithelial cells and DCs interact through the 
release of cytokines and other soluble compounds. CCL2 and CCL20 for example are 
produced by airway epithelial cells following environmental exposures and are known to 
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attract monocytes and immature DCs to the lung 37-39. In addition, airway epithelial cells 
express an array of pattern recognition receptors (PRRs) (TLRs, NOD-like Receptors, C-type 
lectins, Protease-activated receptors (PARs)), used to rapidly detect and respond to 
pathogens or their PAMPs; and to damage-associated molecular patterns (DAMPs), released 
upon cell damage or stress. Signalling through PRRs leads to NF-κB activation and the 
subsequent release of pro-inflammatory cytokines by airway epithelial cells. Hammad et al. 
demonstrated that epithelial activation of TLR4 in response to HDM or LPS drives the 
production of GM-CSF, thymic stromal lymphopoietin (TSLP), IL-25 and IL-33 40. These 
pleiotropic innate cytokines share the capacity to instruct DCs to mount Th2-mediated cell 
responses in the lung. TSLP and GM-CSF for example are key initiators of allergic airway 
inflammation. Neutralization of GM-CSF during sensitization, strongly reduced all salient 
features of HDM-induced asthma 41,42 and overexpression of both cytokines in the murine 
airway compartment induces Th2 sensitization to otherwise innocuous antigens 43,44. In 
addition, naive CD4+ T cells primed by TSLP-stimulated DCs produce the typical proallergic 
cytokines IL-4, IL-5 and IL-13 45. IL-25, also known as IL-17E, has been shown to regulate type 
2 immunity through its direct effect on TSLP-DC activated Th2 memory cells and directly 
stimulates activated memory cells to further differentiate into Th2 effector cells 46,47. 
Furthermore, IL-33, a member of the IL-1 family, interacts with the orphan receptor ST2, 
preferentially expressed on DCs, Th2 cells and mast cells. IL-33-activated DCs are crucial for 
T-cell proliferation and Th2 polarization in the draining lymph nodes 48. Also other members 
of the IL-1 family, such as IL-1α and IL-1β, are released by bronchial epithelial cells upon 
environmental exposures. Willart et al. showed that IL-1α, and to a lesser extent IL-1β, is 
sufficient to promote mucosal sensitization to inhaled protein allergens 42.  
 
In addition to the production of cytokines, DAMPs such as, uric acid (UA) and extracellular 
adenosine triphosphate (ATP) are increased in the airways of mice and asthmatic patients 
following persistent allergen exposure 49-51. Kool et al. demonstrated an important role for 
UA in mediating HDM-induced Th2 cell immunity through the production of innate cytokines 
(GM-CSF, TSLP and IL-25) and the recruitment of inflammatory DCs 49. Furthermore, Idzko et 
al. identified a crucial role for ATP in the process of Th2 sensitization. Administration of 
exogenous ATP to the murine lung induced a break of inhalation tolerance and the enhanced 
recruitment and activation of lung DCs 50.  
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The airway epithelium is not only crucial during mucosal sensitization. The dynamic changes 
of the epithelium due to persistent environmental insults, may alter epithelial-mesenchymal 
communication and may play an important role in airway wall remodeling 52 (Figure 4B). 
One of the early events in the so-called epithelial-to-mesenchymal transition (EMT) is the 
disassembly of tight junction proteins and the epithelial release of repair markers such as 
epithelial growth factor (EGF) and transforming growth factor (TGF)-β. EGF is a key cytokine 
in promoting goblet cell metaplasia 53, however other cytokines (IL-13, IL-25, IL-33) secreted 
from cells of the innate and adaptive immune system are also involved. TGF-β controls the 
proliferation of fibroblasts and their transdifferentiation into myofibroblasts, which promote 
the synthesis of extracellular matrix components, like collagen or fibronectin 54. 
 
2.3. Risk factors for allergic sensitization  
 
Endogenous as well as exogenous factors may affect the chance of being sensitized to 
common allergens. Host factors (atopy, gender, age, race) combined with environmental 
influences (environmental allergens, pollutants, infection history, birth order, diet, drugs, 
obesity) will determine the progression of asthma as a disease. 
Figure 4: Role of the airway epithelium during sensitization and airway wall remodeling. 
Arrows:              migration;             differentiation.  
Figure 4A by Lanckacker EA, based on Hammad et al. Nat Rev Immunol. 2008 Mar;8(3):193-204. 
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Genetic studies identified distinct regions within the human genome, closely associated with 
asthma, atopy and bronchial hyperresponsiveness. Gene variants on chromosome 17q21 
associated with the expression of ORMDL3, are linked with asthma susceptibility and early-
onset asthma, especially in the presence of environmental tobacco smoke (ETS) 55,56. 
Furthermore, variations within the TSLP and IL33 genes and within the IL1RL1 gene, 
encoding the IL-33 receptor, have shown associations with many atopic phenotypes 57,58. 
However, the relationship between allergy and atopy is rather complicated. Not everyone 
with atopy develops clinical manifestations of allergy and not everybody with clinical 
symptoms is atopic.  
 
Besides genetic factors, personal aspects such as age or gender, are known risk factors for 
asthma. Boys suffer more often from asthma than girls, whereas in adults the prevalence is 
reversed 59. Importantly, early childhood represents the ‘prime time’ for initial sensitization. 
Many reports already demonstrated the presence of allergen-reactive T-cells in cord blood, 
giving evidence for transplacental priming 60. Moreover, infant T cells are predominantly 
Th2-prone and neonatal APCs represent a relatively immature phenotype, explaining the 
increased risk for Th2 sensitization early in life 61. 
According to the hygiene hypothesis, a lack of early childhood exposure to infectious agents 
increases the risk for allergic disease 62. Exposure to microbes or their biological products 
(e.g. endotoxin/lipopolysaccharaide (LPS)) can protect against the development of atopy by 
skewing the Th1/Th2 balance away from the allergy-promoting Th2-cells. However, the 
hygiene hypothesis has been abandoned by most researchers as being too simplistic and 
failure of endogenous tolerance mechanisms, rather than a Th1/Th2 imbalance may be 
pivotal in the development of allergic disease 63. 
 
Enhanced susceptibility to allergic sensitization can be further attributed to environmental 
factors, such as the exposure to indoor or outdoor allergens (e.g. HDM, cockroach, cat, dog, 
mould vs. grass, weed, or birch pollens). Especially the role of HDM will be discussed 
extensively in Chapter 2.4.  
The risk for childhood asthma strongly depends on the level of allergen exposure. Reducing 
the indoor allergen dose or the frequency of allergen contact will lower the sensitization risk. 
However, there is no linear relationship between early allergen exposure and asthma 
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Figure 5: Risk for sensitization in relation to allergen concentration. 
Adapted from Holt et al. Nat Immunol. 2005 Oct;6(10):957-60. 
incidence. As illustrated in Figure 5 64, the sensitization risk increases with the allergen dose, 
until a plateau is reached. Beyond this level, a further increase in allergen concentration, 
rather reduces the potential sensitization risk. 
 
 
 
 
 
 
 
 
The sensitizing potential of numerous allergens not only depends on the quantity of the 
inhaled substance but also on the intrinsic properties of the allergen itself. Many of the 
common aeroallergens responsible for asthma development are proteases, including major 
HDM allergen Der p 1 or cat allergen Fel d 1. In addition, allergens with protease activity are 
able to mediate sensitization of non-protease proteins (e.g. pollen allergens) when 
simultaneously inhaled 65,66. Some allergens that lack protease activity can induce epithelial 
barrier dysfunction indirectly through the induction of the angiogenic cytokine vascular 
endothelial growth factor (VEGF) 67. Furthermore, anthropogenic climate changes, such as 
increases in CO2 concentration or surface temperature, may alter allergen production, 
distribution and allergenicity 68. Plants may vary their pollination calendar, advancing and 
prolonging their pollination period, with subsequent effects on the severity and prevalence 
of allergic disease 69,70.  
 
Other factors contributing to the onset or aggravation of allergic diseases are indoor or 
outdoor environmental pollutants (e.g. tobacco smoke, ozone, diesel exhaust). Particularly 
tobacco smoke has been shown to act synergistically with allergen exposure to induce or 
enhance immune regulated lung diseases. Hence, the role of CS in asthmatic disease will be 
fully discussed in Chapter 2.5.  
Furthermore, the causal relationship between proximity to roadways and asthma 71 is 
correlated with ozone 72 and/or diesel exhaust 73,74. Both the organic matter adsorbed to 
diesel exhaust particles (DEP) and the non-extractable carbon core are thought to be 
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responsible for the adjuvant effect 75. DEP can absorb aeroallergens, released by pollen 
grains, which may increase the allergen load in nose and lung 76,77. Moreover, several murine 
sensitization models using ovalbumin (OVA) or HDM (Der f) in the presence of DEP reveal an 
increase in antigen-specific IgG1 or enhanced pulmonary inflammation and goblet cell 
metaplasia 78,79. 
Both tobacco smoke as well as diesel exhaust particles are complex vectors of reactive 
oxygen species (ROS), polycyclic aromatic hydrocarbons (PAHs) and a myriad of other 
noxious xenobiotic compounds. The potential effects of PAHs and oxidative stress on 
pulmonary DCs and their impact on subsequent immune responses in the lung are 
extensively reviewed in Chapter 7. 
 
Finally, respiratory tract viruses or bacterial infections have emerged as the most frequent 
triggers for acute exacerbations in both children and adults. The role of viruses during 
asthma exacerbations is nicely reviewed by Jackson et al. 80,81. 
 
2.4. House dust mite allergens 
 
50 to 85 % of asthmatics are HDM allergic 82. In addition to asthma, other common allergic 
disorders such as rhinitis, rhinoconjunctivitis and atopic dermatitis are associated with HDM 
allergy.  
 
2.4.1. Our intimate associates 
 
The perennial indoor HDM Dermatophagoides pteronyssinus belongs to the taxonomical 
class of the Arachnida, subclass Acari and is more closely related to spiders, scorpions and 
horseshoe crabs than to insects. Dust mites are ubiquitous throughout humid areas of the 
world and are 8-legged as all acari are.  Their size can vary between 0.2 to 0.4 mm which is 
barely visible to the naked eye. During their life cycle, they transform from eggs to larva, 
protonymphs, tritonymphs and adults, with an optimal growth temperature around 25°C. 
Common HDMs feed on human skin flakes, with our bedroom as the focus of infestation 83-
85. 
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Mite bodies and mite feces are the predominant source of many allergens. Fecal pellets are 
composed of food, debris and proteolytic enzymes, bound together by mucus and covered in 
a chitinous peritrophic membrane. The average intact mite dropping is 10 – 40 μm in 
diameter which can be deposited in the conducting airways after inhalation 86. Allergens 
associated with mite fecal matter are enzymes that originate from the mite’s digestive tract. 
Other sources of allergens may be components of the mite saliva, or soluble proteins in their 
body fluids 84. 
 
2.4.2. House dust mite allergenicity 
 
Allergenicity is the property of being an allergen or being able to induce allergic 
sensitization.  Moreover, the ability of an allergen to induce IgE is a measure of the allergic  
Table 1: Characterized allergens of the HDM species D. pteronyssinus. 
Adapted from Gregory et al. Trends Immunol. 2011 Sep;32(9):402-11. 
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state. HDM fecal pellets contain many allergens with either proteolytic activity or enhanced 
TLR stimulatory capacity. D. pteronyssinus produces more than 20 different allergen groups, 
classified according to their sequence homology and biological function (Table 1) 87,88. Of the 
19 denominated allergens, the major IgE binding capacity has been reported for the group 1, 
2, 3, 7, 9, 11, 14 and 15 allergens.  
 
The first major mite allergen identified is Der p 1, a member of the group 1 allergens. Group 
1 allergens are cysteine proteases that share sequence identity with the catalytic site of the 
plant enzyme papain 89. Der p 1 cleaves intracellular tight junctions proteins, with putative 
proteolysis sites identified in occludin and claudin-1 90. Der p 1 can promote the PAR-2-
mediated release of proinflammatory cytokines, such as IL-6 and IL-8 91. Der p 1 allergens are 
ubiquitous in house dust.  Levels starting from 100 ng/g carpet dust are associated with 
increased sensitization risk 92.  
The second major HDM allergen Der p 2 does not possess intrinsic proteolytic activity, 
although recently found to be very allergenic. Trompette et al. demonstrated that Der p 2 
has structural and functional homology with MD-2, the chaperone protein necessary for 
TLR4 signalling. Der p 2 reconstituted the LPS-driven TLR4 activation in the absence of MD-2, 
suggesting the auto-adjuvant activity of Der p 2 93. This is of special importance for the lung, 
as airway epithelial cells express TLR4, but little or no MD-2 94. 
Der p 3, 6 and 9 represent the three HDM serine proteases which display tryptic, 
chymptryptic and collagenolytic activities, respectively. Together with group 1 allergens, 
they account for almost 79% of the proteolytic activity found in house dust 95. Similar to mite 
cysteine proteases, they induce increased epithelial permeability through the cleavage of 
occludin and ZO-1 96. 
Der p 7 and Der p 14 are lipid-binding proteins. They elicit strong IgE and T-cell responses in 
patients with mite allergy. Recently, Der p 7 is found to be similar to the LPS-binding protein 
which interacts with TLRs after binding LPS and other bacterial-derived lipid ligands 97. The 
discovery that group 7, as well as group 2 allergens, are structurally similar to different 
proteins in the TLR pathway, further strengthens the connection between dust mite 
allergens, innate immunity and allergy 87. 
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In addition to the diverse array of protein allergens, we should not underestimate the role of 
the non-protein compounds present in dust mites. HDM extracts are often contaminated 
with low endotoxin levels. Bartonella or other Gram-negative species are thought to be the 
source of this LPS content 98. Phipps et al. found that mice deficient for MyD88 or the LPS 
receptor TLR4, do not develop common features of allergic asthma 99. Recently, Hammad et 
al. elegantly demonstrated that TLR4, present on epithelial cells, activates Th2 cell immunity 
to HDM allergens, through the release of pro-innate cytokines 40. Together, these 
observations suggest an important role for the low LPS content present in dust mite extracts. 
The glucose-derived β-glucan moieties within HDM extract were shown to participate in the 
early events of allergic airway disease. β-glucan motifs stimulate epithelial cells to release 
CCL20, which is a major chemokine for the attraction of lung DCs 37.  
Also other contaminating products might regulate HDM-induced allergic disease. Chitin, a 
glucosamine-based polymer which is part of the mite exoskeleton, induces the accumulation 
of IL-4 expressing eosinophils and basophils in the murine lung 100,101. 
 
2.4.3. The use of HDM extract in experimental research: benefits and pitfalls 
 
The identification and isolation of mites from house dust, and the ability to grow them in 
culture, have led to the production of HDM extracts currently used in research. HDM 
extracts are made from an aqueous extraction of a variable mixture of whole mites, nymphs, 
fecal pellets, eggs and spent culture medium. Based on the number of proteins they contain, 
and based on the production methods they use, extracts are difficult to standardize. Since 
allergenicity originates from mites and their fecal pellets, only extracts containing high 
concentrations of both body and fecal allergens should be used in clinical testing and 
therapy. It is however possible that some allergens are highly abundant in the environment 
but poorly represented in the extracts. This could be due to a poor extraction process (e.g. 
due to hydrophobicity) or may be the result of protein lability. Der p 3, 7 and 14 for example 
are shown to be unstable in aqueous solutions 102. Furthermore, the complexity of HDM 
extracts makes it difficult to understand the contribution of the different HDM elements. 
Although it would be very interesting to clarify the function of each individual allergen, 
humans are not exposed to one single protein, but to a whole range of compounds. To 
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capture the full complexity of HDM allergens, we need to design preclinical mouse models, 
using HDM extracts in their entirety. 
 
The use of HDM to model asthma has some interesting benefits. HDM is one of the most 
important real-life allergens associated with allergic disease, and is clinically far more 
relevant than the previously used model innocuous antigen ovalbumin (OVA) 103. Some HDM 
proteins posses intrinsic Th2-promoting adjuvant activity and have the capacity to induce 
natural sensitization through the respiratory tract 104. Whereas prolonged OVA exposure 
induces inhalation tolerance rather than allergic inflammation 105, HDM can mimic the 
chronicity of human asthmatic disease. Johnson et al. described a murine model of 
intranasal HDM delivery for up to 7 weeks, showing sustained eosinophilic airway 
inflammation along with severe structural changes of the airway wall (goblet cells, collagen 
deposition, increased smooth muscle content) 106.  
 
2.5. Cigarette smoke exposure 
 
Smoking is one of the most common addictions of modern times and a risk factor for 
respiratory diseases like asthma and COPD.  Although the devastating health impact of CS is 
well known, over 1 billion people continue to smoke. 
  
2.5.1. Introduction 
 
CS is an aerosol of liquid droplets (particulate phase) suspended within a mixture of gases 
and semi-volatile compound (gaseous phase). More than 4000 chemicals have been 
identified within CS, including carcinogens (PAHs, tobacco specific nitrosamines, acrolein), 
noxious gases (CO, NOx) or toxic compounds (nicotine, acetone) 107,108.  
Two different emissions can be distinguished, both with different composition and 
properties. Mainstream cigarette smoke is the smoke actually drawn into the mouth during 
puffs (active smoking), whereas sidestream smoke is released from the smoldering end of 
the cigarette. Additionally, the term environmental tobacco smoke (ETS) is used as a mixture 
of sidestream smoke and exhaled mainstream smoke after dilution and aging. Inhalation of 
ETS is called ‘unvoluntary’ or passive smoking 109.  
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2.5.2. Epidemiology of cigarette smoking and asthma ¥ 
 
CS is a major risk factor for the promotion or aggravation of asthmatic disease. However, 
due to differences in composition, the impact of ETS and active smoking on allergic 
sensitization and ensuing asthma development, may differ to some extent. 
 
A large body of evidence establishes a link between ETS exposure and the increased risk for 
asthma development 110,111. Both in utero maternal smoke exposure 112 as well as early 
postnatal exposure 113 or any parental smoking at home significantly increases the risk of 
developing asthma later in life 112,114. The risk for childhood asthma, wheeze or chronic 
cough even increases with the number of parents who smoke 115.  
The relationship between allergic sensitization and ETS exposure is however, less evident 
116,117. ETS exposure promotes the induction of Th2 cytokines in the nasal fluid of allergic 
patients 118, and increases the sensitization risk in children where both parents are allergic 
119. Furthermore, ETS exposure is dose-dependently correlated with greater asthma severity, 
diminished lung function and poorer asthma control, both in children 120,121 and adults 122-124. 
 
Unlike ETS, the impact of active smoking on asthma development is more controversial. 
Active smoking increases asthma prevalence 125,126 and the risk of new onset asthma 127, 
especially among patients with allergic rhinitis 128,129 and those adults exposed to maternal 
smoke in utero 130. Current smoking is associated with increased disease severity 131, higher 
severity scores 132 and less controlled asthma 133-135. Moreover, smoking asthmatics have an 
accelerated decline in lung function, which may improve after smoke cessation 136. Finally, 
current smokers have an increased risk for the sensitization to HDM allergens, but not for 
grass pollen or cat allergens 137. 
 
The clinical manifestations and inflammatory responses between smoking asthmatics and 
patients with COPD may, in some individuals, overlap. In addition, a long duration of asthma 
and a high pack year smoking history may ultimately result in the development of COPD.  
 
 
¥ Based on ‘Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway 
inflammation.’ Maes T, Provoost S, Lanckacker EA, Cataldo DD, Vanoirbeek JA, Nemery B, Tournoy KG, Joos GF. 
Respiratory Research. 2010;11:7. 
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2.5.3. Animal models of cigarette smoking and asthma 
 
In contrast to the clinical relevance, most animal models of asthma used to rely on OVA as 
“surrogate” allergen. OVA is no naturally occurring allergen and is not associated with any 
form of asthma in real life, however most of the insights regarding the mechanisms 
underlying asthmatic disease, result from mouse models of OVA-induced experimental 
asthma.  
 
Murine models, investigating the role of CS (ETS versus active smoking) on asthma 
pathogenesis, discriminate between the impact on sensitization and asthma development or 
aggravation. Results from animal models with 138,139 or without 140-143 prior sensitization to 
OVA, all agree that ETS exposure may facilitate allergic sensitization, as demonstrated by 
increased serum IgE, eosinophil counts, Th2 cytokines, airway hyperresponsiveness and/or 
the development of a memory response 140. However, the role of active smoking as an 
adjuvant for allergic sensitization in mice is less univocal. Some studies indicate that active 
smoking may break inhalation tolerance to OVA 144-146, whereas others do not 146,147. In 
addition, different animal studies have demonstrated a role for ETS in the development 
138,139 or aggravation of “established” asthmatic disease 148. In utero maternal ETS exposure 
aggravated subsequent adult responses to OVA 143. In contrast to the reports on ETS, the 
results of active smoking on the development and aggravation of asthma are again 
controversial 147,149-154, probably because of the dose-dependent effect of CS as adjuvant or 
anti-inflammatory agent 146,151. 
 
As we learned from Chapter 2.4, real-life allergens such as HDM, are far more complex than 
OVA, which is a single chicken egg protein. The difference in biochemical and immunogenic 
character between OVA and common aeroallergens may have an impact on the nature of 
the elicited allergic response and may even impact the relevance of the murine asthma 
model. Recently, a few animal studies already used HDM in combination with CS. Botelho et 
al. demonstrated an attenuated effect of CS on “established” HDM-induced asthma 155, 
whereas Blacquière et al. showed that maternal smoking during pregnancy induces airway 
remodeling in HDM-exposed adult mice offspring 156.  
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3.1. Introduction 
 
Chronic obstructive pulmonary disease (COPD) is a major cause of illness and death 
worldwide. The disease affects about 10% of the general population and is predicted to be 
the third leading cause of death by 2030 19.  
COPD is a chronic inflammatory condition, characterized by progressive and poorly 
reversible obstruction of the smaller airways of the lung. Patients suffering from COPD 
experience abnormal sputum production, chronic cough, wheezing and shortness of breath. 
Cigarette smoking is by far the most important risk factor for the development of the 
disease, however only 20 to 30% of heavy smokers develops COPD, suggesting that genetic 
factors might be important during the disease process 157. 
Despite similarities of some clinical features between asthma and COPD, there is a marked 
difference in the location and pattern of inflammation, linked to differences in the 
immunological mechanisms underlying the disease, and differences in therapy. 
Typical hallmark features of COPD pathophysiology include chronic inflammation, lymphoid 
follicle formation, emphysema and airway wall remodeling (Figure 6).  
 
Figure 6: Immunological aspects of chronic obstructive pulmonary disease.  Figure by Lanckacker EA. 
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3.1.1. Pulmonary inflammation in COPD 
 
The inflammatory disease pattern observed in smokers and patients with COPD is diverse in 
many respects. The accumulation of inflammatory components appears to contribute to 
lung injury and serves as a self-perpetuating stimulus for further immune activation. The 
cellular composition of the infiltrates varies among patients, but there is typically an 
accumulation of macrophages, neutrophils, CD8+ cytotoxic T cells, and to a lesser extent 
CD4+ Th1 lymphocytes 158. 
 
Macrophages orchestrate the inflammation in COPD through the release of chemokines, 
attracting neutrophils (chemokine CXC ligand (CXCL)-1, CXCL-8), monocytes (CCL2) and T 
lymphocytes (CXCL9, CXCL10, CXCL11) to the airways and lungs (Figure 6). Moreover, 
macrophages release a whole repertory of proteolytic enzymes (matrix metalloproteinase 
(MMP)9, MMP12, cathepsins) suggesting a potential role during tissue damage and 
emphysema 159. Increased numbers of activated neutrophils are found in sputum from 
smokers and patients with COPD. Neutrophils are a potent source of inflammatory 
mediators, including ROS and tissue destructive proteases, such as neutrophil elastase, 
MMPs or cathepsin G. Neutrophil proteases may contribute to alveolar destruction and are 
potent stimuli of mucin production and secretion 160,161. Upon the release of CXCL-9, -10 and 
-11 by macrophages, T lymphocytes (which are predominantly CD8+ cytotoxic T-cells (Tc)) 
accumulate in the airways and lungs. Lung CD8+ T cells may contribute to the progression of 
COPD through the release of cytolytic enzymes (perforin, granzyme B) responsible for 
apoptosis or necrosis of structural cells (e.g. epithelial and endothelial cells) 162,163. Although 
less abundant, CD4+ Th1 lymphocytes are also found in smokers with COPD, and at least two 
subtypes have been found. CD4+ Th1 cells are largely responsible for the production of high 
levels of the Th1-typical cytokine interferon (IFN)-γ, whereas CD4+ Th17 cells regulate tissue 
inflammation by producing IL-17A and IL-17F. 
 
3.1.2. Lymphoid follicles in COPD 
 
Lymphoid neogenesis refers to the development of organized lymphoid structures which act 
as secondary lymphoid organs during sustained chronic inflammation. Lymphoid follicles are 
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associated with severe COPD and are known to participate in adaptive humoral and T cell 
mediated responses to antigen 164,165.  
 
Lymphoid tissue formation is the result of a highly coordinated interplay between 
inflammatory cells, resident stromal cells, adhesion molecules, chemokines and cytokines 
(Figure 6). Upon chronic inflammation, activated lymphocytes express lymphotoxin-α1β2 
(LTα1β2) on their surface membrane. Binding of LTα1β2 to the respective lymphotoxin-β 
receptor (LTβR) on neighbouring stromal cells (probably fibroblasts or fibroblast precursors), 
induces the expression of adhesion molecules (intercellular adhesion molecule (ICAM)-1, 
VCAM-1) and chemokines 166,167. Homeostatic lymphoid chemokines orchestrate lymphocyte 
homing and compartimentalization of the lymphoid organ. CCL19 and CCL21 attract CCR7+ T 
lymphocytes and mature DCs to the T cell zone of the follicle, whereas CXCL13 attracts 
CXCR5+ B cells and is involved in germinal centre formation. Persistent chronic inflammation 
will stimulate lymphoid aggregates to become highly organized lymphoid follicles, with 
follicular DCs, Ig-producing plasma cells, and high endothelial venules, which allow the 
additional supply of naïve lymphocytes 168. 
 
It is however not clear yet, whether lymphoid follicles are beneficial or not. Lymphoid 
follicles may develop as a local back up mechanism to protect against infectious agents or 
may be a source of auto-antibodies, maintaining the ongoing inflammatory response 165.  
 
3.1.3. Airway wall remodeling and emphysema in COPD 
 
Whereas in asthma, remodeling is mainly located in the larger airways of the lung, it 
predominantly affects the smaller airways and the alveolar wall in COPD patients. Especially 
peripheral airway wall fibrosis, goblet cell metaplasia and emphysema can be distinguished. 
Emphysema is the abnormal enlargement of air spaces in the lung and results from 
destruction of tissues supporting the alveolar wall (elastin breakdown) 169. Destruction of 
lung parenchyma may be the result of an imbalance between proteases and antiproteases. 
As a clinical outcome, emphysematous lung destruction reduces maximal expiratory airflow 
by decreasing the natural elastic recoil force that drives the air out of the lungs 170.  
 
39
 
40 
3.2. Exacerbations 
 
The natural history of COPD is typically interrupted by acute exacerbations or acute 
aggravation of symptoms. Exacerbations accelerate the decline in lung function, resulting in 
reduced physical activity, poorer quality of life and an increased risk of death.  
Despite the importance of exacerbations, we know relatively little about their incidence, 
their determinants and their immunological effects in COPD. 
 
Exacerbations are usually triggered by either bacterial or viral respiratory tract infections. 
The most commonly isolated bacterial species are nontypable Haemophilus influenzae, 
Streptococcus pneumonia and Moraxella catarrhalis. The major respiratory viruses 
associated with COPD exacerbations are rhinovirus, influenza or respiratory syncytial virus 
(RSV) (Table 2) 171.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Microbial pathogens in COPD.  
Adapted from Sethi et al. N Engl J Med. 2008 Nov 27;359(22):2355-65. 
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Approximately 25% of patients with stable COPD show bacterial colonization of the lower 
respiratory tract, and even higher bacterial counts (50%) are observed during acute 
exacerbations 172.  
The reason for the increased incidence of pulmonary bacterial colonization in patients with 
COPD may be failure of their macrophages to clear pathogens due to reduced phagocytic 
capacity 173,174. Moreover, inflammatory mucus exudates present in the airways of patients 
with COPD, are the ideal soil for bacterial colonization and growth. 
 
COPD exacerbations are associated with increased pulmonary and systemic inflammation. 
Almost all COPD exacerbations are marked by increased sputum neutrophilia, and, or 
eosinophils during viral infections. The presence of microbial PAMPs due to invading 
pathogens, increases the expression of PRRs, which may lead to a subsequent increase of 
neutrophils. Furthermore, a specific antibody response will be generated, characterized by 
increased production of serum IgG and tissue-local production of protective mucosal IgA 158. 
 
3.3. Disease modifying role of Staphylococcus aureus enterotoxins 
 
Although bacterial Staphylococcus aureus (S. aureus) has only infrequently been isolated 
from the airways of patients with COPD exacerbations (Table 2), significantly increased 
levels of IgE antibodies against S. aureus enterotoxins have been identified in serum 175. 
Therefore, the role of these superantigens, as potential aggravating factor of COPD 
pathogenesis, might be underestimated. 
 
S. aureus is an opportunistic pathogen, which is part of the normal microflora of the human 
skin and upper respiratory tract. About 25% of healthy persons may be persistently or 
transiently colonized. Although nasal carriage is a predictor for staphylococcal infections, 
colonization does not ordinarily cause disease 176. Especially impaired mucosal barrier 
function, due to injury of environmental insults, creates the “opportunity“ for the pathogen 
to infect 177. Once they are infiltrated, S. aureus strains secrete a number of pyrogenic toxins, 
known as superantigens because of their potent immunostimulatory effects. Unlike 
conventional antigens, they bind to MHCII molecules outside the antigen-binding groove and 
are presented as unprocessed proteins to certain T cells expressing specific T-cell receptor 
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(TCR) Vβ genes (Figure 7). As a consequence, superantigens stimulate up to 20% of T cells 
while only 1 in 105-106 cells are activated upon normal antigen presentation. Among the 19 
different exotoxins synthesized and released by S. aureus, toxic shock syndrome toxin-1 
(TSST-1) and enterotoxins A, B, C, D and E are the best known 178,179. 
 
 
 
 
 
 
 
 
 
 
Clinical evidence for a role of S. aureus enterotoxins (SEs) in skin and airway allergies have 
been well documented. Atopic dermatitis patients are frequently colonized with S. aureus 
and the presence of enterotoxin specific antibodies is positively correlated with disease 
severity 180,181.  
Also in patients with chronic rhinosinusitis, an increased colonization rate of S. aureus has 
been found, especially in patients with nasal polyps 182. Remarkably, 40% of nasal polyposis 
patients develops lower respiratory tract conditions later in life, mainly severe asthma. 
Recently, the group of Bachert et al. hypothesized a possible causal role for S. aureus 
enterotoxin IgE, instead of allergenic IgE, as a risk factor for the development of severe 
asthmatic disease in nasal polyposis patients 183. 
 
Experimental data have suggested S. aureus enterotoxins as disease modifying agents. As 
shown by in vitro studies, SEB exerts a direct pro-inflammatory effect on human nasal 
epithelial cells (HNEC). SEB stimulation of freshly isolated HNECs, induces chemokine (e.g. 
CCL-2) and growth factor release (e.g. GM-CSF), resulting in the recruitment and prolonged 
survival of granulocytic cells 184. Furthermore, SEB drives the maturation of human 
monocyte-derived DCs and promotes Th2 cell polarization, probably through TLR2 signaling 
185,186. 
Figure 7: Presentation of conventional antigens versus superantigens. 
Figure by Lanckacker EA, based on Papageorgiou et al. Structure 1997 Aug 15;5(8):991-6. 
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Using in vivo animal studies, S. aureus enterotoxins were shown to aggravate allergic airway 
inflammation in mice 186,187. Moreover, SEB is able to facilitate allergic sensitization to the 
innocuous antigen OVA. Concomitant inhalation of SEB and OVA augmented DC migration 
and maturation as well as enhanced allergen-specific T lymphocyte proliferation 188. 
However, the disease modifying role of S. aureus enterotoxins in CS-induced pulmonary 
diseases has not been investigated yet. 
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In the past, animal models have been useful to provide valuable insights regarding the 
mechanisms of a disease or to predict the safety and efficacy of potential therapeutic drugs. 
To be clinically relevant, animal models need to mimic the pathogenesis, as well as the 
heterogeneity of the underlying disease. Phenotypic heterogeneity mainly results from the 
complex environment we are exposed to, with the emphasis on bacteria, viruses and 
ambient air pollution. However, most of the current animal models, mimicking asthma or 
COPD, do not account for this complexity/do not reflect what happens during natural 
exposure when atmospheric pollution mixtures are inhaled. It is thus a challenge to improve 
the clinical relevance of existing animal models, using combined exposures. Such 
combination models will be valuable tools to unravel potential synergistic effects between 
different environmental compounds and to study how these compounds may impact the 
underlying disease (heterogeneity). 
 
The aims of this thesis were four-folded: 
 
i. The role of cigarette smoke in the development of ovalbumin-induced asthma in 
mice: In our lab, Moerloose et al. already established a murine model, in which 
cigarette smoke (CS) exposure facilitates primary allergic sensitization to an 
otherwise innocuous antigen, ovalbumin (OVA). We wanted to elucidate the impact 
of CS on innate immunity and focused on the key innate immune sensors of the lung, 
the airway DC.  Furthermore, we hypothesized a role for the endotoxin-like effects 
of CS as an adjuvant to facilitate airway sensitization in mice and explored a 
possible role for the TLR4 – MyD88 pathway in our model.  
 
ii. The role of cigarette smoke in the development of house dust mite induced-allergic 
asthma – development of a mouse model: Epidemiological studies designate 
cigarette smoke (CS) as a major risk factor for the development of asthma in children 
and adults. Hence, we hypothesized that CS may facilitate the allergic sensitization 
to common real-life aeroallergens. In a first step, we aimed to design a clinically 
relevant mouse model, using low doses of HDM as common indoor allergen, 
combined with CS as major indoor pollutant. Such a combination model may be very 
useful to investigate how CS adversely affects allergic immune responses in the lung 
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and how it may impact asthma therapy. In a second step, we tried to elucidate the 
relative contribution of CS during both sensitization and ensuing asthma 
development. Thirdly, we investigated whether a very short smoke exposure is 
sufficient to induce sensitization towards HDM allergens. And finally, we aimed to 
unravel the impact of short CS exposure on the airway dendritic cell (DC).  
 
iii. The role of the respiratory epithelium during cigarette smoke-induced facilitated 
sensitization and asthma development in mice – preliminary report: Epidemiological 
studies, as well as mouse models of asthma, already revealed a crucial role for the 
airway epithelium in asthmatic disease. Because CS acts as a predisposing factor for 
asthma, we hypothesized a role for the airway epithelium during CS-induced 
facilitated sensitization and disease progression. In a first step, we wanted to 
investigate changes in epithelial barrier function after short CS inhalation during 
primary allergen contact. In a second step, we aimed to elucidate the role of the IL1RI 
signaling pathway during enhanced early sensitization, whereas finally, we aimed to 
unravel the role for danger-associated molecular pattern molecules during CS-
induced facilitated asthma development. 
 
iv. The disease modifying role of bacterial superantigens in CS-induced pulmonary 
inflammation – development of a mouse model: Although Staphylococcus aureus (S. 
aureus) is only infrequently isolated in COPD patients, Rohde et al. identified 
significantly increased levels of IgE antibodies against S. aureus enterotoxins in serum 
of patients with COPD. Hence, we hypothesized a role for S. aureus enterotoxin B 
(SEB) as potential aggravating factor of COPD pathogenesis. We aimed to design a 
novel murine model of concomitant exposure to CS and SEB and to investigate the 
impact of SEB on CS-induced pulmonary and systemic inflammation as well as 
lymphoid follicle formation and the induction of goblet cells. Such aggravation 
models may be very useful to elucidate immunological changes during acute 
exacerbations of COPD. 
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5.1. The development of combined exposure models 
 
5.1.1. Murine model of CS-induced inflammation  
 
Our research group developed a murine CS-exposure model, closely mimicking the 
important hallmark features of COPD (Chapter 3). All combination models used in the thesis 
are based on this CS exposure protocol 1-3. For the detailed description, see Chapter 5.2.1. 
 
5.1.2. Murine model of concomitant OVA and CS exposure 
 
In our lab, Moerloose et al. already established a mouse model in which simultaneous 
inhalation of aerosolized OVA (grade III, Sigma-Aldrich, Bornem, Belgium) together with CS, 
induces features of allergic airway inflammation. To answer the research questions 
described in the aims of the thesis (Chapter 4.i), experiments were based on this 
combination model. For detailed information about the design of the protocol, we refer to 
the paper of Moerloose et al 4. 
 
5.1.3. Murine model of simultaneous HDM and CS exposure 
 
To unravel the impact of CS on the different stages of asthma pathogenesis, we designed a 
clinically relevant combination model of HDM and CS, based on current protocols. 
The majority of the HDM-driven asthma models used today, are based on work published by 
Jordana et al. The intranasal administration of HDM extract (25 μg protein/10 μl saline) once 
a day, 5 days/week for up to several weeks, mimics asthma-like lung inflammation 5 as well 
as the chronicity of the disease 6. However, the daily application of HDM makes it difficult to 
distinguish between the sensitization or allergen challenge phase. More recently, Hammad 
et al. described an acute HDM exposure model (100 μg protein/40 μl saline) with clear 
contrast between the different phases of asthma development (HDM sensitization on day 0, 
allergen challenge on days 7 and 14) 7. Hence, we based our combination model on the 
protocol of Hammad et al. but opted to instill 4 times less HDM (Greer Laboratories, Lenoir, 
NC,USA) in order to evaluate potential aggravating effects upon concomitant CS inhalation. 
Th2-prone Balb/c mice were used to set up the combination model. Because Balb/c mice are 
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considered to be more sensitive to CS than C57Bl/6 mice, we decided to lower the intensity 
of our classic CS exposure protocol (Chapter 5.2.1) (3 instead of 4 times, 5 cigarettes/day). 
Depending on the research aims (Chapter 4ii, 4iii), the duration of the exposure period 
varied from 3 to 17 days.   
 
5.1.4. Murine model of combined SEB and CS exposure 
 
To investigate the role of SEB on CS-induced inflammation, we based our model on the 
publication from Hellings et al, studying the effect of SEB on allergic airway inflammation 8. 
The dose of SEB, chosen for our protocol, was in line with dosing experiment by Hellings et 
al.  Pilot studies, carried out with nasal or bronchial applications of 5, 50 and 500 ng SEB, 
demonstrated that 500 ng SEB potently altered bronchial inflammation without clinical signs 
of wasting disease. Hence, 500 ng SEB (10 μg/ml) (Sigma-Aldrich, Bornem) was chosen to set 
up this model. Starting from week 2 of the classic CS exposure protocol (Chapter 5.2.1.), SEB 
was administered intranasally (see Chapter 5.2.2.) in C57Bl/6 mice on alternate days. 
 
5.2. Methodology 
 
5.2.1. CS-exposure protocol 
 
Practically, 8 to 10 mice are placed in a plexiglass chamber (7500 cm3) and are subjected to 
whole body mainstream CS of 5 simultaneously lit Kentucky Reference cigarettes (2R4F or 
3R4F without filters, University of Kentucky, Lexington,KY). This procedure is repeated 4 
times a day and is interrupted by a 30 minute smoke free interval to mimic the typically 
interrupted smoking pattern, observed in human smokers. Because mice do not tolerate 
undiluted CS, an optimal smoke:air ratio of 1:6 is obtained during the whole protocol. The 
CS-exposure model is classically performed in non-atopic C57Bl/6 mice, regarded as a Th1 
dominant mouse strain with moderate sensitivity to CS. 
The serum carboxyhemoglobin levels of CS exposed mice (8.35 ± 0.46% vs. 0.65 ± 0.25% in 
air exposed mice)9 are comparable to those measured in human smokers 10 or young 
children exposed to secondhand CS 11. Furthermore, 4 weeks of CS exposure are sufficient to 
mimic CS-induced pulmonary inflammation, as observed in human smokers. However, the 
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typical characteristics of COPD pathogenesis, including emphysema, lymphoid follicle 
formation and airway wall remodeling, are obtained after a more chronic exposure period of 
24 weeks.  
 
5.2.2. Intranasal instillation 
 
The intranasal application of HDM or SEB is performed in isoflurane (Forene, Abbott, Wavre, 
Belgium) anesthetized mice, using a continuous flow vaporizer (Harvard Apparatus, 
Edenbridge, UK) (Figure 8A). The mice are manually restrained with the tail anchored 
between the small finger and the palm and are held in a supine position with the head 
elevated (Figure 8B). The end of the micropipette is placed at the external murine nares and 
the solution is poured in slowly, causing a rapid increase of the breathing rate. A delivery 
volume of 35 à 40 μl is known to give a maximum distribution of fluid in the lungs, with 
increasing volumes resulting in greater relative dosing to the lungs 12. As illustrated in Figure 
8C, 40 μl of cardio green (Sigma-Aldrich, Bornem) nicely deposited in the different lobes of 
the lungs.  
 
 
 
 
 
 
 
 
 
A 
Figure 8: Intranasal instillation of isoflurane anesthetized mice. 
A. Isoflurane flow vaporizer; B. Intranasal instillation; C. Cardio green deposition in the lungs. 
C B 
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5.2.3. Experimental techniques 
 
After completion of the exposure protocol, murine blood and tissue samples are collected 
and processed to study pulmonary and systemic manifestations. An overview of the 
collected tissues and their applications is illustrated in Figure 9, followed by a short 
introduction of the applied techniques. More detailed information about the following 
techniques can be found in the Methods section of the original research work (Chapter 6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.3.1. Blood 
 
Blood is collected from the retro-orbital sinus, located behind the murine eye, and is used to 
detect specific antibody activity by means of serum immunoglobulins.  
 
Figure 9: Overview of the murine samples collected during the endpoint. 
Figure by Lanckacker EA 
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5.2.3.2. Bronchoalveolar lavage 
 
To obtain inflammatory cells from the bronchial and alveolar zones of the lung, we 
performed bronchoalveolar lavage. Practically, a tracheal cannula is inserted and a salt 
solution is instilled and withdrawn gently, resulting in 2 fractions. After centrifugation, the 
cell-free supernatant of the first fraction is stored to assess cytokine levels by means of ELISA 
(enzyme-linked immunosorbant assay) or multiplex assays (Merck Millipore, Brussels, 
Belgium) (CBA, Becton Dickinson, Erembodegem, Belgium), whereas the cell pellets of the 
first and second fraction together are used to enumerate and differentiate cells by means of 
cytospin (Figure 10) and flow cytometry (Chapter 5.2.2.5).  
 
 
 
 
 
 
 
 
 
 
 
 
Cytospins stained with May-Grünwald-Giemsa (Sigma-Aldrich, Bornem) (VWR, Leuven) are 
used to perform differential cell counts, based on standard morphological criteria of the 
cells. Macrophages are large mononuclear cells with abundant cytoplasm, enriched with 
numerous cytoplasmic granules. Neutrophils, also called polymorphonuclear neutrophilic 
leukocytes, have a fragmented multi-lobed nucleus (usually three fragments), with barely 
stained cytoplasm after May-Grünwald Giemsa. Eosinophils are characterized by their 
doughnut-shaped nucleus and their pink cytoplasm, indicative of eosinophilic granules. 
Lymphocytes are generally smaller than the previous leukocytes and have a rather big 
round-shaped nucleus with a high nuclear to cytoplasmic ratio (Figure 10). 
 
Figure 10: Cytospins of BAL fluid stained with May-Grünwald-Giemsa. 
1. macrophage; 2. neutrophil; 3. eosinophil; 4. lymphocyte. 
1 
2 
1 
3 
4 
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5.2.3.3. Single cell suspensions 
 
To perform lymph node cultures (Chapter 5.2.2.4) or flow cytometry (Chapter 5.2.2.5) of the 
lungs, single cell suspensions are required. Practically, removed tissues are incubated with 1 
mg/ml collagenase type 2 (Worthington Biochemical, Lakewood, NY) and 0.02 mg/ml DNase 
I (grade II from bovine pancreas, Boehringer Mannheim, Brussels, Belgium) for 45 min at 
37°C and 5% CO2. Red blood cells are lysed using ammonium chloride buffer () and finally, 
cell suspensions are filtered through a 50 μm nylon mesh to remove undigested organ 
fragments.  
 
5.2.3.4. Lymph node culture 
 
To determine the cytokine expression profile within lung draining lymph nodes, mediastinal 
lymph nodes (Figure 9) are removed and digested as described before (Chapter 5.2.2.3). 2 x 
105 cells are cultured in 96-well plates, with or without  15 μg HDM extract/ml culture 
medium. After 5 days in a humidified 5% CO2 incubator at 37°C, culture supernatant is 
harvested to measure typical Th1, Th2 or Th17 cytokines. 
 
5.2.3.5. Flow cytometry 
 
Flow cytometry is a technique used to characterize different cell populations based on cell-
specific phenotypic markers, on or inside the cell. Briefly, antibodies conjugated to 
fluorescent dyes are used to label specific markers on each single cell. When laser light of 
the flow cytometer strikes the fluorescent dye, a fluorescent signal with a certain 
wavelength (read: ‘color’) is emitted and measured by the flow cytometer.  
 
To perform flow cytometry, single cell suspensions  from BAL or the third lobe of the right 
lung (see Chapter 5.2.2.3) are pre-incubated with FcR-blocking antibody (anti-CD16/CD32, 
clone 2.4G2) to minimize non-specific binding of the antibodies. The combination of various 
cell-specific monoclonal antibodies with different fluorescent dyes, allows researchers to 
fully characterize differential cell populations within BAL and lung.  
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The cells described in the thesis are characterized as illustrated in Figure 11. Macrophages 
are defined as high autofluorescent, CD11c+cells (Figure 11A). DCs are low autofluorescent, 
CD11c+ MHCII+ cells and CD11b+ or CD11b- DCs can be distinguished (Figure 11B). T-
lymphocytes are characterized as small, CD3+ cells and various subpopulations exist. In this 
thesis, we identify CD4+ and CD8+ T-lymphocytes in BAL and lung and we further characterize 
the activation status of lung T-cells using CD69 as activation marker (Figure 11C). 
 
 
 
 
5.5.3.6. Lung homogenate 
 
Lung tissue homogenates are prepared to determine the cytokine profile of the lung by 
means of ELISA or multiplex. Practically, the middle lobe of the right lung is minced 
mechanically (TissueRuptor, Qiagen, Hilden, Germany) into 1 ml T-Per tissue protein 
Figure 11: Gating strategy for the characterization of inflammatory cells in BAL and lung. 
A: macrophages; B: CD11b+ DCs; C: CD4+ and CD8+ T-lymphocytes, activated (CD69+) or not (CD69-). 
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extraction reagent completed with 10 μl Protease Inhibitor Cocktail Kit (Thermo Fisher 
Scientific, Waltham, MA, USA). The total protein concentration is defined using the Bradford 
protein assay (Bio-Rad Laboratories, Hercules, CA, USA) and lung homogenates are diluted 
until a final protein concentration of 500 μg/ml is attained. 
 
5.5.3.7. Real time RT-PCR 
 
Real-time reverse transcriptase (RT)-PCR has proven to be a powerful tool to quantify gene 
expression profiles. Briefly, total lung mRNA is extracted from the first lobe of the right lung, 
using the RNeasy Mini kit (Qiagen, Hilden, Germany). The expression of IL-13, MIP-3α, 
CXCL13, CCL19 or CCL20 mRNA relative to the housekeeping gene Hprt (hypoxanthine 
guanine phosphoribosyl transferase) is analysed, using Assay-on-Demand gene expression 
products (Applied Biosystems, Halle, Belgium) or custom designed probes synthesized on 
demand 13. RT-PCR is performed on a LightCycler 480 Instrument (Roche Diagnostics, Basel, 
Switzerland) with murine leukemia virus reverse transcriptase (Applied Biosystems, Halle) 
under previously described conditions 13,14. 
 
5.5.3.8. Histological evaluation 
 
After the left lung is fixed in 4% paraformaldehyde (Klinipath, Olen, Belgium) and embedded 
in paraffin, transversal sections of 3 μm are subjected to chemical (periodic acid-Schiff (PAS), 
Congo Red, toluidin blue staining) or immunohistochemical stainings (α-smooth muscle 
actin, E-cadherin, hyaluronic acid, CD3/B220 double staining).  
Quantitative measurements are performed in a blinded fashion, using a Zeiss KS400 Image 
Analyzer (Oberkochen, Germany). The following morphometric parameters are marked 
manually on the digital representation of the airway (Figure 12): the length of the basement 
membrane (Pbm), the area defined by the basement membrane (Abm), and the area defined 
by the total adventitial perimeter (Ao). Furthermore, the total bronchial wall area (WAt) is 
calculated as WAt = Ao – Abm and normalized to the square length of the Pbm. All airways 
with a 800 μm < Pbm < 2000 μm and cut in reasonable cross-sections (defined by a ratio of 
minimal to maximal internal diameter > 0.5) are included. Measurements are performed on 
at least 5 airways per mouse. 
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Goblet cells are quantified after PAS staining (Klinipath, Olen) and the number of PAS-
positive cells are expressed per millimeter Pbm. Peribronchial infiltration of eosinophils is 
evaluated after Congo Red (Klinipath, Olen) staining and determined as the total number per 
mm2 bronchial wall area (WAt). Mast cells are highlighted after toluidin blue staining (Fluka, 
Bornem) and counted per field (whole left lung lobe). Quantification of α-smooth muscle 
actin (Abcam, Cambridge, UK), E-cadherin (BD Biosciences, Erembodegem, Belgium) or 
hyaluronic acid deposition (Seikagaku, Tokyo, Japan) within the airway wall is performed 
using color recognition, determined by the KS400 software and normalized to Pbm. To 
quantify lymphoid follicles, lung sections are immunostained with a CD3/B220 double-
staining (DAKO, Heverlee, Belgium) (BD, Erembodegem, Belgium). Dense accumulations of 
at least 50 cells are defined as lymphoid follicles and their number is normalized for the 
amount of bronchovascular bundles per lung section. 
Figure 12: Morphometrical parameters defined on a digital representation of the airway.  
AW: airway; BV: blood vessel; Pbm: perimeter basement membrane; PAt: total adventitial 
perimeter; Abm: area defined by the basement membrane; Ao: area defined by the total 
adventitial perimeter; WAt: total bronchial wall area. 
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5.5.3.9. Pulmonary resistance 
 
Airway hyperresponsiveness is a characteristic feature of asthma and implies an increased 
responsiveness of the airways to a provocative agent. In mice, airway resistance can be 
measured using direct triggering agents, e.g. carbachol 15. Carbachol is a muscarinic receptor 
agonist, which directly binds and activates the acetylcholine receptor on airway smooth 
muscle cells, hence inducing bronchoconstriction.  
 
Murine airway resistance is measured invasively in tracheostomized anaesthetized mice 
using the FlexiVent System (SCIREQ, Montreal, QC, Canada) (Figure 13). Therefore, the 
femoral artery and the jugular vein are catheterized to monitor blood pressure and drug 
administration respectively. The animals are placed on a 37°C heated blanket and are 
ventilated with an average breathing frequency of 150 breaths/min. Neuromuscular 
blockade is induced by injecting pancuronium bromide (1 mg/kg) (Inresa, Freiburg, Germany) 
intravenously. To measure airway hyperresponsiveness, mice are challenged with increasing 
doses of carbachol (0, 5, 10, 20, 40, 80, 160 and 320 μg/kg) (Sigma-Aldrich, Bornem). A 
“snapshot perturbation” maneuver is imposed to measure the (dynamic) resistance of the 
whole respiratory system (airways, lung and chest wall). For each concentration, 12 
“snapshot perturbations” are performed and the % increase in lung resistance is calculated 
relative to the baseline resistance.  For each mouse, a dose-response curve is generated and 
the area under the curve is calculated. 
 
 
 
 
 
Figure 13: Flexivent for invasive lungfunction measurement in small laboratory animals. 
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6.1.  CONCOMITANT INHALATION OF CIGARETTE SMOKE AND AEROSOLIZED 
PROTEIN ACTIVATES AIRWAY DENDRITIC CELLS AND INDUCES ALLERGIC 
AIRWAY INFLAMMATION IN A TLR-INDEPENDENT WAY 
 
Lander L. Robays, Ellen A. Lanckacker, Katrien B. Moerloose, Tania Maes, PhD, Ken R. Bracke, 
PhD, Guy G. Brusselle, MD, PhD, Guy F. Joos, MD, PhD, Karim Y. Vermaelen, MD, PhD 
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1. Abstract 
 
Cigarette smoking is associated with the development of allergic asthma. In mice, exposure 
to cigarette smoke sensitizes the airways towards co-inhaled OVA, leading to OVA-specific 
allergic inflammation. Pulmonary dendritic cells (DCs) are professional antigen-presenting 
cells involved in immunosurveillance and implicated in the induction of allergic responses in 
lung. We investigated the effects of smoking on some of the key features of pulmonary DC 
biology, including population dynamics and cellular activation status in different lung 
compartments. We found that cigarette smoke inhalation greatly amplified DC-mediated 
transport of inhaled antigens to mediastinal lymph nodes, a finding supported by the 
upregulation of CCR7 on airway DCs. Pulmonary plasmacytoid DCs, which have been 
involved in inhalational tolerance, were reduced in number after smoke exposure. In 
addition, combined exposure to cigarette smoke and OVA-aerosol increased surface 
expression of MHC Class II, CD86 and PD-L2 on airway DCs, while ICOS-L was strongly 
downregulated. Although endotoxins present in cigarette smoke have been shown to act as 
DC activators and Th2-skewing sensitizers, TLR4-deficient and MyD88-knockout mice did not 
show impaired eosinophilic airway inflammation after concomitant exposure to smoke and 
OVA. From these data, we conclude that cigarette smoke activates the pulmonary DC 
network in a pattern that favors allergic airway sensitization towards co-inhaled inert 
protein. The TLR-independency of this phenomenon suggests that alternative immunological 
adjuvants are present in cigarette smoke. 
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2. Introduction 
 
Increasing epidemiological and experimental data now support an active role of cigarette 
smoking in the development and severity of asthma 1,2. Active smoking interacts with the 
asthmatic phenotype causing more severe allergic symptoms, a greater decline in lung 
function, and impaired therapeutic responses to corticosteroids 3,4. In addition, smoke 
exposure is considered as a risk factor for allergen sensitization and is associated with the 
onset of asthma 5-7.  
In order to better understand these effects, animal models studying the interaction between 
cigarette smoke and allergic responses have been developed 8-16. We and others recently 
established a mouse model in which concomitant inhalation of aerosolized OVA together 
with mainstream cigarette smoke -without prior immunization- induces features of allergic 
airway inflammation 16,17. This allergic response was absent after exposure to OVA alone, 
suggesting a prominent role for cigarette smoking in the establishment of a OVA-specific Th2 
immune response. Indeed, synthesis of IL-5, a Th2-derived cytokine critical for the 
recruitment and survival of eosinophils, was detected in mediastinal lymph node (MLN) cell 
suspensions of OVA/smoke-exposed animals only. However, not all studies supported a 
positive contribution of cigarette smoke exposure to the allergic phenotype and sensitization 
phenomenon, possibly as a result from the variable experimental conditions used among 
different laboratory (e.g. the use of environmental versus mainstream smoke, whole-body 
versus nose-only exposure, etc.) 11,12,14,15. One outstanding observation was that the effects 
of smoke exposure on allergic responses appear to be dose-dependent 15. 
Pulmonary dendritic cells (DCs) are specialized antigen-presenting cells and have emerged as 
central players in the immunological balance of the airways 18,19. A continuous flow of 
migrating DCs interacting with resident airway cells constantly assesses whether inhaled 
material should be confronted with an active immune response, or whether homeostatic 
tolerance should be maintained 20. The outcome of adaptive immune responses depends on 
the context in which the antigen is encountered by airway DCs and is predominantly defined 
by presence or absence of danger signals at the exposed site, such as pathogen-associated 
molecular patterns (PAMPs) betraying the presence of bacterial, fungal or viral pathogens 
and damage-associated molecular patterns (DAMPs) released by stressed or damaged host 
tissue cells 21-23. TLRs expressed on DCs are essential for the integration of these alarm 
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signals, and different pulmonary DC subsets have been shown to express different TLRs, 
potentially leading to different immunological outcomes 24. Triggering of TLRs leads to DC 
activation, manifested by the upregulation of a specific set of costimulatory molecules, 
enhanced migration towards draining LNs and efficient priming of T cells, which will 
recirculate to the periphery in an attempt to neutralize the threat. In the setting of allergic 
airway inflammation, DCs mount an inappropriate Th2-type inflammatory immune response 
against otherwise non-pathogenic inhaled material 25,26. The immunological mechanisms by 
which DCs induce this aberrant response are being unraveled. A working hypothesis is that 
environmental factors acting as DAMPs affect airway DCs in a way that breaks tolerance 
towards co-inhaled inert antigen 18,23. In this study, we asked ourselves whether cigarette 
smoke inhalation affects pulmonary DCs in a way that would facilitate allergic sensitization 
to co-inhaled ovalbumin, a model inert protein antigen. As TLR triggering by trace amounts 
of endotoxin has been shown to spark allergic sensitization to OVA 27-29, and as cigarette 
smoke has been shown to contain bioactive endotoxins 30, we verified whether TLR4 and 
MyD88-dependent TLR signaling signaling contributes to the phenomenon of smoke-induced 
allergic sensitization. 
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3. Methods 
 
Mice 
Balb/c mice (7-9 weeks old) were obtained from Harlan (The Netherlands). TLR4-deficient 
mice (C.C3-Tlr4Lps-d/J, 8-12 weeks old) and control Balb/c mice (7-9 weeks old) were 
purchased from The Jackson Laboratory (Bar Harbor, ME, USA). MyD88-knockout mice on a 
Balb/c background were obtained from the laboratory of G. Lauvau (INSERM, University of 
Sofia Antipolis, Valbonne, France), bred in our facility, and 8 week old mice were kindly 
provided by Dr Kryszko (Ear-Nose-Throat Research Laboratory, Ghent University Hospital). 
Control Balb/c mice were purchased from Harlan. The local Ethical Committee (ECD Faculty 
of Medicine and Health Sciences, Ghent, Belgium) approved all in vivo manipulations. 
 
Cigarette smoke exposure and aerosol challenge 
Groups of 8 mice were subjected to whole body mainstream cigarette smoke exposure of 5 
Kentucky Reference cigarettes (2R4F without filters, University of Kentucky, Lexington, KY, 
USA) for 7 min, 4 times/day, 5 days/week in a plexiglas chamber (17x28x14 cm) with an inlet 
for pressurized air (1.25 l/min). For the MyD88 experiment, 3R4F Kentuky cigarettes were 
used. In the experiments where cigarette smoke and aerosol exposure were performed 
simultaneously, the smoking chamber was additionally connected to an ultrasonic aerosol 
generator. Concurrent aerosol challenge with PBS or 1% OVA (Grade III, Sigma, Belgium) in 
PBS was performed for 7 min, 4 times/day, 5 days/week. The amount of contaminating LPS 
found in the grade III OVA-preparation was measured by the Limulus amebocyte lysate (LAL) 
assay and determined at 5,82 ng bioactive LPS/mg protein. 
 
Bronchoalveolar lavage and cytospins 
Twenty-four hours after the last exposure, mice were sacrificed by a lethal dose of 
pentobarbital. A tracheal cannula was inserted and bronchoalveolar lavage (BAL) was 
performed by instillation of 3 x 300 μl HBSS supplemented with BSA for cytokine analysis. 
Three additional instillations with 1 ml HBSS + EDTA were performed to achieve maximal 
recovery of BAL cells. 50000 BAL cells were processed for cytospins and were stained with 
May-Grunwald-Giemsa for differential cell counting. Remaining cells were used for FACS-
analysis. 
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Preparation of single-cell suspensions 
Lungs were perfused with saline plus EDTA through the pulmonary artery to remove 
contaminating blood cells. Lungs and mediastinal LNs (MLN) were removed and digested as 
detailed previously 31. Briefly, minced lung pieces and LNs were incubated with 1 mg/ml 
collagenase and 20 μg/ml DNAse I for 45 min at 37°. Red blood cells were lysed using 
ammonium chloride buffer. Finally, cell suspensions were filtered through a 50 μm nylon 
mesh to remove undigested organ fragments.  
 
Flow cytometry 
All staining procedures were carried out in calcium and magnesium-free PBS containing 10 
mM EDTA, 1% BSA (Dade Behring, Germany) and 0.1% sodium azide. One million cells were 
preincubated with anti-CD16/CD32 (2.4G2) to block Fc-receptors. Monoclonal antibodies 
used to identify cell surface molecules were anti-CD11c (clone HL3), anti-CD11b (clone 
M1/70), anti-MHCII (I-A/I-E, clone M5/114) and anti-CD86 (clone GL1), all from 
BDBiosciences, Erembodegem, Belgium); anti-ICOS-L (anti-CD275, clone HK5.3), anti-PDL1 
(anti-CD274, clone MIH5), anti-PDL2 (anti-CD273, clone 122), anti-OX40L (anti-CD134L, clone 
RM134L), anti-GITRL (clone YGL386) and anti-CCR7 (CD194, clone 4B12) were from 
eBioscience, San Diego, CA, USA; the PDCA-1 monoclonal antibody (clone JF05-1C2.4.1) was 
from Miltenyi Biotec (Germany). 
 
Evaluation of dendritic cell migration by intratracheal instillation of fluorescent OVA 
After 3 weeks of smoke exposure, mice were anesthetized with avertin (1 mg tribromethanol 
per ml t-amylalcohol in 2.5% in PBS). Dose of the avertin solution was carefully determined 
according to the body weight of each mouse separately so that no respiratory depression 
was observed. 70 μl of fluorescein-conjugated OVA (OVA-FITC, Invitrogen, Belgium) diluted 
in sterile PBS (5 mg/ml) was injected intratracheally using pyrogen-free catheders in order 
not to cause any local pulmonary inflammation, as described previously 31. Mice were 
further exposed to smoke until they were sacrificed at indicated time points after instillation. 
M LNs were removed and processed as described above to obtain single cell suspensions. 
The number of OVA-bearing airway-derived DCs (AW-DC) was calculated by flow-cytometry 
as the fraction of FITC-positive CD11c+ MHCIIhigh LN cells multiplied by total number of LN 
cells. PBS-instilled mice were used as a control to eliminate background fluorescence. 
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Histology 
Left lung was fixed in 4% paraformaldehyde and embedded in paraffin. Transversal sections 
of 3 μm were stained with Congo-Red (Klinipath, Belgium) for the visualization of eosinophils 
or with periodic acid-Schiff (PAS) to identify mucopolysaccharides in tissue and 
counterstained with hematoxyline (Sigma, Belgium). PAS-positive cells were identified as 
goblet cells and quantified in airway walls with a perimeter basement membrane between 
800 and 2000 μm. 
 
Measurement of OVA-specific IgE 
Blood was collected by cardiac puncture for measurement of total and OVA-specific IgE with 
a home-made ELISA as described before 17. 
 
RNA preparation and RT-PCR 
RNA from lung tissue was extracted using the Qiagen RNeasy Mini Kit (Qiagen, Valencia, CA, 
USA). Real-time RT-PCR was performed on a Lightcycler 480 Instrument (Roche Diagnostics, 
Basel, Switzerland) with Assays-on-Demand Gene Expression Products (Applied 
Biosystems, USA) starting from 20 ng of cDNA. Monitoring of the RT-PCR occurred in real-
time using a FAM/TAMRA probe. For IL-13, a 2-step RT-PCR protocol was used. Reverse 
transcription was performed by 10 min at 25°C, 60 min at 42°C and 10 min at 70°C, using 
random hexameres and RevertAid M-MuLV Reverse transcriptase (Fermentas, Canada). 
After 10 min incubation at 95°C for denaturation of RNA-DNA heteroduplexes, a DNA-
amplification was performed with 50 cycles of 95°C for 15 sec and 60°C for 60 sec, using the 
Taqman Universal Primer Mix No AmpErase UNG (Applied Biosystems). Expression of the 
mRNA of gene of interest relative to hypoxanthine guanine phosphoribosyl transferase 
(hprt) mRNA was calculated.  
 
Statistical analysis 
Reported values are expressed as mean ± SEM. Statistical analysis was performed with SPSS 
software (version 15.0) using non-parametric tests (Kruskal-Wallis and Mann-Whitney U-
test) without Bonferroni corrections. Values of p < 0.05 were considered significant (* = p < 
0.05, ** = p < 0.01 and *** = p < 0.001). 
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4. Results 
 
4.1. Combined exposure to cigarette smoke and OVA induces allergic airway inflammation 
The effect of cigarette smoking on the development of allergic responses was illustrated by 
exposing mice to a combination of OVA-aerosol and cigarette smoke without prior 
immunization to OVA 17. As we observed earlier, 3 weeks of simultaneous exposure induced 
features of allergic airway inflammation, demonstrated by accumulation of eosinophils, 
neutrophils and lymphocytes and in the BAL-fluid (Fig. 1A), production of OVA-specific IgE in 
serum (Fig. 1A), eosinophilic infiltrates in the peribronchial tissue (Fig. 1B) and marked 
airway goblet cell hyperplasia on histological airway sections (Fig 1C), fully consistent with 
earlier observations in this model 17. In line with the goblet cell hyperplasia, we observed a 
strong induction of pulmonary IL-13 expression in mice concomitantly exposed to OVA and 
cigarette smoke compared to OVA alone (Fig 1C). IL-13 protein levels in the BAL fluid were, 
however, below the detection limit (data not shown). We also showed earlier that this 
allergic response was associated with OVA-specific Th2-cytokine production in the draining 
LNs 17. Taken together, this suggests that cigarette smoke possessed adjuvant properties 
toward concomitantly inhaled OVA that favored the development of mucosal Th2 responses.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Allergic sensitization of mice exposed to cigarette 
smoke and OVA. (A) Absolute numbers of eosinophils, 
lymphocytes and neutrophils in BAL-fluid and serum OVA-
specific IgE of mice exposed to PBS or OVA combined with 
cigarette smoke or air for 3 weeks. Cells were identified on 
cytospins stained with May-Grunwald-Giemsa Concentra-
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tion of OVA-specific IgE in serum was determined by ELISA. (B) Histological evaluation of eosinophilic 
peribronchial infiltrates on Congo Red stained lung tissue sections counterstained with hematoxylin. (C) 
Histological evaluation of goblet cell hyperplasia on periodic acid-Schiff (PAS) stained lung tissue sections. 
Quantification of the number of goblet cells per mm perimeter basement membrane (BM) of airway walls with 
a perimeter between 800 and 2000 μm of mice exposed to OVA with or without cigarette smoke. mRNA 
transcripts for IL-13 relative to a housekeeping gene (hprt) were measured in whole lung homogenates by real 
time RT-PCR. A representative experiment (n=8 mice per group) of 3 independent experiments is shown. 
*represents a significant difference (p<0.05) between the OVA/air and OVA/smoke group. 
 
4.2. Effects of cigarette smoke exposure on pulmonary DC dynamics and antigen transport 
Pulmonary DC trafficking can be divided into a recruitment phase towards the lung, 
progressing to an emigration phase towards MLNs. Combined exposure to cigarette smoke 
and OVA induced a strong elevation in DC numbers in the BAL compartment, indicating that 
the developing allergic inflammation in these mice stimulated DC recruitment to the airways 
(Fig. 2A), which is consistent with earlier observations using i.p. alum as an adjuvant 32. 
Airway-antigen specific T cell priming relies on the capture and transport of inhaled antigen 
by DCs migrating to the MLN. Hence, we investigated whether smoke inhalation as such 
could affect airway DC trafficking and antigen transport. We delivered fluorescently labeled 
OVA into the airways once after 3 weeks of smoke exposure alone. At various time points 
after intratracheal challenge, FITC+ cells were detected within CD11c+ MHCIIhigh airway-
derived DCs in the MLNs (AW-DCs), according to previous studies 31 (Fig. 2B, upper graph). 
Time course of these FITC+ AW-DCs in LNs of sham-exposed animals illustrated steady-state 
kinetics characterized by a peak of DCs infiltrating the LNs at 24h after antigen challenge, 
slowly declining thereafter (Fig. 2B, lower graph). By contrast, smoke-exposed animals 
showed a marked amplification of DC-mediated antigen transport to LNs, i.e. more antigen-
loaded DCs reaching the draining LNs (Fig. 2B, lower graph). This large wave of DCs carrying 
antigens to the LNs during smoke-exposure peaked at 24-48h after antigen challenge and 
rapidly declined thereafter. Accordingly, we found that cigarette smoke exposure selectively 
upregulated surface expression of CCR7 on airway DCs, i.e. the population primarily involved 
in airway antigen capture (Fig. 2C). No CCR7 could, however, be detected on lung 
parenchymal DCs.  
Last, different subsets of DCs have been found in the lung with conventional and 
plasmacytoid DCs (pDCs) representing the main subsets. Pulmonary pDCs were shown to 
actively contribute to tolerance towards inhaled antigen 33. Hence we evaluated how the 
numbers of pDCs were affected by cigarette smoke exposure. Remarkebly, numbers of 
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CD11cint MHCIIlow/int PDCA-1+ cells (generally regarded as pDCs) were reduced in lung and 
MLNs of smoke-exposed mice (Fig 2D).  
 
 
Figure 2: Migration of pulmonary dendritic cells during cigarette smoke exposure. (A) Numbers of DCs in the 
BAL of mice exposed to a combination of cigarette smoke and aerosolized OVA for 3 weeks. DCs were identified 
as low-autofluorescent CD11chigh cells in the cellular fraction of BAL fluid. * represents a significant difference 
(p<0.05) between the OVA/air and OVA/smoke group. (B) Kinetics of DC emigration to the draining LNs. Mice 
were exposed to mainstream cigarette smoke (smoke) or sham-exposed (air). After 3 weeks exposure, 70 μl of 
an OVA-FITC solution in sterile PBS was instilled into the airways and MLNs were isolated at various time points 
after instillation. Single cell suspensions were prepared from LNs by enzymatic digestion and labeled with CD11c 
and MHCII. FITC+ cells were exclusively found within the fraction of CD11c+ MHCIIhigh airway-derived dendritic 
cells (AW-DC). Graph depicts time course of absolute numbers of FITC+ AW-DC at various time points after 
instillation between cigarette smoke-exposed mice (smoke) and sham-exposed mice (air). (C) CCR7 expression 
on pulmonary DCs from 3 weeks cigarette smoke-exposed mice (smoke) and sham-exposed mice (air). Single cell 
suspensions derived from BAL fluid and enzymatically digested lung tissue and MLNs were stained with 
monoclonal antibodies for CD11c, MHCII and CCR7. DCs were identified as low-autofluorescent CD11chigh cells in 
BAL-fluid (BAL DC) and lung tissue (lung DC) and as CD11c+ MHCIIhigh cells in LNs (LN DC). Representative 
histogram of CCR7 expression on DCs is shown (grey shaded) relative to isotype control staining (black line). 
Cells of 3 mice (n=9 mice per group) were pooled before staining. (D) Numbers of plasmacytoid DCs (pDCs) 
characterized as CD11cint MHCIIlow/int PDCA-1+ cells in lung digests and MLNs of cigarette smoke versus air 
exposed mice (for 4 weeks). 
 
 
88
  
 
89 
4.3. Effects of inhaled cigarette smoke and/or aerosolized OVA on pulmonary dendritic cell 
activation and costimulatory molecule expression 
Costimulatory molecules expressed on DCs during antigen presentation contribute to the 
outcome of T cell stimulation and polarization. We therefore examined expression levels of 
various costimulatory molecules on the cell surface of pulmonary DCs during smoke and/or 
OVA antigen exposure. We focused on accessory molecules with documented involvement 
in the establishment of tolerance versus Th2-development. Examination of the expression 
levels of MHCII and CD86 showed that the majority of pulmonary DCs from airway 
compartment and lung tissue of OVA/smoke-exposed mice exhibited a mature or activated 
phenotype (Fig. 3). This was also observed on DCs from PBS/smoke-exposed mice in the 
airway compartment and peripheral lung tissue, consistent with our previous results 34,35.  
 
Figure 3: Costimulatory molecule profile of pulmonary dendritic cells during cigarette smoke and/or 
aerosolized OVA exposure. Mice were exposed to cigarette smoke (smoke) or sham-exposed (air) together with 
a PBS- or OVA-aerosol for 3 weeks. Single cell suspensions were prepared from BAL-fluid and enzymatically 
digested lung tissue and MLNs and stained with monoclonal antibodies. DCs were identified as low-
autofluorescent CD11chigh cells in BAL-fluid (BAL DC) and lung tissue (lung DC) and as CD11c+ MHCIIhigh cells in 
LNs (LN DC). Expression levels of various costimulatory markers (grey histograms) are shown relative to isotype 
control staining (black line). Relative mean fluorescence intensity (MFI antibody corrected for MFI isotype 
control) is indicated. Cells of 3 mice (n=9 mice per group) were pooled to obtain sufficient cells for staining. 
Representative histograms of 2 independent experiments are shown. 
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Expression of inducible costimulator ligand (ICOS-L, CD275), a member of the B7 family and a 
negative regulator of immune responses 36, was downregulated from the cell surface of 
airway and lung DCs of OVA/smoke DCs compared to other groups. Alternatively, expression 
of two other B7 family members, programmed death ligand-1 (PD-L1, CD274) and PD-L2 
(CD273), both ligands for the inhibitory T cell receptor programmed death receptor-1 (PD-1, 
CD279), was increased on DCs from OVA/smoke-exposed mice in the airway compartment 
and lung tissue. Remarkably, PD-L2 was clearly upregulated on airway-derived DCs in MLNs 
of combined OVA/smoke and PBS/smoke-exposed mice. We were not able to detect 
significant amounts of GITR-L or OX40-L (CD134L) on pulmonary DCs by flow-cytometry 
(compared to OX40-L positive control staining on splenocytes stimulated with LPS; data not 
shown).  
 
4.4. Toll-like receptor independency of cigarette smoke-induced allergic sensitization  
TLR4 has previously been reported to play a pivotal role in the allergic sensitization of 
airways towards inhaled OVA 27,28. Accordingly, we examined whether the observed allergic 
sensitization could be due to endotoxin-like effects of cigarette smoke. Therefore, we 
challenged TLR4-deficient mice with cigarette smoke and OVA simultaneously for 3 weeks 
and measured the degree of eosinophilic inflammation. Remarkably, TLR4-deficient mice 
were clearly able to develop a Th2-response comparable to the levels observed in Balb/c 
control mice, as measured by BAL eosinophilia, BAL lymphocytes, BAL DCs and serum OVA-
specific IgE (Fig. 4A). In addition, histological evaluation of lung tissue showed peribronchial 
eosinophilic infiltrates in both TLR4-deficient and control mice exposed to cigarette smoke 
and OVA simultaneously (Fig. 4B).  
To exclude the contribution of alternative TLRs in cigarette-smoke induced allergic airway 
sensitization, we repeated the experiment in Myd88-gene deficient animals. MyD88 is an 
essential adaptor molecule broadly shared among members of the TLR/IL-1R family. 
OVA/smoke-exposed Myd88-knockout mice did not show any significant reduction in 
eosinophilic airway inflammation, lymphocytic BAL infiltration and airway DC recruitment 
(Fig. 4C). In contrast, and consistent with earlier observations in murine models of cigarette 
smoke-induced lung inflammation 37, neutrophil and macrophage recruitment into the 
airways in response to OVA/smoke inhalation was clearly impaired in the absence of MyD88. 
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Figure 4: Allergic sensitization of TLR4-deficient mice exposed to cigarette smoke and OVA. (A) Absolute 
numbers of eosinophils, lymphocytes and DCs in the bronchoalveolar lavage (BAL) fluid and concentration of 
OVA-specific IgE in serum of control mice (Balb/c) or TLR4-deficient mice (TLR4d) exposed to PBS or OVA 
combined with cigarette smoke or air for 3 weeks. Eosinophils and lymphocytes are identified on cytospins 
stained with May-Grunwald-Giemsa, while DCs are identified by flow-cytometry as CD11chigh low-
autofluorescent cells. n = 9 mice per group. (B) Histological evaluation of eosinophilic peribronchial infiltrates on 
Congo Red stained lung tissue sections counterstained with hematoxylin of Balb/c mice and TLR4-deficient mice. 
(C) Numbers of eosinophils, lymphocytes, neutrophils, DCs and macrophages in the BAL-fluid of MyD88-
knockout or Balb/c control mice after 3 weeks of OVA-aerosol with (black bars) or without (grey bars) cigarette 
smoke simultaneously. Eosinophils, lymphocytes and neutrophils were identified on cytospins, whereas DCs 
(CD11chigh low-autofluorescent cells), CD11b+ DCs (CD11b+ CD11chigh low-autofluorescent cells) and 
macrophages (CD11chigh high-autofluorescent cells) were differentiated using FACS analysis. OVA-specific IgE is 
determined using ELISA. n = 7 mice per group. * represents a significant difference (p<0.05) between the 
OVA/air and OVA/smoke group, unless otherwise indicated. 
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5. Discussion 
 
Concomitant inhalation of aerosolized OVA and cigarette smoke in mice induces a Th2-type 
airway inflammation that is absent after exposure to either agent alone. This aberrant 
immune response has high clinical relevance, as illustrated by the interaction between 
smoking habits and the development of asthma in predisposed subjects. The present study 
was designed to investigate the triggering of allergic airway inflammation by cigarette smoke 
from a pulmonary DC point of view. Key features of pulmonary DC biology are (i) recruitment 
to the antigen exposed lung, (ii) sampling of inhaled antigen and transport towards draining 
MLNs, (iii) maturation (i.e. increase in costimulatory molecule expression), which is 
necessary to generate antigen-specific effector T cells. Subsequently, we sought to gain 
mechanistic insight in the observed phenomenon: based on previous knowledge, we focused 
on potential endotoxin-like activity in cigarette smoke. 
We first confirmed that combined smoke and OVA protein aerosol exposure induces a strong 
increase in DC numbers in the airway compartment, which is consistent with observations 
made previously in OVA/alum-sensitized, OVA-aerosol challenged mice 32,38. Transport of 
antigens from the airways to the T cell areas of draining LNs represents an additional key 
step in the antigen-presenting function of airway DCs. Here, we reveal that there is strongly 
amplified DC-mediated transport of inhaled protein antigen towards MLN in the presence of 
co-inhaled cigarette smoke. In accordance with this observation, we detected an 
upregulation of the LN-homing chemokine receptor CCR7 on airway DCs. Migration of DCs to 
the LNs is enabled by CCR7 expression on the cell surface of DCs interacting with the 
chemokines CCL21 and CCL19 displayed on lung lymphatics and in T cell zones of LNs. An 
alternative explanation for the enhanced capture and transport of airway antigen by DCs 
could be the recently described alteration of airway epithelial tight junctions by mainstream 
cigarette smoke 39. The resulting increase in epithelial permeability could lead to enhanced 
penetration of airborne antigen and promote the activation of the subepithelial DC network 
40. In addition to changes in DC trafficking to the LNs, perturbation of the epithelial 
homeostasis could also affect DCs in a way that can trigger Th2-oriented sensitization. GM-
CSF for instance, a product of the airway epithelium which is increased in smoke-exposed 
airways 13,17,41, has been shown to induce allergic sensitization to inhaled OVA by means of 
airway DC activation, in the absence of any other adjuvant 42. Furthermore, allergic 
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sensitization by cigarette smoking was recently found to be, at least partially, GM-CSF 
dependent 16. Thymic stromal lymphopoietin (TSLP) is another candidate cytokine which can 
be secreted by the respiratory epithelium and is both a powerful activator of DCs leading to 
a Th2-polarized immune response in an OX40-OX40L-dependent manner 43. Interestingly, 
intanasal administration of cigarette smoke-extract induced TSLP expression in the mouse 
lung and blocking TSLP activity inhibited OVA-specific Th2 responses and airway 
inflammation after concomittant cigarette smoke-extract and OVA exposure 44. However, in 
our experiments, we could not detect significant modulation of GM-CSF or TSLP expression 
after either smoke or concomitant OVA/smoke inhalation, nor did we observe upregulation 
of OX40L on pulmonary DC populations (data not shown).  
The pattern of accessory or costimulatory molecule expression on the antigen-transporting 
DCs is a known determinant in the outcome of immune responses. Our data show that DCs 
in the airway compartment of OVA/smoke-exposed lungs display an increased expression of 
accessory molecules previously known for their role in modulating allergic immune 
responses. In line with our earlier observations 34,35, cigarette smoke inhalation induces 
upregulation of CD86 (B7-2) on airway DCs. This costimulatory molecule has been clearly 
shown to be involved in the priming of Th2 responses and the subsequent development of 
allergic airway inflammation towards inhaled protein 32,45, and could thus be a means 
through which cigarette smoke exerts it’s Th2-skewing properties in this model. The striking 
downregulation of ICOS-L on airway DCs of mice concomitantly exposed to cigarette smoke 
and OVA is also consistent with our previous observations in the OVA-alum-i.p./OVA-aerosol 
asthma model 32. Expression of ICOS-L on DCs during initial priming of T cells drives the 
formation of regulatory T cells in lung draining LNs and has been involved in the 
establishment of respiratory tolerance 36. Withdrawal of this inhibitory signal might 
contribute to the preferential Th2 priming towards inhaled antigens. An intriguing 
observation is the upregulation of PD-L2, another member of the B7 family, on airway-
derived DCs in the draining MLNs of mice with OVA/smoke-induced eosinophilic airway 
inflammation. This is reminiscent of the previously described increase in PD-L2 on airway 
DCs of OVA-alum-sensitized/OVA-aerosol-challenged allergic mice 46, and might thus be a 
characteristic feature of allergic immune responses. PD-L2 costimulation during allergen 
priming and challenge was shown to exacerbate immune and inflammatory allergic 
responses in mice, supporting a Th2-potentiating function 47. It has also been proposed that 
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Th2 cells specifically regulate PD-L2 expression on DCs via reverse signaling 48,49. The novel 
finding in our study, however, is a striking upregulation of PD-L2 on airway-derived LN DCs 
after cigarette smoke inhalation alone. Whether this creates a context prone to Th2-
polarized sensitization towards co-inhaled protein is a tempting hypothesis. Further 
investigations using e.g. blocking antibodies or local delivery of siRNA may help to elucidate 
the role of DC-expressed PD-L2 in cigarette smoke-induced allergic airway inflammation. 
Interestingly, cigarette smoke exposure resulted in a reduction of pDC numbers in the lungs 
and thoracic lymph nodes. pDCs have been recently described for their capacity to maintain 
inhalational tolerance: selective depletion of pulmonary pDCs was able to spark Th2-
polarized airway inflammation towards inhaled inert antigen, in the absence of any adjuvant 
33. Together with the activation of conventional airway DCs and the increase in DC-mediated 
transport of inhaled antigen towards lymph nodes, the reduced number of pDCs in smoke-
exposed lungs might thus establish a general climate of reduced inhalational tolerance. 
In contrast to our current findings, a recent study by Robbins et al. reported that cigarette 
smoke leads to a decrease in lung DC numbers, a decrease in DC activation markers and no 
change in migration towards MLNs 50. These findings are likely attributable to fundamental 
methodological differences. The most important element (not obvious in the 
abovementioned study) is the exposure system used, i.e. nose-only vs. whole-body, as this 
leads to large differences in dose intensity as reflected by carboxyhemoglobin (HbCO) levels. 
The protocol we used involves more frequent exposures and results in HbCO levels 
comparable to those measured in human smokers 51,52. In addition, we report surface 
expression of costimulatory molecules on DCs as shifts in mean fluorescence intensity (MFI), 
which is more accurate than % positive cells for these types of markers. Finally, in our study 
we aim to discriminate effects on lung parenchymal DCs obtained by enzymatic digestion 
versus airway DCs harvested by BAL. This allows us to detect the confinement of smoke 
effects (e.g. the upregulation of accessory molecules and CCR7) to the DCs in the airway 
compartment. 
We sought to gain mechanistic insight in the Th2-skewing adjuvant properties of cigarette 
smoke co-inhaled with inert protein. We hypothesized that this effect would rely on the 
presence of endotoxin-like activity within the smoke itself. Indeed, whereas endotoxin-free 
OVA induces inhalational tolerance, co-inhalation of OVA and low-dose endotoxin has been 
shown to trigger OVA-specific allergic airway inflammation 27. This phenomenon, along with 
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the activation and enhanced migration of airway DCs, appeared TLR4-dependent 28. TLR4 
also appears to be a determining factor in the initiation of allergic responses against inhaled 
house dust mite allergen 53,54. Furthermore, our group and others previously showed that 
acute cigarette smoke exposure induces airway DC maturation in a TLR4-dependent fashion 
34,37. Finally, both mainstream and sidestream cigarette smoke are known to contain 
bioactive endotoxin 30. Therefore, we were surprised to observe unhampered development 
of allergic airway inflammation in TLR4-deficient mice exposed to cigarette smoke and OVA. 
Any endotoxin potentially contaminating the cigarette smoke and/or the OVA used in these 
studies would have its pro-allergic effects greatly diminished in the absence of functional 
TLR4. cigarette smoke exposure could also activate alternative TLRs, such as TLR2 which can 
bind heat shock protein-70, an endogenous danger signal known to be released in smoke-
exposed airways 37. However, smoke-induced allergic sensitization was unhampered in 
Myd88-gene deficient animals, thereby ruling out the contribution of TLR2 and several other 
members of the TLR/IL-1R family of innate immune sensors. This is in contrast to airway 
neutrophilia that disappeared completely in our model (consistent with 37) and the Myd88-
dependency of allergic responses observed after house dust mite challenge, intranasal 
challenge of OVA with low-dose LPS or in the presence of bacterial infection 29,55,56.  
The fact that in our experiments the development of allergic inflammation is unaffected by 
TLR4/MyD88-deficiency suggests immunological adjuvant mechanisms of a different kind. 
The cellular stress inflicted by cigarette smoke in the airways, for instance, could lead to the 
release of compounds that trigger TLR/MyD88-independent immunogenic pathways. One of 
these endogenous compounds could be ATP, which was recently reported to trigger 
purinergic receptors on the airway DC network, leading to a DC-dependent allergic 
sensitization towards inhaled inert protein 57. Furthermore, alum, a prototypical Th2-
skewing adjuvant, was shown to exert its adjuvant effect in a TLR4-independent way and 
activate the NLRP3 inflammasome pathway either directly, or through the release of uric 
acid from the local tissue micro-environment 58,59. It is worth noting that aluminum has been 
detected at high concentrations in cigarette smoke, potentially precipitating as alum-like 
hydroxy-salts in the epithelial lining fluid overlying the airway DC network 60. In support of 
this, MyD88-signaling is not always necessary for alum to act as an adjuvant for humoral 
adaptive responses 61. Hence, cytotoxic compounds in cigarette smoke could act in a 
TLR/MyD88-independent manner by activating airway DCs either directly or by means of 
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endogenous danger signals released by stressed airway cells (reviewed in 62). Whether this 
could result in a deviation of immune homeostasis towards an aberrant Th2-driven 
inflammation, is a compelling working hypothesis for further investigation. 
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1. Abstract 
 
Objective: Epidemiological studies indicate that cigarette smoke (CS) exposure is a risk factor 
for increased sensitization and asthma development. The aim of the study was to examine 
the impact of CS on sensitization and allergic airway inflammation, in response to a low dose 
of house dust mite (HDM), and to obtain potential mechanistic insights. 
Methods: Mice were exposed to low doses of HDM extract combined with air or CS 
exposure, either during allergen sensitization or during development of allergic airway 
disease.  
Results: Mice concomitantly exposed to low dose HDM, combined with CS for 3 weeks, 
demonstrated an asthmatic phenotype with significantly increased airway eosinophilia, 
goblet cell metaplasia, airway hyperresponsiveness and a rise in HDM-specific serum IgG1, 
compared to sole HDM or CS exposure. In addition, short CS inhalation, during the initial 
contact with HDM allergens, was sufficient to facilitate sensitization and development of a 
complete asthmatic phenotype after rechallenge with HDM. Mechanistically, short CS 
exposure amplified DC-mediated transport of FITC-labelled HDM allergens to the 
intrathoracic lymph nodes and generated a local Th2 response. 
Conclusion: Short CS exposure is sufficient to facilitate allergic sensitization and the 
development of low dose HDM-induced allergic asthma, possibly through affecting dendritic 
cell function. 
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2. Introduction 
 
Most asthma begins in early childhood after sensitization and re-exposure to ubiquitous 
environmental allergens, like house dust mites (HDM), moulds, plant pollen or animal 
dander. The risk for sensitization is strongly dependent on the level of allergen exposure 1.  
Over the last decades, the incidence of asthma has increased worldwide, especially in 
industrialized countries. This strong rise in asthma prevalence emphasizes an important role 
for environmental and socio-economic conditions 2.  
One of the main environmental risk factors, associated with asthma is the exposure to 
cigarette smoke (CS) 3. Epidemiological studies have shown that smoking is responsible for 
higher asthma severity scores 4,5, diminished lung function 5,6 and poorer asthma control 7,8. 
Smoking is even associated with increased sensitization to HDM allergens 9, and appears to 
be a risk factor for new onset asthma among children and adults 10-13. The mechanisms 
mediating the adverse effects of smoking on asthma pathogenesis remain to be elucidated. 
Most murine models, designed to characterize the complex interaction between smoking 
and allergic airway inflammation, used to rely on the sensitization to the “surrogate” 
allergen ovalbumin (OVA) 14-19. As OVA is an intrinsically inert protein, the role of CS might 
have been overestimated in the past. Moreover, the differences in biochemical character 
between OVA and real-life allergens remain an undeniable limitation of the previously used 
OVA models. 
 
To explain the observed increase in asthma prevalence due to CS exposure, we hypothesized 
that CS may lower the threshold for sensitization to HDM allergens. We developed a 
clinically relevant murine model of allergic asthma, using low doses of HDM as real-life 
aeroallergen, combined with CS. We examined the effect of CS on both sensitization and 
ensuing asthma development and checked whether a few days of smoke exposure are 
sufficient to prime local sensitization in the lymph nodes.  Finally, we looked for potential 
mechanistic insights. 
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3. Methods 
 
Mice 
Male Balb/c mice (6-8 weeks old) were purchased from Harlan (Zeist, the Netherlands). All in 
vivo manipulations were approved by the Animal Ethical Committee of the Faculty of 
Medicine and Health Sciences of Ghent University.   
Cigarette smoke (CS) exposure and house dust mite (HDM) administration 
Mice (n = 10 per group) were subjected to whole body CS (3R4F Kentucky Reference 
cigarettes) as described before 20. Control mice were exposed to air. 30 minutes after the 
last smoke exposure, 25 μg HDM extract (Dermatophagoides pteronyssinus) (Greer 
Laboratories, Lenoir, NC, USA) (25,27 μg Der p1/mg protein; 8.43 endotoxin U/mg) or PBS 
was administered intranasally in isoflurane anesthetized mice on days 0, 7 and 14 and mice 
were analysed on day 17. To evaluate the impact of CS on the development of HDM-induced 
allergic asthma, we performed Protocol 1 (Figure 1). To unravel the impact of CS during the 
sensitization phase, mice were subjected to HDM and CS according to Protocol 2 or 4 (Figure 
1). The impact of CS during the challenge phase was evaluated using Protocol 3 (Figure 1).  
Bronchoalveolar lavage (BAL) and cytospins 
24 hours after the last smoke exposure and 72 hours after the last HDM application, mice 
were euthanized with an overdose of pentobarbital (Sanofi-Ceva, Paris, France). BAL, 
cytospins and cell differentiation were performed as described previously 20.  Remaining cells 
were used for FACS-analysis. 
Lung and mediastinal lymph node (mLN) single-cell suspensions 
Lungs were perfused with saline plus EDTA through the pulmonary artery to remove 
contaminating blood cells. Lungs and mLN were removed and digested as described before 
21.  
Flow cytometry 
Staining procedures, data acquisition and analysis were performed as described previously 
20. Monoclonal antibodies (mAbs) used to identify mouse DC populations were anti-CD11c 
(clone HL3), anti-MHC class II (I-A/I-E, clone M5/114.15.2) and anti-CD11b (clone M1/70). 
CD11b+ DCs were defined as CD11c-bright, low autofluorescent cells which strongly express 
104
                                                                                                                             
 
 
105 
MHC class II and CD11b on their surface. The following mAbs were used to stain mouse T-cell 
subpopulations: anti-CD3 (clone 145-2C11), anti-CD4 (clone GK1.5), anti-CD8 (clone 53-6.7) 
and anti-CD69 (clone H1.2F3) (all mAbs from BD Pharmingen, San Diego, CA, USA). 
MLN cell culture 
Paratracheal and parathymic intrathoracic LNs were collected into sterile tubes containing 
cold (4°C) tissue culture medium (TCM) and digested (see above) to obtain a single cell 
suspension.  TCM was prepared using RPMI 1640 supplemented with 10% fetal bovine 
serum, L-glutamine, penicillin/streptomycin and β-mercaptoethanol (all from Gibco BRL; 
Invitrogen Corp). Cells were then transferred in triplicate to round-bottom, 96-well plates 
(Becton Dickinson (BD), BD, CA, USA) with or without 15 μg HDM extract/ml culture medium, 
at a density of 2 x 105 cells per well and incubated in a humidified 37°C incubator with 5% 
CO2.  After 5 days, supernatants were harvested and frozen for cytokine measurements. 
Histology 
The left lung was fixed in 4% paraformaldehyde and embedded in paraffin. Transversal 
sections of 3 μm were stained with Congo Red (Klinipath, Olen, Belgium) to highlight 
eosinophils, with periodic acid-Schiff (PAS) to identify goblet cells or immunostained for α-
smooth muscle actin to evaluate airway smooth muscle content. Quantitative 
measurements were performed using a Zeiss KS400 Image Analyzer platform (Oberkochen, 
Germany) as described earlier 22. To identify mast cells, lungs were stained with toluidin 
blue. The number of mast cells was counted per field (whole left lung lobe).  Only those 
located in the airway wall were included for analysis. 
Protein measurements 
Total IgE was measured using coated microtiter plates and biotinylated polyclonal rabbit 
anti-mouse IgE (S. Florquin, ULB, Brussels, Belgium). For the detection of HDM-specific IgG1, 
microtiter plates were coated with HDM extract. Serum was added, followed by a 
horseradish peroxidase (HRP) conjugated polyclonal goat anti-mouse IgG1 antibody (Bethyl 
Laboratories, Montgomery, USA). Levels of HDM-specific IgG1 were reported in optical 
densities (OD). MLN supernatants were assayed for IL-4, IL-5, IL-13, IL-10 and IFN-gamma by 
means of multiplex (Merck Millipore, Brussels, Belgium). In the supernatants of crushed 
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lungs, IL-25, IL-33, TSLP, GM-CSF and IL-1β were measured with ELISA (R&D Systems, 
Abingdon, UK) following the manufacturer’s instructions.  
Assessment of airway responsiveness 
Airway responsiveness was measured in tracheostomized anaesthetized mice using the 
FlexiVent System (SCIREQ, Montreal, QC, Canada). Neuromuscular blockade was induced by 
injecting pancuronium bromide (1 mg/kg) intravenously. To check for airway 
hyperresponsiveness, mice were challenged with increasing doses of carbachol (0, 5, 10, 20, 
40, 80, 160 and 320 μg/kg). A “snapshot perturbation” manoeuvre was imposed to measure 
the (dynamic) resistance (R) of the whole respiratory system (airways, lung and chest wall). 
For each mouse, a dose-response curve was generated and the area under the curve (AUC) 
was calculated. 
Evaluation of DC migration by intratracheal instillation of fluorescent HDM 
To obtain fluorescently labelled HDM, HDM extract (Greer Laboratories, Lenoir, NC, USA) 
was dialysed against a carbonate-bicarbonate buffer (pH 9.5), overnight at 4°C.  10mg/ml 
FITC in DMSO (Sigma Aldrich, Bornem, Belgium) was added to the HDM solution and rotated 
for 1 hour at room temperature. The whole procedure was performed under dark, sterile 
conditions. After 4 days of CS exposure, anesthetized mice (i.p. ketamine (80 mg/kg; 
Ketamine 1000 CEVA; Ceva Sante Animale, Brussels, Belgium) – xylazine (8 mg/kg; Rompun 
2%; Bayer AG, Leverkusen, Germany)) were held vertically and 50 μl of FITC conjugated HDM 
(100 μg) or PBS was pipetted just above their vocal cords. Mice were sacrificed 0, 24 and 48 
hours after instillation. MLN were removed and processed as described above.  
Discrimination in the mLN between the airway derived (AW-DCs) (CD11cint-high/MHCIIhigh) and 
non-airway derived DCs (NAW-DCs) (CD11c+/MHCIIint) was performed using the method 
published by Vermaelen et al 21.  The % of HDM-bearing airway-derived DCs (AW-DCs) was 
determined by flow cytometry as the fraction of FITC+ MHCIIhigh CD11cint-high cells.  The results 
were expressed as the % of FITC+ DCs regarding to the total DC population. 
Statistical analysis 
Statistical analysis was performed with PASW Statistics 18 using nonparametric tests.  The 
different experimental groups were compared by a Kruskall-Wallis test for multiple 
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comparisons.  Pairwise comparisons were made by means of a Mann-Whitney U-test. A p-
value p ≤ 0.05 was considered significant. Reported values are expressed as mean ± SEM. 
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4. Results 
 
4.1. CS facilitates the development of new onset allergic asthma 
 
To evaluate the role of CS in the 
pathogenesis of HDM-induced 
allergic asthma, Balb/c mice were 
exposed to CS or air for 3 weeks and 
instilled with HDM (25 μg) or PBS 
once a week (Figure 1 – Protocol 1). 
We instilled 4 times less HDM 
compared with our previously 
described model 23, in order to limit 
the biological effects of HDM on its 
own. 
 
 
Figure 1: Exposure protocols.  4 groups 
were included in our experimental set-up: 
PBS/air, PBS/CS (sole CS), HDM/air (sole 
HDM) and HDM/CS. Abbreviations: PBS = 
phosphate buffered saline, HDM = house 
dust mite, CS = cigarette smoke 
 
 
4.1.1. Exposure to both HDM and CS aggravates the allergic response in BAL fluid and lung  
The intranasal delivery of sole HDM elicited a faint asthmatic phenotype with increased 
eosinophils, CD11b+ DCs and CD4+ and CD8+ T lymphocytes as compared to PBS exposed 
control mice (Figure 2). CS exposure as such enhanced the amount of total cells and 
macrophages (data not shown), neutrophils, CD11b+ DCs and CD4+ and CD8+ T lymphocytes 
in the BAL fluid compared to air exposed mice (Figure 2). The concomitant exposure to HDM 
and CS amplified the allergic phenotype considerably.  This is reflected by a 10-fold increase 
in the number of eosinophils and a rise in CD11b+ DCs and CD4+ and CD8+ T lymphocytes in 
BAL fluid as compared to the other groups. No further increase in macrophages (data not 
shown) or neutrophils was observed (Figure 2).  
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Figure 2: Inflammatory response from mice simultaneously exposed to phosphate buffered saline (PBS) or 
house dust mite (HDM), combined with air or cigarette smoke (CS) for 3 weeks. Cell differentiation of 
bronchoalveolar lavage (BAL) fluid. Results are expressed as means ± SEM; n=10 animals/group.  *p<0.05; 
**p<0.01; ***p<0.001. 
 
In line, lung single cell suspensions had more CD11b+ DCs and activated CD4+CD69+ and 
CD8+CD69+ T cells as compared to sole HDM or CS (Figure 3a). Histological analysis revealed 
peribronchovascular eosinophilic inflammation and mucin-producing goblet cells in HDM 
exposed mice, compared with naive control mice (Figure 3b,c). However, exposure to both 
CS and HDM, resulted in a further increase of eosinophils, goblet cells and mast cells (Figure 
3b,c,d). Other features of airway wall remodelling, such as quantification of airway smooth 
muscle content, revealed no differences between the 4 groups (data not shown). 
4.1.2. Combined exposure to HDM and CS increases HDM-specific IgG1 production in serum 
Total serum IgE did not differ between the 4 groups (data not shown), but HDM exposed 
mice showed significantly elevated allergen-specific IgG1 titers in the serum, compared with 
naive control mice. This level was further increased after combined exposure to HDM and CS 
(Figure 4a). HDM-specific IgE measurements were below detection limit.   
 
4.1.3. Concomitant exposure to HDM and CS amplifies the production of Th2 cytokines  
HDM restimulated mLN cells from the sole HDM group showed increased production of the 
inflammatory cytokines IL-4, IL-5, IL-13 and IL-10, together with decreased levels of the 
typical Th1 cytokine IFN-γ (Figure 4b). The HDM/CS combination yielded in a further increase 
in IL-4, IL-5, IL-13 and IL-10 (Figure 4b).  IFN-γ had a further tendency to decrease (Figure 4b).  
The role of the epithelium was investigated by measuring innate pro-Th2 cytokines in lung 
homogenate.  Exposure to both HDM and CS, resulted in more IL-25, IL-33 and IL-1β (Figure 
4c).  TSLP and GM-CSF were below detection limit. 
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Figure 3: Histopathological evaluation from mice simultaneously exposed to phosphate buffered saline (PBS) 
or house dust mite (HDM), combined with air or cigarette smoke (CS) for 3 weeks. a) Cell differentiation of 
lung digest. b) Photomicrographs of eosinophilic peribronchial infiltrates. c) Photographs of goblet cells. d) Total 
number of mast cells. Results are expressed as means ± SEM; n=10 animals/group.  *p<0.05; **p<0.01; 
***p<0.001. 
 
 
4.1.3. Concomitant exposure to HDM and CS amplifies the production of Th2 cytokines 
HDM restimulated mLN cells from the sole HDM group showed increased production of the 
inflammatory cytokines IL-4, IL-5, IL-13 and IL-10, together with decreased levels of the 
typical Th1 cytokine IFN-γ (Figure 4b). The HDM/CS combination yielded in a further increase 
in IL-4, IL-5, IL-13 and IL-10 (Figure 4b).  IFN-γ had a further tendency to decrease (Figure 4b).  
The role of the epithelium was investigated by measuring innate pro-Th2 cytokines in lung 
homogenate.  Exposure to both HDM and CS, resulted in more IL-25, IL-33 and IL-1β (Figure 
4c).  TSLP and GM-CSF were below detection limit.  
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4.1.4. CS exposure exacerbates HDM-induced airway hyperresponsiveness  
Figure 4d shows the dose-response curve of the in vivo reactivity of all 4 groups.  HDM or CS 
exposed mice were slightly responsive towards the highest carbachol dose. Mice 
concomitantly exposed to both stimuli were more responsive (Figure 4d). 
 
Figure 4: Immunoglobulins, cytokines and airway hyperresponsiveness of mice simultaneously exposed to 
phosphate buffered saline (PBS) or house dust mite (HDM), combined with air or cigarette smoke (CS) for 3 
weeks. a) HDM-specific IgG1.  b) Protein levels of IL-4, IL-5, IL-13, IL-10 and IFN-γ in the supernatant of HDM 
restimulated lymph node cells. c) Measurements of IL-25, IL-33 and IL-1β in supernatant of crushed lungs. d) 
Airway hyperresponsiveness to carbachol. Dose-response curve and area under the curve (AUC). Results are 
expressed as means ± SEM; n=10 animals/group. *p<0.05; **p<0.01; ***p<0.001. 
 
4.2. CS exposure during sensitization and not during allergen challenge is important for 
subsequent asthma development 
 
To investigate the putative role of CS during sensitization, Balb/c mice were briefly exposed 
to CS (for 4 consecutive days) and instilled with HDM (25 μg) once a week during 3 
consecutive weeks (Figure 1 – Protocol 2).  In the sera of HDM/CS exposed mice, enhanced 
allergen-specific IgG1 titers were detected (Figure 5a). In contrast to Protocol 1, where mice 
received CS for 3 weeks, we observed no neutrophils after limited CS exposure in Protocol 2. 
(Figure 5b). Mice concomitantly exposed to HDM and only 4 days of CS showed more BAL 
CD11b+ DCs, CD4+ and CD8+ T-lymphocytes in comparison to all other groups and had a 20-
fold increase in the number of BAL eosinophils (Figure 5b). Compared to Protocol 1, the 
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inflammation in BAL fluid was less pronounced and even in lung single cell suspensions, the 
number of DCs and T-lymphocytes no longer increased upon combined HDM/CS exposure  
(Figure 5c). Histological examination revealed however significantly more eosinophils (Figure 
5d) and goblet cells in the airway wall (Figure 5e) together with increased airway 
hyperresponsiveness in concomitantly exposed mice (Figure 6a).  
 
Figure 5: Immunoglobulins, inflammatory response and histopathological evaluation of mice simultaneously 
exposed to phosphate buffered saline (PBS) or house dust mite (HDM) and 4 days of air or cigarette smoke 
(CS). a) HDM-specific IgG1. b) Cell differentiation of bronchoalveolar lavage (BAL) fluid and c) lung digest. d) 
Quantification of eosinophils.  e) Measurement of goblet cells.  Results are expressed as means ± SEM; n=10 
animals/group. *p<0.05; **p<0.01; ***p<0.001. 
 
 
Altogether, these Th2 associated airway responses were accompanied by increases in IL-4, 
IL-5, IL-13 and IL-10 in the supernatant of restimulated mLN cultures of HDM/CS exposed 
mice (Figure 6b), but no differences in IL-25, IL-33 and IL-1β production could be observed 
between all 4 groups (Figure 6c).   
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Figure 6: Airway hyperresponsiveness to carbachol and cytokine responses of mice simultaneously exposed to 
phosphate buffered saline (PBS) or house dust mite (HDM) and 4 days of air or cigarette smoke (CS).  a) Dose-
response curve to carbachol and area under the curve (AUC). b) Protein levels of IL-4, IL-5, IL-13 and IL-10 in 
supernatant of HDM restimulated lymph node cells. c) Measurements of IL-25, IL-33 and IL-1β in supernatant of 
crushed lungs. Results are expressed as means ± SEM; n=10 animals/group. *p<0.05; **p<0.01; ***p<0.001. 
 
 
On the contrary, exposure to CS exclusively during the HDM challenge phase (Figure 1 – 
Protocol 3) was unable to induce an allergic phenotype and did not show increased HDM 
specific IgG1 (Figure 7a), nor elevated numbers of eosinophils, CD11b+ DCs or T lymphocytes 
in BAL fluid (Figure 7b) and lung tissue, except for a rise of CD4+CD69+ T cells in the lung 
(Figure 7c). Additionally, we found no increase in the number of goblet cells (Figure 7d) or 
airway hyperresponsiveness in these mice (Figure 7e).  
 
4.3. Short exposure to CS enhances HDM uptake and DC migration to the mLN and 
facilitates sensitization to common aeroallergens 
To investigate if 4 days of smoke inhalation already affects airway DC trafficking and antigen 
transport to the draining LNs, we delivered fluorescently labelled HDM intratracheally to CS 
or air exposed mice. FITC+ DCs were exclusively found within the population of CD11cint-
high/MHCIIhigh AW-DCs. At various time points after HDM instillation (24h, 48h), CS exposed 
mice showed a marked increase in DC-mediated HDM transport to the draining LNs, 
compared to air exposed mice (Figure 8a). 
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Figure 7: Immunoglobulins, inflammatory response, histopathological evaluation and airway hyperrespon-
siveness of mice simultaneously exposed to phosphate buffered saline (PBS) or house dust mite (HDM) and 
air or cigarette smoke (CS) during the allergen challenge phase. a) HDM-specific IgG1. b) Cell differentiation of 
bronchoalveolar lavage (BAL) fluid and c) lung digest. d) Quantification of goblet cells. e) Airway 
hyperresponsiveness to carbachol. Results are expressed as means ± SEM; n=10 animals/group. *p<0.05; 
**p<0.01; ***p<0.001. 
 
 
To characterize the role of CS during initial sensitization towards common aeroallergens, we 
exposed Balb/c mice to CS for 3 consecutive days and instilled HDM allergens on the first day 
(25μg) (Figure 1 – Protocol 4). This short interaction between CS and HDM allergens 
significantly increased the number of CD11b+ DCs in BAL fluid and lung tissue (Figure 8b,c), 
with enhanced activation of BAL DCs, as read out by the expression of CD86 (Figure 8b). At 
the functional level, we found that brief exposure to CS during the first contact with HDM 
allergens was sufficient to induce sensitization in the mLN, characterized by a pronounced 
Th2 cytokine profile in HDM/CS exposed mice (Figure 8d).  To explain this heightened state 
of allergen-specific sensitization, we measured typical DC-activating cytokines, released by 
bronchial epithelial cells early in the sensitization process.  TSLP and GM-CSF were below 
detection limit, but IL-25, IL-33 and IL-1β were elevated in CS exposed mice (Figure 8e). IL-1β 
increased further after concomitant exposure to HDM and CS. 
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Figure 8: Migration, recruitment and maturation of pulmonary DCs and corresponding cytokine profiles upon 
phosphate buffered saline (PBS) or house dust mite (HDM) and acute air or cigarette smoke (CS) exposure. a) 
Dendritic cell (DC) migration to the mediastinal lymph nodes. b) CD11b+ DCs and expression of CD86 on BAL DCs 
c) and lung DCs (calculated within the population of low autofluorescent, CD11c+, MHCII+ DCs). d) Protein levels 
of IL-4, IL-5 and IL-13 in HDM restimulated lymph node cells. e) Measurements of IL-25, IL-33 and IL-1β in 
supernatant of crushed lungs.  Results are expressed as means ± SEM; n=10 animals/group. *p<0.05; **p<0.01; 
***p<0.001. 
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5. Discussion 
 
In this paper, we demonstrate that cigarette smoke (CS) exposure can play a determining 
role during allergic sensitization and asthma development. (i) We show that concomitant 
exposure to CS and a low dose of house dust mite (HDM) results in a pronounced Th2-
related asthmatic phenotype, which is hardly present when sole HDM is used. In addition, 
we demonstrate that, (ii) in the presence of allergens, acute CS exposure is sufficient to 
cause sensitization and subsequent asthma development, (iii) possibly by the amplified 
allergen transport of airway DCs towards the mLNs. 
 
The strongest predictive factor for asthma development is the sensitization to common 
environmental allergens, like house dust mites (HDMs), grass pollen or animal dander. 
Epidemiological studies provide indirect clinical evidence that smoking is associated with 
increased sensitization to HDM allergens 24. Smoke exposure is even correlated with higher 
asthma incidence and severity of the disease. Especially children become more susceptible 
due to smoke exposure, as illustrated by the increased wheeze and asthma prevalence 
among children and young adolescents upon passive smoke inhalation 25.  
Within our lab, we created a murine model, supporting the findings from epidemiological 
studies and using HDM as clinically relevant allergen. HDM is the most significant source of 
indoor allergens, responsible for atopic symptoms in 10% of individuals. It is a complex 
mixture of various protein allergens and non-protein compounds, with some allergens 
having the natural capacity to induce mucosal sensitization through the respiratory tract 24. 
Although the content of commercially available preparation of HDM extract can vary 
extensively 26, these extracts might be a good representation of the indoor HDM allergens, 
present in our homes. To examine whether CS can lower the threshold for asthma 
development, we first created a mild murine asthma model by down-titration of the HDM 
protein content until almost no asthmatic phenotype could be elicited (data not shown). 
Such models are relevant to evaluate potential synergistic effects upon CS inhalation. 
In this paper, we demonstrate that CS exposure facilitates and aggravates the asthmatic 
disease, as illustrated by the increased eosinophils and neutrophils in BAL. These  findings 
are in agreement with our previous work, investigating the role of CS in asthma 
development with ovalbumin (OVA) as “surrogate” allergen 15,27. However, OVA is no 
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naturally occurring allergen and prolonged exposure elicits inhalation tolerance, rather than 
allergic inflammation in mice 28.  
An important novelty of our study, using adolescent mice of 6-8 weeks old, is the striking 
result that only 3 days of CS exposure during the initial allergen contact are sufficient to 
prime HDM-specific Th2 cells in the LNs. This process might be driven by the enhanced HDM 
transport of the airway DCs. Our findings suggest that adolescent smokers and young 
children, may become more susceptible to allergic sensitization and ensuing asthma 
development, due to (short) CS inhalation. To our opinion, these results can be extrapolated 
to humans, since our murine CS exposure protocol reaches carboxyhemoglobin (COHb) 
levels comparable to those in human smokers 29,30 and since COHb levels of young children 
(aged 1-2) exposed to parental smoke are similar to those measured in adult smokers 31.  
Furthermore, we focussed on the release of innate pro-allergic cytokines, known to instruct 
DCs to mount Th2-mediated cell responses in the lung 32. Three weeks of HDM and CS 
exposure resulted in significantly more IL-25, IL-33 and IL-1β.  In contrast, when stopping CS 
exposure after the initial sensitization, no differences in these cytokines were found 2 weeks 
after smoke cessation. This suggests a synergistic role for CS, particularly during the ongoing 
allergic response and illustrates the direct impact of CS on airway epithelial cells and on the 
release of innate pro-Th2 cytokines, the driving force in activating DCs and ensuing asthma 
development. IL-1β and IL-33 were even increased after 1 HDM administration concomitant 
with 3 days of smoke exposure, suggesting a role for these cytokines during the sensitization 
phase and in facilitating the sensitization process due to CS. This idea is supported by Willart 
et al. confirming the role of these cytokines early in asthma development. Neutralizing IL-1β 
during HDM sensitization reduced the production of Th2 cytokines, whereas blocking IL-33 
signalling at the time of sensitization decreased the number of eosinophils and lymphocytes 
in the BAL 33. 
 
To our knowledge, this is the first in vivo model showing unambiguous synergy between CS 
and HDM allergens. In line with our observation, Rusznak et al. found increased 
inflammatory mediator release from primary in vitro cultures of human bronchial epithelial 
cells, after exposure to CS and Der p allergens 34. Blacquière et al. examined the effect of 
maternal smoking during pregnancy 35. Upon HDM exposure, mice offspring of smoking 
mothers showed increased airway wall remodelling and AHR, but no increase in 
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inflammatory response or elevated Th2 cytokines could be demonstrated in HDM/CS 
exposed mice. Mitchell et al. investigated the role of progesterone and, or CS in exacerbating 
allergic airway disease. Although the difference in experimental setup, they found some 
indications for increased allergic inflammation due to CS, however less pronounced than in 
our model 36,37. In contrast to our current findings, a recent study by Botelho et al. 38 using a 
murine model of established allergic asthma, reported significantly attenuated eosinophilia 
in BAL fluid of mice exposed to both HDM and CS, together with decreased mucus 
production and no difference in CD4+ T cell activation nor AHR between HDM and, or CS 
exposed mice.   
Disparities between our data and the studies mentioned above, might be related to 
fundamental differences in allergen and CS exposure protocol, such as the use of alum as 
Th2 skewing adjuvant 36,37 or the timing, duration and intensity of smoke exposure. In 
addition, the variability between commercially available preparations of HDM extract (e.g. 
endotoxin content) may affect the development of potential Th2 responses in the lung 38.  
Compared to the previous studies, our model is innovative since we show synergy using a 
mild asthma model and a short CS exposure protocol. The clear distinction between the 
sensitization and allergen challenge phase, made it possible to examine the impact of CS on 
different phases of asthma pathogenesis.  Because of the diversity of asthma phenotypes, 
preclinical mouse models of combined exposures to allergens and environmental pollutants 
will become more important in the future. Combination models mimic more closely the real- 
life situation in humans and are therefore more reliable to provide mechanistic insights and 
to test potential therapeutic strategies. 
 
In conclusion and in agreement with epidemiological studies, we provide biological 
mechanistic data, supporting the hypothesis that environmental factors such as cigarette 
smoke, are risk factors for sensitization and ensuing asthma development. We found that 
even short-term cigarette smoke exposure can lower the threshold for allergen sensitization, 
making individuals more vulnerable to future asthma development. 
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1. Abstract 
 
Objective: Cigarette smoke (CS) exposure is associated with increased asthma development 
in children and adults. The aim of the study was to obtain mechanistic insights into the role 
of CS as a risk factor for allergic sensitization and subsequent asthma development, with the 
main focus on the airway epithelium. 
Methods: To unravel the impact of CS during mucosal sensitization or asthma development, 
mice were subjected to whole body CS (3 times/day, 5 days/week) or air, combined with 
house dust mite extract (HDM) or PBS (intranasal, 1/week) for 3 days or 3 weeks. 
Results: Expression analysis of E-cadherin in mice exposed to HDM or CS for 3 days showed 
no significant changes in epithelial integrity. However, the induction of early Th2 immunity 
as well as the inflammatory response upon acute HDM/CS exposure were IL1RI dependent. 
In addition, investigation of danger-associated molecular pattern molecules, revealed uric 
acid as well as hyaluronan to be additionally increased upon acute and, or prolonged 
concomitant HDM/CS exposure. 
Conclusion: Preliminary results point to a role for IL1RI signaling, uric acid and hyaluronan 
during increased allergic sensitization or asthma development upon CS inhalation. However, 
additional experiments are needed to further elucidate the airway epithelial function. 
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2. General introduction 
 
Although individuals with asthma are often genetically predisposed, the interaction with 
environmental factors is critical for the expression of the disease 1. Epidemiological studies 
have demonstrated that cigarette smoke (CS) exposure is a major risk factor in the 
development or aggravation of asthma 2,3. To obtain mechanistic insights into the role of CS 
as adjuvant during allergic sensitization and ensuing asthma development, we previously 
designed a murine model of facilitated allergic inflammation after acute (3 days) and 
prolonged (3 weeks) concomitant house dust mite (HDM) and CS inhalation 4. We 
demonstrated that acute CS exposure during primary allergen sensitization may induce local 
Th2 immunity in the lymph nodes. Because respiratory epithelial cells play a pivotal role in 
asthma pathogenesis 5, we focused on the airway epithelium as a key factor in promoting 
early mucosal sensitization in the lung. More precisely, we investigated potential 
contributions of the airway epithelial barrier function, IL1RI signaling and damage associated 
molecular pattern (DAMP) molecules.  
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3. The role of the airway epithelial barrier function during allergic sensitization 
 
3.1. Introduction 
The airway epithelium acts as a physical barrier between the internal and external milieu of 
the lungs. To protect against inhalants, the epithelial integrity depends on tight junction (e.g. 
occludin, claudin, ZO-1) and adherens junction molecules (e.g. E-cadherin), which form 
adhesive forces between adjacent epithelial cells 6. In asthma, the airway epithelium is often 
compromised, possibly the result of proteolytic activity from inhaled aeroallergens or as a 
result of irritant compounds. Indeed, HDM allergens, as well as CS, have been shown to 
damage airway epithelial cells, by decreasing the E-cadherin expression 7,8 or disrupting tight 
junction proteins 8-11. To explain the observed increase in allergic sensitization due to CS 
inhalation, we hypothesize that CS may synergize with HDM allergens to further decrease 
the epithelial barrier function. Decreased epithelial integrity may facilitate transepithelial 
delivery of HDM allergens to antigen-presenting cells, hence increasing the sensitization risk.  
 
3.2. Preliminary results 
3.2.1. Analysis of epithelial integrity after acute HDM/CS exposure 
To investigate the role of the epithelial barrier function during CS-induced facilitated 
sensitization, we exposed mice to CS for 3 days, instilled HDM on the first day (Figure 1) and 
measured the E-cadherin expression on lung tissue sections. We observed no significant 
difference in E-cadherin expression between all 4 groups, although the E-cadherin level of 
some individual subjects within the PBS/air groups appeared to be higher. (Figure 2a,b).  
 
 
 
 
 
 
 
Figure 1: Exposure protocol 1.  To analyse whether short cigarette smoke inhalation during primary allergen 
contact, facilitates allergic sensitization, we exposed male mice (n= 8 à 10) for 3 days to cigarette smoke and 
instilled HDM (Greer) at the first day. 4 groups were included in our experimental set-up: PBS/air, PBS/CS (sole 
CS), HDM/air (sole HDM) and HDM/CS. 
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Figure 2: E-cadherin membrane expression in Balb/c mice simultaneously exposed to phosphate buffered 
saline (PBS) or house dust mite (HDM) and 3 days of air or cigarette smoke (CS). a) Photomicrographs of E-
cadherin staining between airway epithelial cells. b) Quantification of E-cadherin positive staining, with levels 
expressed as the percentage of E-cadherin positivity relative to the total surface area of the airway epithelium. 
Each individual point refers to the mean E-cadherin staining per mouse, measured on at least 7 lung sections. 
Means are shown ; n=8 à 10 animals/group. *p<0.05; **p<0.01; ***p<0.001. 
 
 
3.3. Discussion 
We investigated the role of the airway epithelial barrier function during CS-induced allergic 
sensitization in mice. Although we did not find significant differences between all 4 groups, 
some individual E-cadherin values within the PBS/air control group seemed to be higher, 
which is in line with previous findings from the literature. De Boer et al. demonstrated 
decreased E-cadherin expression in bronchial biopsies from atopic asthmatic patients 
compared with non-atopic controls 8. In addition, in vitro studies on human bronchial 
epithelial cells revealed a transient fall in E-cadherin after HDM stimulation 7,12 and reduced 
the expression of epithelial tight junction proteins upon exposure to CS extract 13.  
Future experiments will be performed on larger experimental groups to increase the power 
of the E-cadherin analysis. Moreover, because possible differences in E-cadherin expression 
may become more explicit after a more prolonged exposure period, the expression analysis 
will also be performed in a more extended 3 week exposure protocol 4. 
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4. The role of IL1RI signaling during CS-induced allergic sensitization 
 
4.1. Introduction 
Activation of airway epithelial cells has been shown to release innate pro-allergic cytokines, 
such as thymic stromal lymphopoietin (TSLP), granulocyte macrophage colony-stimulating 
factor (GM-CSF) or interleukin (IL)-1 14-16. We previously showed that IL-1β is significantly 
increased during facilitated sensitization due to CS inhalation 4. IL-1α and IL-1β are both pro-
inflammatory isoforms, acting on the same IL1RI receptor. Although IL-1α is generally 
released as an ‘alarmin’ 17, both cytokines are enhanced in response to inflammatory stimuli. 
IL-1α and IL-1β are both synthesized as precursor proteins and unlike IL-1α, the IL-1β 
precursor form requires proteolytic cleavage to become fully activated (generally performed 
by caspase-1) 18. Upon IL1RI activation, transcription factors NF-κB or AP-1 are stimulated to 
further express pro-inflammatory genes. Because the IL-1 signaling pathway is involved in 
many inflammatory disorders, such as rheumatoid arthritis or asthmatic disease, we are 
interested whether the IL1RI signaling is important to facilitate allergic sensitization upon CS 
inhalation. 
 
4.2. Preliminary results 
4.2.1. IL-1β but not IL-1α is increased after acute HDM/CS exposure 
Because IL-1α and IL-1β are both cytokines with shared biological activity, we were 
interested whether IL-1α, like IL-1β (see Chapter 6.2.), is significantly increased after acute 
HDM/smoke exposure (Figure 1). 3 days of CS exposure increased the level of IL-1α in lung 
homogenates, however in contrast to IL-1β, no additional increase could be found after 
exposure to HDM and CS together (Figure 3a,b).  
 
Figure 3: Pulmonary levels of IL-1α 
and IL-1β in mice concomitantly 
exposed to phosphate buffered 
saline (PBS) or house dust mite 
(HDM) and 3 days of air or cigarette 
smoke (CS). a) IL-1a and b) IL-1b in 
lung homogenate of Balb/c mice, 
measured by ELISA. Results are 
expressed as means ± SEM; n=8 
animals/group. *p<0.05; **p<0.01; 
***p<0.001. 
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4.2.2. IL1RI is implicated in acute HDM/CS-induced pulmonary inflammation 
To further unravel the role of IL-1 during CS-induced facilitated allergic sensitization, we 
concomitantly exposed WT and IL1RI KO mice to CS for 3 days and instilled HDM on the first 
day (Figure 1). In accordance with our previous results 4, C57Bl/6 WT mice exposed to a 
combination of HDM and CS had significantly more BAL and lung CD11b+ DCs (Figure 4a,b), 
and additionally more BAL neutrophils (Figure 4c). In contrast, HDM/CS treated IL1RI KO 
mice were protected against this acute increase of inflammatory cells (Figure 4a,b,c). At this 
short time point, no eosinophils could be enumerated. 
 
Figure 4: The effect of IL1RI deficiency on pulmonary inflammation and the development of local Th2 
immunity in C57/Bl6 mice concomitantly exposed to phosphate buffered saline (PBS) or house dust mite 
(HDM) and 3 days of air or cigarette smoke (CS). a) % of CD11b+ dendritic cells (DC) in bronchoalveolar lavage 
(BAL) and b) lung digest using flow cytometry. c) % of neutrophils in BAL fluid quantified on cytospins. d) Protein 
levels of IL-4, e) IL-5 and f) IL-13 in the supernatant of HDM restimulated lymph node cells, measured by ELISA. 
Results are expressed as means ± SEM; n=8 animals/group. *p<0.05; **p<0.01; ***p<0.001. 
 
 
4.2.3. IL1RI is involved in the development of local Th2 sensitization in the lymph nodes 
To check whether IL1RI is necessary to prime local Th2 responses in the draining lymph 
nodes, mediastinal lymph node cells from WT and IL1RI KO mice were cultured in vitro and 
restimulated with HDM. Culture supernatant of HDM/CS treated WT mice revealed more IL-
4, IL-5 and IL-13 compared to all control groups. However, in contrast, IL1RI KO mice were 
protected against CS-induced allergic sensitization, as illustrated by lower levels of Th2 
cytokines (Figure 4d,e,f).  
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4.3. Discussion 
We evaluated the role of IL1RI during CS-induced facilitated sensitization. Using knockout 
mice, we showed that both the cellular influx as well as the induction of early Th2 immunity 
were IL1RI dependent. Previous work already demonstrated the IL1RI dependence during 
CS- 19-21 or HDM-induced inflammation 15,22, however we are the first to display the 
importance after combined HDM/CS inhalation during the early sensitization phase. In 
conflict with Willart et al, HDM-treated IL1RI-/- mice were not fully protected against Th2 
sensitization, a discrepancy that might be explained because of differences in exposure 
protocol and timing of analysis. Furthermore, in line with Pauwels et al, 3 days of CS 
inhalation already enhanced the level of IL-1α and IL-1β in lung homogenate, though 
concomitant HDM/CS inhalation only additionally increased IL-1β. This finding suggests a 
potential role for the IL-1β – IL-1RI pathway during CS-induced facilitated sensitization, 
however, neutralization with blocking antibodies is required to confirm this assumption.  
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5. The role of DAMP molecules during sensitization and subsequent asthma development 
 
5.1. Introduction 
Upon epithelial injury or cellular stress, damage associated molecular pattern (DAMP) 
molecules or ‘alarmins’ are released to alert the host. DAMP molecules are sensed by the 
innate immune system through pathogen recognition receptors (PRRs) and are known to 
orchestrate airway inflammation by the recruitment of innate inflammatory cells. Uric acid, 
as well as, high-mobility group box 1 or hyaluronic acid are a few examples of DAMP 
molecules, which are markedly increased in pulmonary secretions of patients with asthma 23-
26. Endogenous uric acid (UA) crystals are the metabolic breakdown product of purine 
nucleotides. UA is released from dying or stressed cells and is known to promote Th2 
immunity through the activation of inflammatory DCs 23. High-mobility group box 1 (HMGB-
1) is a highly conserved chromatin binding protein 27, which enhances the production of pro-
inflammatory cytokines by activating neutrophils and DCs 28,29. Hyaluronic acid (HA) is a high 
molecular weight (HMW >1 x 106) polysaccharide, ubiquitously present in the extracellular 
matrix of all vertebrates. Upon tissue damage or inflammation, HMW HA breaks down into 
small low molecular weight (LMW) fragments (average molecular mass of 25 x 104 Da) with 
various pro-inflammatory properties, such as enhanced maturation of DCs 30 or activation of 
alveolar macrophages 31. HA synthase genes Has1 and Has2 are responsible for the 
production of HMW HA, while Has3 creates LMW fragments. In addition, hyaluronidase 
Hyal2 degrades HMW HA into LMW fragments, which are further degraded into 
oligosaccharides by Hyal1 encoded enzymes 32. Since DAMP molecules are released upon 
tissue damage or stress, we hypothesize that CS may synergize with HDM allergens to 
further increase epithelial injury and the release of DAMP molecules.  
 
5.2. Preliminary results 
5.3.1. Uric acid is increased after acute and prolonged HDM/CS exposure 
3 days of CS inhalation and one HDM application (Figure 1) significantly increased the level 
of uric acid (UA) in lung homogenate, compared to sole HDM or CS exposed mice (Figure 5a). 
The difference in UA concentration between the experimental groups, became even more 
pronounced after 3 weeks of concomitant HDM/CS exposure (Figure 5b) (Figure 6), meaning 
that UA might be an important trigger during CS-induced facilitated sensitization and 
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subsequent asthma development. No difference in BAL uric acid concentrations were 
measured between the groups (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Pulmonary levels of uric acid a) in Balb/c mice simultaneously exposed to phosphate buffered saline 
(PBS) or house dust mite (HDM) combined with air or cigarette smoke (CS) for 3 days or b) 3 weeks. Results are 
expressed as means ± SEM; n=8 animals/group. *p<0.05; **p<0.01; ***p<0.001. 
 
 
 
 
 
 
 
Figure 6: Exposure protocol 2.  To evaluate the effect of cigarette smoke on the development of HDM-induced 
allergic asthma, we exposed mice to cigarette smoke for 3 consecutive weeks and instilled HDM extract once a 
week. 4 groups were included in our experimental set-up: PBS/air, PBS/CS (sole CS), HDM/air (sole HDM) and 
HDM/CS. 
 
5.3.2. Hyaluronan is increased after prolonged, concomitant HDM and CS exposure  
The level of total hyaluronan in BAL fluid was enhanced after 3 days of CS exposure (Figure 
1) (Figure 7a), but even further increased after a more prolonged and concomitant exposure 
to HDM and CS for 3 weeks (Figure 6) (Figure 7b). Within the 3 week exposure model, we 
quantified the deposition of HA in the airway wall after immunohistochemical staining of 
lung tissue sections. Using color recognition, quantification revealed no difference between 
all 4 groups (Figure 7c). To find an explanation for the enhanced concentration of HA in BAL 
fluid after 3 week of HDM and CS, we studied the expression of the HA synthase and 
hyaluronidase genes on total lung. RT-PCR revealed a significant decrease of the mRNA 
expression of Has1 after sole HDM or CS exposure and an increased expression of Has3 after 
CS inhalation (Figure 7d,e). In addition, no difference in the expression profile of Has2, Hyal1 
and Hyal2 was found between the groups (data not shown).  
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Figure 7: The role of hyaluronic acid (HA) during concomitant exposure to phosphate buffered saline (PBS) or 
house dust mite (HDM) combined with air or cigarette smoke (CS). a) Protein levels of HA in Balb/c mice 
exposed to PBS or HDM, combined with air or CS for 3 days. b) Protein levels of HA in mice exposed to PBS or 
HDM, combined with air or CS for 3 weeks. c) Quantitative measurement of the HA deposition in lung tissue 
upon 3 weeks of PBS or HDM and air or CS exposure. d) mRNA expression of HA modulating enzymes Has1 and 
e) Has3 in mice concomitantly exposed to PBS or HDM and air or CS exposure of 3 weeks. Results are expressed 
as means ± SEM; n=8 animals/group. *p<0.05; **p<0.01; ***p<0.001. 
 
5.3.3. High-mobility group box 1 is not enhanced after simultaneous HDM/CS exposure 
The evaluation of the HMGB-1 level in BAL fluid after acute HDM/CS exposure revealed no 
difference between the 4 groups (Figure 8a). HMGB-1 was significantly enhanced after 3 
weeks of sole HDM or CS exposure, but not additionally after concomitant exposure to both 
stimuli (Figure 8b). 
 
 
 
 
 
Figure 8: Bronchoalveolar lavage (BAL) levels of high-mobility group box 1 (HMGB-1) a) in Balb/c mice 
simultaneously exposed to phosphate buffered saline (PBS) or house dust mite (HDM) combined with air or 
cigarette smoke (CS) for 3 days or b) 3 weeks and measured by ELISA. Results are expressed as means ± SEM; 
n=8 animals/group. *p<0.05; **p<0.01; ***p<0.001. 
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5.3. Discussion 
We examined the production of DAMP molecules during allergic sensitization and asthma 
development. We observed a significantly higher release of uric acid (UA) upon acute and 
prolonged HDM/CS exposure, suggesting a potential role for this molecule during CS-induced 
facilitated sensitization and asthma progression. UA as been identified as a promoter of 
mucosal Th2 sensitization by amplifying the epithelial production of innate pro-Th2 
cytokines and the activation of DCs 23. Kool et al. elegantly demonstrated the release of 
endogenous UA upon HDM administration 23 or alum injection 33. Because alum has been 
detected at high concentrations in CS 34, the presence of this adjuvant may explain the 
additional release of UA upon concomitant HDM/CS exposure and may clarify the observed 
increase in allergic sensitization upon CS inhalation. Furthermore, UA is a potent antioxidant 
which is produced in response to oxidative stress 35, originating from environmental factors 
such as HDM allergens or CS 36,37. 
In line with previous reports 38,39, we demonstrated increased pulmonary hyaluronic acid 
(HA) after acute CS inhalation. Moreover, BAL levels of HA further enhanced upon prolonged 
and concomitant HDM/CS exposure, illustrating the synergistic effect of CS during ongoing 
allergic inflammation. The observed increase in HA after 3 weeks of concomitant HDM/CS 
exposure, could not be explained from the gene expression profile of HA modulating 
enzymes on total lung. However, mRNA expression of Has1 and Has3 rather suggested a net 
production of pro-inflammatory LMW fragments. Importantly, the possible difference in 
gene expression between various groups, can become lost in total lung. Therefore, it might 
be useful to examine the expression of HA modulating enzymes in more specific cells types, 
such as fibroblasts or airway epithelial cells. 
 
These preliminary results point to a role for DAMP molecules during enhanced CS-induced 
allergic sensitization and asthma development in mice, however additional experiments are 
needed to unravel their impact into more detail. 
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6. Methods 
 
Mice 
Balb/c mice (6-8 weeks old) were purchased from Harlan (Zeist, the Netherlands). 
Homozygous breeding pairs of IL1RI knockout (KO) mice and C57Bl/6 control mice (6-10 
weeks old) were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Mice were 
bred in the animal facility at the Faculty of Medicine and Health Sciences, Ghent University 
(Ghent, Belgium). Animals were maintained in standard conditions under a 12 hour 
light/dark cycle, provided a standard diet and chlorinated tap water ad libitum. All in vivo 
manipulations were approved by the Animal Ethical Committee of the Faculty of Medicine 
and Health Sciences of Ghent University.  
 
Exposure protocol 
To unravel the impact of CS on the early sensitization phase or on asthma development, 
mice (n = 8 mice per group) were subjected to whole body CS (3R4F Kentucky Reference 
cigarettes), for 3 days (Figure 1) or 3 consecutive weeks (Figure 6) respectively. Control mice 
were exposed to air. 30 minutes after the last smoke exposure, 25 μg HDM extract 
(Dermatophagoides pteronyssinus) (Greer Laboratories, Lenoir, NC, USA) or PBS was 
administered intranasally, once a week. 24 hours after the last smoke exposure and 72 hours 
after the last HDM application, mice were euthanized with an overdose of pentobarbital 
(Sanofi-Ceva, Paris, France).  
 
Bronchoalveolar lavage and cytospins 
A tracheal cannula was inserted and BAL was performed by instillation of 3 x 300 μl of HBSS 
supplemented with 1% BSA (Dade Behring, Eschborn, Germany).  The supernatant of the 
recovered BAL fluid was used for cytokine analysis.  Three additional instillations with 1 ml of 
HBSS plus EDTA were performed to achieve maximal recovery of BAL cells. A total cell count 
was performed in a Bürker chamber and differential cell counts (on at least 400 cells) were 
performed on cytocentrifuge preparations using standard morphologic criteria after May-
Grünwald-Giemsa staining.  Remaining cells were used for FACS-analysis. 
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Lung and mediastinal lymph nodes single-cell suspensions 
Lungs were perfused with saline plus EDTA through the pulmonary artery to remove 
contaminating blood cells. Lungs and mediastinal lymph nodes (mLN) were removed and 
digested as described previously 40. Briefly, minced lung pieces and LNs were incubated with 
1 mg/ml collagenase type 2 (Worthington Biochemical, Lakewood, NY) and 0.02 mg/ml 
DNase I (grade II from bovine pancreas, Boehringer Mannheim, Brussels, Belgium) for 45 min 
at 37°C and 5% CO2. Red blood cells were lysed using ammonium chloride buffer. Finally, cell 
suspensions were filtered through a 50 μm nylon mesh to remove undigested organ 
fragments.  
 
Flow cytometry 
All staining procedures were performed in PBS without Ca2+ or Mg2+ containing 5mM EDTA 
and 1% BSA.  To minimize non-specific binding, single-cell suspensions were pre-incubated 
with Fc-blocking antibody (anti-CD16/CD32, clone 2.4G2). Monoclonal antibodies (mAbs) 
used to identify mouse DC populations were anti-CD11c (clone HL3), anti-I-Ab (clone AF6-
120.1) and anti-CD11b (clone M1/70). In a last step before analysis, cells were incubated 
with 7-aminoactinomycin D (or viaprobe; BD Pharmingen) to check cell viability. Flow 
cytometry data acquisition was performed on a FACSCaliburTM running CellQuestTM software 
(BD Biosciences, San Jose, CA, USA). FlowJo software was used for data analysis (TreeStar 
Inc., Ashland, OR, USA). 
 
Mediastinal lymph node cell culture 
MLN were collected into sterile tubes containing cold (4°C) tissue culture medium (TCM) and 
digested to obtain a single cell suspension. TCM was prepared using RPMI 1640 
supplemented with 5% fetal bovine serum, L-glutamine, penicillin/streptomycin and β-
mercaptoethanol (all from Gibco BRL; Invitrogen Corp). Cells were then transferred in 
triplicate to round-bottom, 96-well plates (Becton Dickinson (BD), BD, CA, USA) with or 
without 15 μg HDM extract/ml culture medium, at a density of 2 x 105 cells per well and 
incubated in a humidified 37°C incubator with 5% CO2.  After 5 days, supernatants were 
harvested and frozen for cytokine measurements. 
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Cytokine and DAMP measurements 
Uric acid was evaluated in BAL supernatant, using the Amplex Red Uric Acid/Uricase Assay 
Kit (Invitrogen, Merelbeke, Belgium). BAL hyaluronan (HA) and HMGB-1 were measured 
using commercially available ELISA kits (Tebu-bio, Boechout, Belgium) (Gentaur, 
Kampenhout, Belgium). IL-α and IL-1β were determined in the supernatant of crushed lungs 
with ELISA (R&D Systems, Abingdon, UK). Within the supernatant of MLN cultures, IL-4, IL-5 
and IL-13 were assayed by means of ELISA (R&D Systems, Abingdon, UK) following the 
manufacturer’s instructions.  
 
Histology 
The left lung was fixated by intratracheal infusion of 4% paraformaldehyde. Histolocalization 
of HA was determined on paraffin sections using biotin-labeled HA-binding protein (HABP-b) 
(Seikagaku, Tokyo, Japan). Sections were subjected to deparaffinization followed by 
rehydration and were stained with HABP-b (2 μg/ml) at room temperature for 1 hour. After 
washing, the DAKO Cytomation Streptavidine ABComplex/HRP system was used according to 
the manufacturer’s instructions (DAKO, Glostrup, Denmark). Enzymatic reactivity was 
visualized with the Vector NovaRED peroxidase substrate kit (Vector, Burlingame, CA). 
Sections were lightly counterstained with hematoxylin and mounted in Faramount (DAKO). 
The HABP-b staining in the airway walls was quantified, using a Zeiss KS400 image analyser 
platform (KS400, Zeiss, Oberkochen, Germany). For the visualization of E-cadherin, lung 
sections were stained with mouse-anti-E-cadherin (1/800, BD Biosciences, Erembodegem, 
Belgium) as described before 12. Immunostains were developed using 3-amino-9-
ethylcarbazole (AEC) substrate and quantifications were performed using color recognition 
by the KS400 software. 
 
RT-PCR 
Total lung RNA was extracted with the RNeasy Mini Kit (Qiagen, Hilden, Germany). Real-time 
PCR reactions were performed in duplicate using diluted cDNA (dilution 1:25), 0.6 
pmol/primer (custom designed) and IQ SYBR Green Supermix I dye (Bio-Rad, Hercules, CA) in 
a total volume of 20 μl as described in reference 38. RT-PCR was performed on a LightCycler 
480 Instrument (Roche Diagnostics, Basel, Switzerland). The expression of the hyaluronan 
synthase (Has1, Has2, Has3) and hyaluronidase genes (Hyal1, Hyal2) was corrected by a 
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normalization factor, calculated based on the expression of three reference genes (Hprt1, 
Ppia, Rpl13a).  
 
Statistical analysis 
Reported values are expressed as mean ± SEM. Statistical analysis was performed with PASW 
Statistics 18 using non-parametric tests. The different experimental groups were compared 
by a Kruskal-Wallis test for multiple comparisons. Only when a p-value ≤ 0.05 was obtained 
with the Kruskal-Wallis test, we performed post hoc pairwise comparisons by means of a 
Mann-Whitney U test. A p-value ≤ 0.05 was considered significant. 
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1. Abstract 
 
Background: Cigarette smoke (CS) is a major risk factor for the development of COPD. CS 
exposure is associated with an increased risk of bacterial colonization and respiratory tract 
infection, because of suppressed antibacterial activities of the immune system and delayed 
clearance of microbial agents from the lungs. Colonization with Staphylococcus aureus 
results in release of virulent enterotoxins, with superantigen activity which causes T cell 
activation. 
Objective: To study the effect of Staphylococcus aureus enterotoxin B (SEB) on CS-induced 
inflammation, in a mouse model of COPD. 
Methods: C57/Bl6 mice were exposed to CS or air for 4 weeks (5 cigarettes/exposure, 
4x/day, 5 days/week). Endonasal SEB (10 μg/ml) or saline was concomitantly applied starting 
from week 3, on alternate days. 24 h after the last CS and SEB exposure, mice were sacrificed 
and bronchoalveolar lavage (BAL) fluid and lung tissue were collected. 
Results: Combined exposure to CS and SEB resulted in a raised number of lymphocytes and 
neutrophils in BAL, as well as increased numbers of CD8+ T lymphocytes and granulocytes in 
lung tissue, compared to sole CS or SEB exposure. Moreover, concomitant CS/SEB exposure 
induced both IL-13 mRNA expression in lungs and goblet cell hyperplasia in the airway wall. 
In addition, combined CS/SEB exposure stimulated the formation of dense, organized 
aggregates of B- and T- lymphocytes in lungs, as well as significant higher CXCL-13 (protein, 
mRNA) and CCL19 (mRNA) levels in lungs. 
Conclusions: Combined CS and SEB exposure aggravates CS-induced inflammation in mice, 
suggesting that Staphylococcus aureus could influence the pathogenesis of COPD.  
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2. Introduction 
 
Cigarette smoking is associated with an increased risk of bacterial colonization and 
respiratory tract infection, because of suppressed antibacterial activities of the immune 
system and delayed clearance of microbial agents from the lungs 1. This is particularly 
relevant in COPD patients, where bacterial colonization in the lower respiratory tract has 
been shown 2. These bacteria are implicated both in stable COPD and during exacerbations, 
where most commonly pneumococci, Haemophilus influenza, Moraxella catarrhalis and 
Staphylococcus aureus (S. aureus) are found 3. Interestingly, colonization with S. aureus may 
embody a major source of superantigens as a set of toxins are being produced including S. 
aureus enterotoxins (SAEs) 4. These toxins activate up to 20% of all T cells in the body by 
binding the human leukocyte antigen (HLA) class II molecules on antigen-presenting cells 
(APCs) and specific V beta regions of the T cell receptor 5. Between 50 and 80% of S. aureus 
isolates are positive for at least one superantigen gene, and close to 50% of these isolates 
show superantigen production and toxin activity 6. 
During the last few years, it became increasingly clear that SAEs are known to modify airway 
disease 7, like allergic rhinitis 8, nasal polyposis 9 and asthma 10. Furthermore, studies have 
shown a putative role for SAEs in patients suffering from the atopic eczema/dermatitis 
syndrome (AEDS), where colonization with S. aureus is found more frequently (80-100%) 
compared to healthy controls (5-30%) 11, and S. aureus isolates secrete identifiable 
enterotoxins like Staphylococcus aureus enterotoxin A and B (SEA, SEB) and toxic shock 
syndrome toxin (TSST)-1. Until now, evidence for SAE involvement in the pathogenesis of 
upper airway disease like chronic rhinosinusitis with nasal polyposis (CRSwNP), arises from 
the finding that IgE against SEA and SEB has been demonstrated in nasal polyps 12 and levels 
of SAE-specific IgE in nasal polyposis correlated with markers of eosinophil activation and 
recruitment 13. Similarly, in COPD patients, a significantly elevated IgE to SAE was found, 
pointing to a possible disease modifying role in COPD, similar to that in severe asthma 14. 
Moreover, we have recently demonstrated the pro-inflammatory effect of SEB on human 
nasal epithelial cells in vitro, resulting in augmented granulocyte migration and survival 15.  
In murine research, the role of SAEs as inducer and modifier of disease has been 
demonstrated in models of airway disease 16,17, allergic asthma 18, atopic dermatitis 19 and 
food allergy 20. These findings highlight the important pathological consequences of SAE 
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exposure, as these superantigens not only cause massive T-cell stimulation, but also lead to 
activation of B-cells and other pro-inflammatory cells like neutrophils, eosinophils, 
macrophages and mast cells 21. 
To date, the exact pathomechanisms of COPD are not yet elucidated. Cigarette smoking is a 
primary risk factor for the development of COPD, but only 20% of smokers actually develop 
the disease, suggesting that genetic predisposition plays a role 22. However, understanding 
the impact of toxin-producing bacteria on cigarette-smoke induced inflammation might 
provide novel insights into the pathogenesis of smoking-related disease such as COPD. 
Therefore, we investigated the effects of concomitant Staphylococcus aureus Enterotoxin B 
(SEB) application on a well established mouse model of cigarette-smoke (CS) induced 
inflammation 23. We evaluated inflammatory cells and their mediators in bronchoalveolar 
lavage (BAL) fluid and lung tissue, looked at systemic effects by measuring serum 
immunoglobulins, and evaluated goblet cell hyperplasia and lymphoid neogenesis. 
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3. Methods 
 
Experimental protocol 
Male C57BL/6 mice (n=8), 6–8 weeks old were purchased from Charles River Laboratories 
(Brussels, Belgium). Mice were exposed to the tobacco smoke of five cigarettes (Reference 
Cigarette 2R4F without filter, University of Kentucky, Lexington, KY, USA) four times per day 
with 30 min smoke-free intervals 24. The animals were exposed to mainstream cigarette 
smoke (CS) by whole body exposure, 5 days per week for 4 weeks. Control groups (8 age-
matched male C57BL/6 mice) were exposed to air. Starting from day 14 of the CS exposure, 
mice received concomitant endonasal application of SEB (50 μL – 10 μg/mL - Sigma-Aldrich, 
LPS content below detection limit) or Saline, on alternate days. This dose was chosen based 
on Hellings et al. 18.  For the application, mice were slightly anaesthetized with isoflurane, 
and six applications were performed as depicted in Figure 1. All experimental procedures 
were approved by the local ethical committee for animal experiments (Faculty of Medicine 
and Health Sciences, Ghent University). The results section contains data from one 
representative experiment out of three independent experiments. 
 
Figure 1: Experimental protocol. Male C57BL/6 mice (n = 8) were exposed to cigarette smoke(CS) of five 
cigarettes, four times per day with 30 min smoke-free intervals. Controls were exposed to air. Starting from day 
14 of the CS exposure, mice received concomitant endonasal application of SEB (50 μL - 10 μg/mL) or saline, on 
alternate days. 
 
Bronchoalveolar lavage and cytospins 
Twenty-four hours after the last cigarette smoke (CS) exposure and endonasal application, 
mice were sacrificed by a lethal dose of pentobarbital (Sanofi-Synthelabo). A cannula was 
inserted in the trachea, and BAL was performed by instillation of 3 x 300 μl of HBSS 
supplemented with BSA for cytokine measurements. Three additional instillations with 1 ml 
of HBSS plus EDTA were performed to achieve maximal recovery of BAL cells. A total cell 
count was performed in a Bürker chamber. Approximately fifty thousand BAL cells were 
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processed for cytospins and were stained with May-Grünwald-Giemsa for differential cell 
counting. The remaining cells were used for FACS analysis. 
 
Preparation of lung single-cell suspensions 
Blood was collected via retro-orbital bleeding. Then, the pulmonary and systemic circulation 
was rinsed to remove contaminating blood cells. Lungs were taken and digested as described 
previously 24. Briefly, minced lung pieces were incubated with 1 mg/ml collagenase and 20 
μg/ml DNase I for 45 min at 37°C. Red blood cells were lysed using ammonium chloride 
buffer. Finally, cell suspensions were filtered through a 50-μm nylon mesh to remove 
undigested organ fragments. 
 
Flow cytometry 
All staining procedures were conducted in calcium- and magnesium-free PBS containing 10 
mM EDTA, 1% BSA (Dade Behring), and 0.1% sodium azide. Cells were preincubated with 
anti-CD16/CD32 (2.4G2) to block Fc receptors. Antibodies used to identify mouse DC 
populations were anti-CD11c-allophycocyanin (APC; HL3) and anti-I-Ab-phycoerythrin (PE; 
AF6-120.1). The following mAbs were used to stain mouse T-cell subpopulations: anti-CD4-
fluorescein isothiocyanate (FITC; GK1.5), anti-CD8-FITC (53-6.7), anti-CD3-APC (145-2C11) 
and anti-CD69-PE (H1.2F3). To identify granulocytes, anti-Gr-1-PE (RB6-8C5) and anti-CD11c-
APC (HL3) were used. As a last step before analysis, cells were incubated with 7-
aminoactinomycin D (or viaprobe; BD Pharmingen) for dead cell exclusion. All labeling 
reactions were performed on ice in FACS-EDTA buffer. Flow cytometry data acquisition was 
performed on a FACScaliburTM running CellQuestTM software (BD Biosciences, San Jose, CA, 
USA).  
 
Measurement of Immunoglobulins 
Retro-orbital blood was drawn for measurement of total IgE, IgG, IgM and IgA with ELISA. 
Commercially available ELISA kits were used to determine serum and BAL titers of IgG 
(ZeptoMetrix, Buffalo, NY, USA), IgM (ZeptoMetrix, Buffalo, NY, USA) and IgA (Alpha 
Diagnostic International, San Antonio, TX, USA).  For the measurement of total IgE, a two-
side in-house sandwich ELISA was used, with two monoclonal rat anti-mouse IgE antibodies 
reacting with different epitopes on the epsilon heavy chain (H. Bazin, Experimental 
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Immunology Unit, UCL, Brussels, Belgium). The second antibody was biotinylated and 
detected colorimetrically after adding horseradish peroxidase-streptavidine conjugate.  
Absorbance values, read at 492 nm (Labsystems Multiscan RC, Labsystems b.v., Brussels, 
Belgium) were converted to concentrations in serum and BAL fluid by comparison with a 
standard curve obtained with mouse IgE of known concentration (H. Bazin). 
 
Goblet cell analysis 
Left lung was fixed in 4% paraformaldehyde and embedded in paraffin.  Transversal sections 
of 3 μm were stained with periodic acid-Schiff (PAS) to identify goblet cells. Quantitative 
measurements of goblet cells were performed in the airways with a perimeter of basement 
membrane (Pbm) ranging from 800 to 2000 μm. Results are expressed as the number of 
goblet cells per millimeter of basement membrane. 
 
Morphometric quantification of lymphoid neogenesis 
To evaluate the presence of lymphoid infiltrates in lung tissues, sections obtained from 
formalin-fixed, paraffin-embedded lung lobes were subjected to an immunohistological 
CD3/B220 double-staining as described previously 24. Infiltrates in the proximity of airways 
and blood vessels were counted. Accumulations of ≥50 cells were defined as lymphoid 
aggregates. Counts were normalized for the number of bronchovascular bundles per lung 
section. 
 
RT-PCR analysis 
Total lung RNA was extracted with the Rneasy Mini kit (Qiagen, Hilden, Germany). 
Expression of CXCL-13, CCL19, IL-13 and MIP-3α mRNA relative to HPRT mRNA 25, were 
performed with Assay-on-demand Gene Expression Products (Applied Biosystems, Foster 
City, CA, USA).  Real-time RT PCR for CCL21-leucine and CCL21-serine started from 25 ng of 
cDNA.  Primers and FAM/TAMRA probes were synthesized on demand (Sigma-Proligo).  
Primer/probe sequences and PCR conditions were performed as described previously 26,27. 
 
Protein measurement in BAL 
CXCL13 protein levels in BAL supernatant were determined using a commercially available 
ELISA (R&D Systems, Abingdon, UK). Cytometric Bead Array (BD Biosciences, San Jose, CA, 
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USA) was used to detect the cytokines KC, MCP-1, IL-17A and IFN-γ in the supernatant of BAL 
fluid. 
 
Statistical analysis 
Reported values are expressed as mean ± SEM. Statistical analysis was performed with SPSS 
software (version 18.0) using nonparametric tests. The different experimental groups were 
compared by a Kruskal-Wallis test for multiple comparisons. When a p-value ≤ 0.05 was 
obtained with the Kruskal-Wallis test, pairwise comparisons were made by means of a 
Mann-Whitney U test with Bonferroni corrections for multiple comparisons. A p-value p ≤ 
0.05 was considered significant. 
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4. Results 
 
4.1. SEB aggravates the CS-induced pulmonary inflammation 
To evaluate the effects of Staphylococcus aureus enterotoxin B (SEB) on cigarette smoke 
(CS)-induced pulmonary inflammation, C57Bl/6 mice were exposed to CS for 4 weeks, with a 
concomitant SEB exposure during the last 2 weeks (Figure 1). 
In BAL fluid, sole endonasal SEB application and sole CS-exposure resulted in increased 
numbers of total cells, alveolar macrophages, dendritic cells (DCs), lymphocytes and 
neutrophils, compared to air/saline exposed animals (Figure 2A-E). However, these increases 
in cell numbers were much more pronounced upon SEB application compared to CS-
exposure. Also a modest eosinophilic inflammation was observed in the SEB-exposed groups 
(Figure 2F). 
Figure 2: BAL fluid analysis. Total BAL cells and cell differentiation in BAL fluid of mice exposed to saline or SEB, 
combined with air or CS. A) Total BAL cells, B) macrophages, C) dendritic cells, D) lymphocytes, E) neutrophils, F) 
eosinophils. Results are expressed as mean ± SEM, n = 8 animals/group, *p < 0.05, **p < 0.01. 
 
 
Interestingly, the combination of CS exposure and SEB significantly increased BAL neutrophil 
numbers compared to sole CS or SEB exposure (Figure 2E). Also BAL lymphocyte numbers in 
smoke-exposed mice were increased upon SEB application (Figure 2D).  
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In lung single cell suspensions, SEB solely induced an increase in DCs, CD3+ T cells and 
macrophages, whereas CS exposure caused increased DCs and CD3+ T cells in lung tissue 
(Figure 3A,D,B). Interestingly, combined CS and SEB exposure caused a further increase in 
CD3+ T cells, and more specifically CD8+ T-cells, compared to CS or SEB alone (Figure 3D,F). 
Also DC, CD4+ T-cells and GR1+ cells tended to be higher in the combined CS/SEB group 
versus sole CS or SEB application (Figure 3A,E,C).  
Figure 3: Lung cell differentiation. Flow cytometric analysis of cells from lung digest: A) dendritic cells, B) 
macrophages, C) GR1+ cells, D) CD3+ T lymphocytes, E) CD4+ T lymphocytes and F) CD8+ T lymphocytes from 
mice exposed to saline or SEB, combined with air or CS. Results are expressed as mean ± SEM, n = 8 
animals/group, *p < 0.05. 
 
 
4.2. Increased IL-17A in BAL upon combined SEB and CS exposure 
As previously described [24], 4-wk CS-exposure clearly induced high levels of KC (mouse 
homolog for IL-8) and MCP-1 in BAL (Figure 4A,B). In contrast sole SEB application induced a 
modest increase in KC, and very low levels of IFN-γ and IL-17A (Figure 4A,D,C) . Whereas the 
CS-induced KC and MCP-1 levels in BAL were not affected by an additional SEB exposure, the 
combined CS and SEB exposure did induce IL-17A levels in BAL, compared to single CS or SEB 
exposure (Figure 4C). Also IFN-γ levels tended to be highest in the combined CS/SEB group 
(Figure 4D). mRNA levels of MIP-3α were increased after both CS or SEB exposure. Combined 
CS/SEB exposure did not cause a further MIP-3α increase (Figure 4E). 
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Figure 4: Protein measurements in BAL fluid. Protein levels of A) KC, B) MCP-1, C) IL-17A, D) IFN-γ in BAL fluid of 
mice exposed to saline or SEB, combined with air or CS, as measured with ELISA. E) mRNA expression of MIP-3α 
in total lung tissue, measured by RT-PCR. The results are expressed as ratio with hypoxanthine guanine 
phosphoribosyltransferase (HPRT) mRNA. Results are expressed as mean ± SEM, n = 8 animals/group, *p < 0.05, 
**p < 0.01. 
 
4.3. SEB induces IgA and IgM levels in BAL 
Systemic effects of either CS or SEB, or both were evaluated in serum, but no significant 
differences in total IgG, IgM, IgA or IgE levels were detected between the experimental 
groups. In BAL, CS exposure tended to increase IgA. Both IgA and IgM levels in BAL were 
significantly increased upon SEB-exposure (Figure 5). IgE in BAL was below the detection 
limit. 
 
Figure 5: BAL fluid immunoglobulin levels. A) Total IgA and B) total IgM in BAL fluid of mice exposed to saline 
or SEB, combined with air or CS. Results are expressed as mean ± SEM, n = 8 animals/group, *p < 0.05. 
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4.4. Combined CS/SEB exposure affects epithelial remodeling 
Epithelial remodeling was evaluated by counting the number of PAS-positive goblet cells per 
millimeter of basement membrane. A strong tendency towards increased numbers of goblet 
cells in the CS/SEB mice was observed, compared to all other conditions (Figure 6A,B). This 
finding correlated nicely with a significant increase in IL-13 mRNA expression in total lung in 
CS/SEB mice (Figure 6C). 
Figure 6: Epithelial remodeling. A) Histological evaluation of goblet cell hyperplasia on Periodic Acid Schiff 
(PAS) stained lung tissue sections of mice exposed to saline or SEB, combined with air or CS. B) Quantification of 
goblet cells. C) mRNA expression of IL-13, relative to a housekeeping gene (HPRT) was measured on total lung 
homogenates by RT-PCR. Results are expressed as mean ± SEM, n = 8 animals/group, *p < 0.05. 
 
4.5. Combined CS/SEB induces the formation of dense lymphoid aggregates in lung tissue 
Previously, our group has demonstrated increased lymphoid neogenesis after 6 months of 
CS-exposure 25. As earlier shown in the CS-model, subacute CS-exposure as such did not 
result in lymphoid neogenesis. Interestingly however, already after 4-wk CS-exposure, 
dense, organized lymphoid aggregates could be demonstrated in the combined CS/SEB 
group whereas air/SEB mice displayed mainly loose, non-organized lymphoid aggregates 
(Figure 7). 
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Figure 7: Evaluation of lymphoid aggregates in lung tissue. A) Photomicrographs of lymphoid aggregates in 
CD3/B220 immuno-stained lung tissue of mice exposed to saline or SEB, combined with air or CS (brown: CD3 
positive cells; blue: B220 positive cells). B) Quantification of loose and dense lymphoid aggregates located in the 
bronchovascular area. Results are expressed as mean, n = 8 animals/group, *p < 0.05, **p < 0.01. 
 
Since CXCL13, CCL19 and CCL21 are chemokines involved in the homeostatic trafficking of 
leukocytes, mainly lymphocytes, to the secondary and tertiary lymphoid tissues, their 
expression was also evaluated in this model. The increase in dense lymphoid aggregates in 
CS/SEB mice correlated nicely with significant increases in CXCL13 (protein levels in BAL fluid, 
mRNA levels in total lung) (Figure 8A,B) and CCL19 (mRNA levels) expression in CS/SEB mice 
compared to all other groups (Figure 8E). CCL21 mRNA levels (both isoforms CCL21-Ser and 
CCL21-Leu) decreased upon CS exposure, confirming previous findings of CCL21 
downregulation upon subacute CS exposure 26 and decreased even further in the CS/SEB 
group. Intriguingly, the CCL21 mRNA levels of both isoforms tended to increase upon sole 
SEB exposure (Figure 8C,D). 
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Figure 8: Chemokines involved in the homeostatic trafficking of leukocytes. Measurements of lymphoid 
chemokines in lung tissue and BAL fluid. mRNA expression of A) CXCL-13, C) CCL21-Ser, D) CCL21-Leu and E) CCL-
19 in total lung tissue of mice exposed to saline or SEB, combined with air or CS, measured by RT-PCR. The 
results are expressed relative to HPRT mRNA. B) Protein levels of CXCL-13 in BAL fluid as measured by ELISA. 
Results are expressed as mean ± SEM, n = 8 animals/group, *p < 0.05. 
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5. Discussion 
 
We hereby describe a novel mouse model of combined Staphylococcus aureus enterotoxin B 
(SEB) application and cigarette smoke exposure, which results in a significant aggravation of 
key features of cigarette smoke (CS)-induced pulmonary inflammation, such as neutrophils 
and CD8+ T cells in BAL and lung. Furthermore, levels of IL-17A in BAL were significantly 
increased upon concomitant SEB and CS exposure, compared to sole exposures of SEB or CS. 
In addition, tendencies of increased goblet cell hyperplasia, IL-13 mRNA expression and 
lymphoid neogenesis in smoke/SEB mice have been demonstrated, as well as increased 
expression of the relevant chemokines CXCL13 and CCL19. Altogether, these findings point 
to a possible disease-modifying role for SEB in CS-induced inflammation in this mouse model 
of subacute CS exposure. 
Increasing evidence from human and murine research suggests that SEB is able to aggravate 
underlying disease. Moreover, SEB itself is also able to induce inflammation, depending on 
the dosage and timing of the experimental protocol {892}{895}. Interestingly, these findings 
are not confined to SEB, as other staphylococcal superantigens demonstrate similar effects 
upon mucosal contact 28,29. In line with previously reported findings, in our model sole 
endonasal SEB application caused an increase in total BAL cell number, lymphocytes and 
neutrophils 16. Moreover, we could demonstrate raised numbers of macrophages and 
dendritic cells, a finding previously reported after S. aureus enterotoxin A exposure 28,29. In 
the latter studies however, the authors could not demonstrate increased eosinophils, which 
was the case in our model. The superantigen effect of SEB caused the expected lymphocyte 
accumulation in BAL, which appeared to be non-specific, as both CD4+ and CD8+ T cells were 
increased. These data stress the potency of staphylococcal superantigens of initiating a 
massive immune response. 
Concomitant CS/SEB exposure lead to a remarkable increase in neutrophil number, 
compared to CS or SEB exposure alone. Although the findings for neutrophils in lung 
(measured with granulocyte marker GR-1) were less convincing than in BAL, the combined 
CS/SEB group showed the highest number of GR-1+ cells. Interestingly, also the CD8+ T cell 
fraction in lung single cell suspensions, was significantly upregulated when smoke and SEB 
were combined. The potential clinical relevance of increased neutrophil and CD8+ T-cell 
numbers lays in the fact that neutrophilic inflammation in the airways in smokers correlates 
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with an accelerated decline in lung function 30, and increased T-cell numbers correlate with 
the amount of alveolar destruction and the severity of airflow obstruction 31.  
We confirm an increased MIP-3α expression in lungs after CS exposure leading to an 
accumulation of dendritic cells in this model 24. Interestingly, this increase in MIP-3α is also 
seen after SEB exposure, with raised DCs in BAL and airway parenchyma in these groups.  
As previously demonstrated in the subacute CS-model, we have observed an increase in 
levels of KC and MCP-1 after 4-wk CS exposure 24, explaining the accumulation of 
inflammatory cells in BAL and lung. Sole SEB application on the other hand resulted in raised 
levels of KC, IFN-γ and IL-17A, but not MCP-1. Interestingly, the combined exposure of 
smoke and SEB further increased the IL-17A levels, which might explain the exacerbated BAL 
neutrophilia in CS/SEB mice. Indeed, IL-17 is known to be important in neutrophil 
maturation, migration and function in the lung tissue and airways. Furthermore, IL-17 
induction of neutrophil activation and migration is important in defense against organisms 
infecting the lung 32. Interestingly, IL-17 can also induce eosinophilic accumulation, in 
particular circumstances 33.  
IL-17 is normally produced by CD4+ T cells, although it might also arise from CD8+ T cells and 
in some cases even from macrophages, neutrophils or eosinophils 34, as a necessary step in 
the normal immunity against bacterial infections in the airways. However, IL-17 has been 
linked to unfavorable outcome to infection, in particular in the presence of IFN-γ 35, resulting 
a high inflammatory pathology and tissue destruction. Increasing evidence dedicates a role 
to exaggerated recruitment and activation of neutrophils in the clinical course of airway 
diseases like COPD. Therefore, it is tempting to speculate on a role for SEB in the induction of 
IL-17 release, leading to the aggravation of cigarette smoke-induced inflammation, with 
increased number and activation of neutrophils, which causes amplification of tissue 
destruction and subsequent disease progression.  
In addition, we could observe already after 4-wks an increase in the number of dense 
lymphoid aggregates in CS/SEB mice, linked to increased levels of CXCL13 and CCL19, which 
are attractants for B- and T-cells respectively. Moreover, it has been described that the 
respective receptors for these chemokines – CXCR5 and CCR7 – are also expressed on Th17 
cells migrating into inflamed tissue 36, indicating a potential contribution of IL17-producing 
Th17 cells in this model of early COPD. The finding that lymphoid aggregates and the 
chemokines responsible for their neogenesis and organization 25 are already upregulated 
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after 4-wk CS/SEB exposure, stresses the clinical relevance of this novel model of combined 
CS and enterotoxin exposure. 
Staphylococcal superantigens are able to cause massive polyclonal T and B cell proliferation. 
Upon local application, as is done in this model, this leads to the mucosal synthesis of 
immunoglobulins, explaining the observed increase in BAL IgA and IgM. In humans, it is 
thought that continuous microbial stimulation leads to B cell turnover and plasma cell 
formation in nasal polyp disease, leading to an overproduction of immunoglobulins 37.  
In this mouse model of early stage COPD with goblet cell hyperplasia and increased number 
of lymphoid follicles, endonasal SEB application has resulted in augmented CS-induced lower 
airway inflammation. CS and subsequent bacterial colonization are, amongst others, factors 
believed to determine both progression of COPD, as well as the frequency and severity of 
COPD exacerbations 38. Therefore, mouse models of CS and bacterial co-exposure have been 
used in the past, mainly using Haemophilus influenza 39.  Bacterial colonization and infection 
is rare in lower airways, but not in upper airways. Local carriage of enterotoxin-producing S. 
aureus in the nasal cavity is common, although multiple sites can be colonized (e.g. skin, 
pharynx and perineum) 40. These toxins, like toxic shock syndrome toxin-1 (TSST-1), are 
known superantigens causing systemic diseases like food poisoning and toxic shock 
syndrome 4. In nasal polyp disease, these toxins are believed to drive the local 
immunoglobulin production in response to enterotoxin-producing S. aureus. 
The use of a single toxin instead of S. aureus in this model is both a strength and a limitation, 
since it simplifies the interpretation on one hand, but is not the real life situation on the 
other hand. Another limitation is that we cannot rule out endotoxin related effects in our 
model, although the LPS content of our SEB was below detection limit. Also the potential 
differences between our mouse model and the human situation concerning exposure to 
bacterial toxins and its effects on the balance of cytokines and inflammation is a limitation of 
the study. In addition, SEB on itself has resulted in pronounced inflammation in BAL and 
lungs, as it is a known superantigen. Finally, another possible limitation of this model is the 
short term (4-wk) CS exposure, whereas COPD is a chronic disease. Despite these limitations, 
altogether our findings indicate the importance of bacterial toxins present in the upper 
airways, affecting lower airway inflammation.  
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6. Conclusion 
 
The possible disease-modifying role for SAEs in COPD that has been described in humans 14, 
combined with our findings stress the potential role of airway colonizing and toxin-producing 
Staphylococcus aureus, in the pathophysiology of COPD 3.   
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Abstract 
 
The pulmonary innate immune system has evolved over millions of years to provide swift 
detection of inhaled microbial agents and trigger well-balanced protective responses. Much 
more recent on the evolutionary scale is human activity, which has resulted in the release of 
a new class of potentially harmful, non-microbial compounds into the air. These xenobiotics 
include combustion by-products such as reactive oxygen species and polycyclic aromatic 
hydrocarbons. This review will summarize evidence showing how airborne xenobiotics can 
engage pulmonary innate immunity components at many levels. We will focus on potential 
effects of xenobiotics on airway dendritic cells, as these constitute key innate immune 
sensors in the lung, with the unique ability to initiate adaptive immunity. We propose that 
the aberrant processing of inhaled xenobiotics by an innate immune system that is now 
evolutionarily maladapted underlies the increase in chronic inflammatory lung diseases in 
modern times. 
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Ancient meets new: pulmonary innate immunity and the rise of anthropogenic airborne 
compounds 
 
The innate immune system of the lung is one of the most critical homeostatic systems in our 
body. Life-threatening damage to the delicate gas-exchange structures can either occur by a 
failure to rapidly detect and clear inhaled airborne pathogens, or can result from an 
unbridled inflammatory response. Pulmonary innate immune defenses consist of several 
interacting components 1. The integrity of the epithelial layer, combined with the 
mucociliary transport form a first mechanical barrier in the conductive airways. Surfactant 
proteins, synthesized by the epithelium of the deeper alveolar zones, bear structural analogy 
to serum complement and constitute an additional immediate defense mechanism 2. 
Phagocytic cells such as macrophages and neutrophils complete the picture by neutralizing 
persistent inhaled pathogens. Invariant NK-T-cells and dendritic cells are also important 
innate immune sensors of the lung, with the latter being unique in their ability to initiate 
primary adaptive immune responses. Both structural cells (epithelium) and leukocyte 
components of the pulmonary innate immune system are equipped with pathogen 
recognition receptors (PRRs), i.e. Toll-like receptors (TLRs), NOD-like receptors (NLRs) and 
RIG-like receptors (RLRs) and provide immediate sensing of pathogen-associated molecular 
patterns (PAMPs) from inhaled bacteria, viruses or fungi 3. 
It can be assumed that the pulmonary innate immune system had to co-evolve with the 
development of lungs in the first terrestrial vertebrates, i.e. during the Devonian era some 
350 million years ago. The explosive colonization of the land by a myriad of organisms that 
charactarized that period must have brought a constant selection pressure on the very first 
airway innate defense mechanisms. This would have forced a repertoire diversification of 
pathogen recognition receptors, which were in part structural variations on a theme that 
also evolved in land-based arthropods (e.g. Toll-molecules in insects). Seen in this time-scale, 
human evolution is an extremely recent event. Since prehistoric times, and boosted by the 
first industrial revolution, human activity has resulted in the ever increasing release of 
airborne products largely derived from the combustion of biomasses and fossil fuels. 
Inhalational exposure to carbonaceous fine particles such as diesel exhaust particles (DEPs), 
as well as to a broad array of volatile molecules such as carbon monoxide, nitrogen oxides, 
sulfur dioxides and the potentially carcinogenic polycyclic aromatic hydrocarbons (PAHs) 4 
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has increased proportionally with the growth of human communities (Table 1). Even higher 
levels of exposure to combustion products have been reached since the widespread use of 
tobacco. 
The purpose of this review is to examine how the immune system of the lung reacts to these 
evolutionary recent anthropogenic stimuli. Among the different cellular actors of pulmonary 
innate immunity, we will particularly focus on the network of airway dendritic cells, given 
their unique role as both innate immune sensors and controllers of adaptive immune 
responses. 
 Table 1: Overview of the major primary and secondary air pollutants and their natural vs anthropogenic sources.  
Primary pollutants constitute direct emissions, whereas secondary pollutants are formed as a result of primary 
pollutants undergoing chemical reactions. An important example of a secondary pollutant is ground level ozone, 
one of the pollutants that make up “photochemical” smog and a rich source of reactive oxygen species. 
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Airway dendritic cells: specialized immune sensors at the forefront of the lung-air interface 
 
Dendritic cells (DCs) are professional antigen presenting cells (APCs) capable of priming and 
sustaining the expansion of naïve T cells.  They are present in tissues in close contact to the 
external environment, such as the skin (called Langerhans cells), and mucosal surfaces of  
upper and lower airways, gastro-intestinal and urogenital tract. In the lung, DCs are located 
as a network immediately above and beneath the basement membrane of conductive 
airways, as wells as within the interalveolar septa of the deeper lung parenchyma 5. In the 
steady state, airway DCs can project their dendrites in between epithelial cells without 
breaking the epithelial layer integrity and sample the epithelial lining fluid which is in direct 
contact with the inhaled air 6. DCs are equipped with specialized receptors (e.g. C-type lectin 
receptors, TLRs) for antigen capture and for sensing PAMPs and danger-associated molecular 
patterns (DAMPs), the latter being released as a result of tissue damage (whether as result 
of microbial invasion or not) 7. Inhalational exposure to PAMPs unveils the innate character 
of airway DC dynamics, as reflected by a fast and massive recruitment of these cells into the 
airways, being at least as rapid as the prototypical neutrophilic influx 8. Capture of inhaled 
antigen in the presence of PAMPs and/or DAMPs leads to DC activation, which initiates a 
series of events leading to the adaptive immune response: stimulated migration to the T-cell 
zones of draining thoracic lymph nodes, strong upregulation of processed antigen on surface 
major histocompatibility molecules (MHC) and upregulation of T-cell costimulatory 
molecules such as CD40 and B7-1, B7-2. An emerging paradigm is that the resulting T-cell 
polarization (T-helper 1, 2 or 17) is likely “programmed” as result of DC exposure to specific 
molecular patterns present at the time and place of antigen encounter in the periphery. This 
includes both direct stimulation of DCs by pathogen-derived factors, or indirect conditioning 
by innate factors released by surrounding cells. As an illustration of the latter, stimulation of 
TLR4 on airway epithelial cells results in the production of innate cytokines (including TSLP, 
GM-CSF and IL-33) and secondary activation of the DC network, which in this case is 
conditioned to induce a T-helper 2 polarized immune response 6.  
By contrast, aero-antigen sampling in the absence of innate stimuli is followed by steady 
state airway DC migration and antigen presentation in the draining LN 9, resulting in the 
induction of regulatory T-cells and establishment of inhalational tolerance 10. 
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With these concepts in mind, the question arises whether airborne xenobiotics can act 
directly as innate stimuli on airway dendritic cells, and if so, how this could affect the 
outcome of pulmonary immune responses. In the next sections, we will highlight the effects 
of two main active components in  inhaled xenobiotics on DC biology: reactive oxygen 
species (ROS) and polycyclic aromatic hydrocarbons (PAHs). It should be stressed that 
insights into these mechanisms have mostly been derived from in vitro models. Hence, 
extrapolation to in vivo situations must be made with caution: in a more realistic tissue or 
whole organism context, effects on DCs can also be indirect, as mentioned earlier. Co-culture 
models can provide additional useful information, as shown in a study involving dendritic 
cells incubated with bronchial epithelial cells. In this system, addition of DEPs triggers, in an 
oxidant-dependent manner, epithelial release of TSLP which then activates DCs and induces 
Th2 polarization 11. In vivo animal studies aim to be more relevant to clinical observations, 
but are not without drawbacks either: animal exposure models such as inhalation of tobacco 
smoke or diesel exhaust particles involve multiple potential mediators acting simultaneously 
on several receptor systems on a broad range of cells, making it difficult to clearly delineate 
relevant pathogenetic molecular mechanisms. For instance, both diesel exhaust particles 
and tobacco smoke are complex vectors for ROS, PAHs and a myriad of other bioactive 
compounds. Moreover, DEPs and tobacco smoke are often administered to animals in ways 
that do not reflect real-world situations, i.e. use of excessive doses, and/or instillation of 
soluble extracts rather than inhalation of airborne forms 12. 
 
How oxidative stress can affect pulmonary dendritic cells 
 
Reactive oxygen species are now recognized as important elements in the pathogenesis of 
several inflammatory disorders. ROS, which include oxygen ions, free radicals and peroxides, 
are highly unstable molecules with unpaired electrons, capable of initiating oxidation of 
cellular components. Endogenous ROS are generated by biochemical redox reactions of the 
natural cell metabolism including mitochondrial respiration or the oxidative burst of 
phagocytic cells, whereas exposure to air pollutants is the main source of exogenous ROS 13. 
Carbonacous fine particulate matter (including diesel exhaust particles), gases such as ozone, 
nitrogen dioxide and sulphur dioxide are all potential sources of ROS-generation at the level 
of airway surfaces. Not surprisingly, the lung has evolved elaborate anti-oxidant mechanisms 
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to limit damage caused by ROS. ROS can affect cells at multiple levels. ROS generation in 
close proximity to the cell membrane oxidizes membrane phospholipids, resulting in the 
formation of highly reactive aldehydes such as acrolein, 4-hydroxy-2-nonenal (4-HNE) and 
related 4-hydroxy-2,3-alkenals (HAKs) 14 (Figure 1). HNE and HAKs possess high affinity 
towards specific amino-acid residues of intracellular proteins involved in several aspects of 
cell signalling, chromatin remodelling and gene transcription. 4-HNE for instance, is capable 
of inducing adenylate cyclase activation, increase cAMP levels and thus affect cellular 
function by activating cAMP-dependent protein kinases (PKAs) 15. Reactive aldehydes can 
form stable adducts with JNK1/2 leading to subsequent activation of the transcription factor 
activator protein 1 (AP-1) and suggesting a possible role for 4-HNE in the modulation of cell 
proliferation and differentiation 16.  Interestingly, 4-HNE and HAKs both possess chemotactic 
activity towards neutrophils and monocytes, an important aspect of innate immunity 17. 
Isoprostanes are alternative by-products of membrane lipid oxidation, which are further 
processed into bioactive molecules, such as 1-palmitoyl-2-(5)oxovaleroyl-sn-glycero-3-
phosphorylcholine (POVPC), 1-palmitoyl-2-epoxyiso-prostane-sn-glycero-3-phosphorylcho-
line (PGPC) and (1-palmitoyl-2-epoxyisoprostane-sn-glycero-3-phosphorylcholine (PEIPC). 
These molecules possess innate pro-inflammatory effects as they can activate monocyte and 
neutrophil adhesion to the endothelium and increase their cytokine release 18. 
Protein nitration is another product of ROS-induced tissue damage. A reaction between NO 
en O2- radical results in the formation of peroxynitrite anions (ONOO-).  These are highly 
reactive radicals, able to nitrosylate tyrosine residues to produce the stable product 
nitrotyrosine. Tyrosine nitration affects the function of important intracellular proteins such 
as NFkB 19, MAPK 20 and HDACs 21.  In addition, oxidation of cystein residues in the DNA 
binding domain of so-called redox sensitive transcription factors (NFkB, AP-1) can have 
profound effects on inflammatory gene expression and cell differentiation 22. An important 
redox-sensitive protein is Nuclear erythroid 2 p45-related factor 2 (Nrf2). Oxidative stress 
interferes with the default cytoplasmic anchoring of Nrf2 to the cytoskeleton-associated 
protein Keap1. Thus freed, Nrf2 translocates to the nucleus and activates transcription of 
several genes which have been shown to have anti-oxidant and anti-inflammatory activity in 
the lung 23. Also, in homeostatic conditions Nrf2 activity is low as a consequence of a Keap1-
dependent proteosomal degradation 24. 
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Finally, ROS can also mediate the activation of the NALP3 inflammasome and trigger the 
secretion of the pro-inflammatory cytokine IL-1β, as was shown in a model of asbestos fiber 
inhalation 25. Like IL-1β, IL-18 is produced following cleavage of a pro-form by the NALP3-
activated caspase 1. Interestingly, Nrf2-deficient DCs challenged with ambient particulate 
matter show enhanced production of IL-18 compared to wildtype DCs 26, suggesting a 
possible interaction between inflammasome-dependent IL-18 generation and Nrf2 redox 
sensing mechanisms. 
Figure 1. Schematic overview on the cellular-molecular effects of reactive oxygen species, with a special 
emphasis on pathways that are relevant to DC biology, such activation of NFkB, ERK/MAPK and AP-1 signalling 
cascades. See main text for details. 
 
 
With that knowledge in mind, several groups have used in vitro systems to closely dissect 
the effects of ROS on key features of dendritic cell biology. Preynat-Seauve et al analyzed the 
effects of oxidative stress on antigen processing and T cell presentation and indicated that 
oxidative stress inhibits the capacity of APCs to process antigens and to initiate a primary T 
cell response 27. By contrast, a study by Kantengwa et al demonstrated a ROS-induced early 
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maturation of human monocyte-derived DCs, characterized by a clear up-regulation of co-
stimulatory molecules (CD80, CD83 and CD86) and a decrease in endocytic activity 28. 
Likewise, it was shown that exposure of DCs to H2O2 induces up-regulation MHC II and 
costimulatory molecules (CD40, B7-2). Accordingly, H2O2 conditioned DCs were more 
efficient in promoting T cell proliferation than non-treated DCs 29.  These findings link ROS 
production and subsequent tissue damage to the innate activation of DCs and the initiation 
of adaptive immune responses. The involvement of oxidative stress mechanisms in DC 
activation and cytokine secretion includes a significant increase in protein oxidation, 
measured by the formation of carbonyl radicals, and triggers p38 and extracellular signal-
regulated mitogen-activated protein kinase (ERK/MAPK), resulting in the upregulation of 
CD40 30. Thus, MAPK, which has been described earlier as an important mediator of DC 
maturation following innate immune stimuli 31, appears to be an important target of ROS 
attack in itself. The exquisite sensitivity of DCs to oxidative influences is further illustrated by 
a study showing how treatment with anti-oxidants can virtually paralyze the NFkB, MAPK, 
and PKC response following innate inflammatory stimuli such as LPS or IL-1β. Interestingly, 
this led to the preferential induction of regulatory T-cells by the DCs 32. In the same line, 
Vassallo and coworkers showed that the high production of the neutrophil chemoattractant 
CXCL8 by in vitro tobacco smoke-conditioned DCs and ex vivo DCs isolated from tobacco 
smoke-exposed mice can be suppressed by the use of the antioxidant N-acetyl-cysteine 
(NAC) 33.  In contrast to these observations, Kroening et al demonstrated that activation of 
ERK-dependent pathways in DCs by oxidative stress from soluble cigarette smoke 
components, potently inhibits the production of IL-12 and IL-23 by mature DCs 34. 
Further reinforcing the notion that ROS may promote DC-dependent pro-allergic responses, 
Williams et al showed exacerbated DC maturation, inflammatory cytokine secretion and 
Th2-polarization in Nrf2-deficient dendritic cells 26 exposed to particulate matter-associated 
ROS. This was consistent with a study by the same group showing that Nrf2-deficient mice 
develop more severe features of allergic airway inflammation in an ovalbumin 
sensitization/challenge model than wildtype controls 35.  
The contrasting results of ROS and DC response investigations are an unevitable 
consequence of the reductionist nature of the experimental models and reflect the complex 
nature of oxidative stress effects on living cells. ROS-sensitive epigenetic modulation of gene 
expression adds another layer of complexity to the impact of oxidative stress on DCs. An 
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important element of epigenetic regulation is post-translational modification of histones by 
histone acetylases (HATs) and deacetylases (HDACs), whereby histone deacetylation results 
in compact winding of chromatin, obstructing access to transcription factors and suppressing 
gene transcription 36. As mentioned earlier, HDACs are a target of ROS attack by means of 
lipid peroxidation products or tyrosine residue nitrosylation. ROS can inactivate certain 
histone deacetylases (HDAC-2, -5 and -8) to promote the expression of pro-inflammatory 
genes in a number of pulmonary cells 37. Interestingly, HDACs are increasingly recognized as 
important regulators of innate immune responses and of DC function in particular, as 
illustrated by several studies. For instance, pharmacological HDAC inhibition (by the 
synthetic compound LAQ824) can alter TLR-4 dependent activation of macrophages and DCs 
and suppress Th1 but not Th2-cell activation and migration 38. In a different study, it was 
shown that HDAC inhibition decreases TLR- mediated activation of proinflammatory gene 
expression, due to impaired transcription factor recruitment 39. HDAC inhibition also changes 
DC differentiation by affecting the expression of costimulatory and adhesional molecules. 
The HDAC inhibitor butyrate inhibits the expression of CD1 molecules, but not CD83, CD86 
and MHCII molecules and butyrate-treated immature DCs showed lower production of IL12 
and IL-6 40. The observed defects in DC function after HDAC inhibition seem to rely on 
impaired nuclear translocation of NFκB, IRF-3 and IRF-8 41. Thus, ROS-induced defects in 
HDAC activity could have profound effects on normal innate responses of pulmonary DC, just 
as it does on other cells in the lung. 
Recently, an intriguing report was published pointing to a fundamental role of Toll-like 
receptors as alternative sensors for exogenous oxidants in the lung. The study by Paul-Clarck 
et al clearly identified TLR2, but not TLR4, as an important receptor mediating the 
production of CXCL8 after exposure to soluble oxidants 42. This may shed a new light on the 
finding by our group that tobacco smoke-induced airway inflammation, pulmonary DC 
recruitment and DC activation occur in a TLR4-dependent fashion 43.  In an in vivo mouse 
model of tobacco smoke inhalation, we observed a marked upregulation of MHC II and the 
costimulatory molecules CD40 and B7-2 on airway DCs, and this effect was profoundly 
impaired in TLR4-deficient mice. In vivo studies from a different group have raised doubts 
whether the TLR4-dependent effects of tobacco smoke are due to the well-documented 
presence of endotoxin 44. Consequently, the link between ROS-exposure and TLR-signalling 
may offer an attractive alternative explanation. 
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Polycyclic aromatic hydrocarbons as a separate class of innate stimuli for dendritic cells 
 
Airborne PAHs are mainly byproducts of industrial activity as well as domestic combustion 
processes such as woodfire heating, tobacco smoking and cooking. Because PAHs are highly 
resistant to metabolic breakdown, they tend to accumulate in the body, hence further 
extending exposure time and increasing the risk for a broad range of adverse health effects 
including carcinogenesis, immunotoxicity and endocrine dysregulation. The toxic effects of 
PAHs, among which dioxin-like compounds, are mediated by the aryl hydrocarbon receptor 
(AhR) 45. This is a ligand-dependent basic helix-loop-helix transcription factor involved in the 
regulation of xenobiotic metabolism and detoxification. The evolutionary highly conserved 
structure of the AhR suggests interactions with endogenous ligands. This is illustrated by 
functions which are unrelated to detoxification of modern environmental xenobiotics 46, 
including vascular development, regulation of circadian rhythm and modulation of immune 
responses, as discussed below. In the non-activated form, the AhR is a soluble cytosolic 
protein, forming a complex with chaperone proteins hsp90 (heat shock protein 90) and an 
immunophilin-like protein called XAP2 (Figure 2). Both chaperone proteins bind to the AhR 
nuclear localization sequence (NLS), preventing the inappropriate trafficking of the receptor 
into the nucleus. Upon ligand activation, the XAP2 protein disocciates from the AhR, 
resulting in the exposure of NLS and subsequent translocation to the nucleus. Once in the 
nucleus, the AhR dissociates from hsp90 and dimerizes with ARNT (AhR nuclear translocator) 
to reconstitute an active transcription factor. The AhR-ARNT complex binds to specific DNA 
response elements known as dioxin-responsive elements (DREs) or xenobiotic responsive 
elements (XREs). DREs are present in many promotors and drive transcription of a wide 
range of genes, not only for xenobiotic metabolism (i.e. induction of cytochrome family of 
proteins), but also genes involved in the regulation of cell differentiation, proliferation and 
activation 47.  
There is growing evidence pointing to an active role of the AhR signaling pathway in immune 
responses 46. Engagement of the AhR leads to diverse, sometimes opposing immunological 
effects depending on ligand binding characteristics as well as the broader cellular and 
molecular environmental context. Exposure to TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin), a 
prototype of PAH with high affinity to the AhR, can lead to both pro-inflammatory effects 
with the induction of TNF-α, IL-1β, COX-2 and IL-8 48,49,50 or suppression of adaptive 
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immunity. TCDD-dependent activation of the AhR can induce suppression of B and T cell-
dependent responses and result in increased susceptibility to infection 51. A series of in vivo 
studies have highlighted the complex effects of AhR-triggering in the setting of influenza 
infection, a good model to illustrate the shift from innate immunity to adaptive response in 
the lung (reviewed in 52). The innate response characterized by neutrophilia and interferon 
production is amplified in TCDD-treated, infected mice, while the clonal expansion of virus-
specific CD8 T-cells is profoundly suppressed. Interestingly, the latter phenomenon appears 
indirect, as CD8 T-cells from Ahr -/- animals are still prone to suppression when transferred 
into Ahr +/+ hosts 53. This suggests that the defect in adaptive immune response after AhR 
triggering occurs at the level of the accessory cell, i.e. most probably targeting the dendritic 
cell. Several in vitro studies have further highlighted the immunosuppressive effects of AhR 
ligands. Benzo(a)pyrene (BP) has been reported to impair antigen presentation by mouse 
macrophage and alters the T cell-macrophage interaction 54. Similarly, PAHs can impair 
differentiation of blood-derived monocytes into functional macrophages 55. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Hypothetical diagram illustrating possible effects of aryl hydrocarbon receptor signalling in DCs. A 
central element is the dual nature of interactions of AhR with components of the NFkB signalling cascade, the 
latter being essential for DC activation following innate stimuli and the acquisition of T-cell immunostimulatory 
power. Probably depending on the ligand, AhR engagement can engage different subunit of NFkB complexes 
and lead to both suppression or induction of inflammatory gene expression. 
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When it comes to dendritic cells specifically, direct effects of PAHs are similarly complex, 
often producing contradicting reports. Jux et al provided evidence for a physiological role of 
the AhR in Langerhans cells (LCs), the predominant DC population of the epidermis. They 
observed an impaired upregulation of costimulatory molecules in TCDD-stimulated, AhR-
deficient murine LCs compared to AhR-competent LCs, and consequently an impaired 
induction of contact hypersensitivity. Interestingly, the AhR was also necessary for the 
upregulation of Indoleamine-2,3-dioxygenase (IDO) expression in DCs. IDO enzymatic activity 
in DCs is known result in T-cell anergy or the generation of regulatory T-cells 56.  
Laupeze et al studied the effects of PAHs on the differentiation, maturation and biological 
function of human monocyte-derived DCs in vitro. Exposure of monocytes to BP during their 
development into DCs resulted in impaired upregulation of DC-specific differentiation and 
maturation markers such as CD1a, CD80 and CD40.  Moreover, DCs generated in the 
presence of BP displayed decreased endocytic activity and showed impaired IL-12 secretion.  
BP-exposed DCs poorly stimulated T cell proliferation compared to their untreated 
counterparts 57. In a recent report, Platzer et al further highlight the suppressive effects of 
AhR triggering on DC biology. Using the synthetic AhR ligand VAF347, they reveal the 
involvement of the AhR in suppressing commitment of human myeloid progenitors towards 
the monocyte/DC lineage 58. In a different report, VAF347 also appears capable of inhibiting 
the upregulation of MHCII and B7-2 on DCs 59. In the same line, Hwang (and Lee) et al. 
showed that the AhR ligand benzopyrene inhibits the growth and functional differentiation 
of mouse bone marrow-derived DCs. BP induced little alterations in CD11c, MHCII and CD86 
surface expression, but clearly impaired production of IL-12, IL-10 and TNF-α as well as 
allogeneic T cell stimulating ability. This was accompanied by a reduced expression of the 
RelB NFkB protein family member, which is known to be pivotal for DC differentiation and 
function 60. Even though BP and the dioxin-like TCDD are both ligands of the AhR, their 
effects on the development and function of DCs can be divergent. This is illustrated by a 
study in which TCDD-treated DCs expressed significantly higher levels of DC differentiation 
markers such as MHCII and the co-stimulatory molecule CD86, impaired IL-10 and intact IL-
12 production. Accordingly, T-cell stimulatory capacity was increased in TCDD-treated 
compared to control DCs 61. Also Vogel et al showed increased maturation of human 
monocyte-derived DCs after AhR activation by TCDD, as manifested by characteristic 
morphological changes and upregulation of costimulatory molecules. Again, AhR triggering 
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by TCDD in DCs led to induction of IDO expression and enzymatic activity. A similar effect of 
AhR-triggering was observed in vivo, with increased IDO expression in lung and spleen of 
TCDD-treated mice, resulting in the induction of FoxP3 transcripts (pointing to an increased 
differentiation of regulatory T-cells)  62. 
Insights into the divergent effects of PAHs on DCs came with the discovery that the AhR is 
involved in a complex cross-talk with several members of the NFkB pathway. Specifically, 
AhR can dimerize with RelA and antagonize the canonical NFkB pathway, leading to 
suppression of inflammatory gene expression. At the same time, the AhR can form a 
complex with RelB and in some cases enhance transcription of inflammatory cytokines and 
chemokines 63, or presumably affect functional features of DCs which rely on non-canonical 
NFkB activation (eg antigen cross-presentation) 64. Which downstream signalling pathway 
will be activated following binding of a specific AhR ligand will likely depend on concomitant 
innate stimuli, as well as the differentiation/maturation state of the DC target. 
 
From airborne xenobiotic exposure to pulmonary immunopathology: the dendritic cell link? 
 
Given their anatomical distribution, airway DCs constitute unevitable targets of inhaled 
xenobiotics. Because innate receptors of DCs have not evolved under selective pressure of 
anthropogenic compounds, it can be assumed that confrontation of airway DCs with these 
agents will initiate aberrant pulmonary immune responses, or modulate the outcome of 
classical anti-microbial defenses. This working hypothesis may shed new light on the 
pathogenesis of several chronic inflammatory pulmonary diseases. A good illustration is the 
implication of tobacco smoke (TS) exposure in the development of asthma. Tobacco smoke 
inhalation activates multiple mechanisms that can potentially program DCs to polarize pro-
allergic T-helper 2 type responses towards co-inhaled antigen. TS is a known vector for 
endotoxin-like compounds, the latter having been implicated in the induction of Th2 
responses 65. Despite this fact, our group has recently shown unimpaired development TS-
induced allergic sensitization in TLR4 and Myd88 gene deficient mice (Robays et al, in press). 
This suggests alternative Th2-promoting effects of TS on DCs, such as ROS-induced activation 
of the MAPK/ERK pathway 34, or the secondary release of Th2-promoting innate factors such 
as TSLP, ATP or IL-33 66. Another illustration of pulmonary immunopathology with a strong 
link to human activity is COPD, a chronic pulmonary disease associated with the inhalation of 
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tobacco smoke and presumably biomass combustion products in general. Among the many 
xenobiotics present in smoke, the dual effects of PAHs as both promoting chronic 
inflammation, while simultaneously suppressing adaptive immunity, may contribute to the 
relentless progression of pulmonary damage, coexisting with the enhanced sensitivity to 
infection that charactizes COPD. This is reflected in the specific changes in airway DC 
populations observed in COPD patients, i.e. increased recruitment of airway epithelial DCs (a 
sign of innate pro-inflammatory response), which however display an immature phenotype 
67. COPD is clearly a disease of aberrant immunostimulation in the lung and it is very likely 
that the reprogramming of pulmonary DCs by smoke-derived xenobiotics plays a central role 
in perpetuating the chronicity of the inflammation, even after smoking cessation. Epigenetic 
reprogramming of DCs is an interesting hypothesis to explain the hard-wiring of this aberrant 
response. In support of this, extensive studies have unveiled progressive reduction in HDAC 
activity in COPD bronchial biopsies, a phenomenon that was proportional to COPD severity. 
Specifically, HDAC activity was suppressed in alveolar macrophages from COPD-patients, 
resulting in enhanced and glucocorticoisteroid-resistant production of innate pro-
inflammatory cytokines 37. It is very likely that airway DCs are subject to similar epigenetic 
modulations, probably under influence of ROS, as detailed above. In contrast to the innate 
scavenger function of alveolar macrophages, the impact of these effects on DCs is more far-
reaching, as DC function can shift from innate immune sensor to initiator of adaptive 
immnunity, with the potential to instruct tolerance vs active immune response. Accordingly, 
reports have recently emerged suggesting the presence of an aberrant adaptive response in 
COPD, including reactivity against self-antigens within the lung tissue 68.  Provided the 
necessary stimuli are present, DCs are probably the only antigen-presenting cells powerfull 
enough to override this self-tolerance.  
Besides asthma and COPD, the lung is also the stage for other chronic, often debilitating 
immunopathologies such as interstitial pneumonitis/fibrosis, vasculitis (e.g. Churg-Strauss, 
Wegener disease) and granulomatous inflammation (e.g sarcoidosis). The etiology of these 
diseases is still obscure, and it remains to be examined whether airborne anthropogenic 
xenobiotics, by acting on pulmonary DCs, could provide the necessary spark to initiate an 
aberrant immune response in predisposed individuals. 
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Conclusion 
 
In summary, it appears increasingly evident that the pulmonary innate immune system is a 
critical target of airborne xenobiotics. The large amount of experimental data available 
reflects the complex nature of these man-made compounds in terms of triggering specific 
innate molecular responses. Diverging effects are observed depending on co-existing stimuli 
and the cellular and tissue context. Nevertheless, it is worth noting that classical pathogen-
associated molecules and human-made xenobiotics can use common sets of innate 
receptors such as TLRs and presumably inflammasome components. Even more intriguing is 
the way the aryl hydrocarbon receptor system and the cellular response to oxidative stress 
interconnect with immunological pathways. In this review, we provided evidence that 
molecular responses to xenobiotics can operate at the level of the dendritic cell. Given the 
extensive network of DCs in the airways, and the pivotal role of these cells in linking innate 
and adaptive immunity, we believe intensive preclinical and translational research in this 
field may produce unexpected insights in many pulmonary immunopathologies. 
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Over the last decades, the incidence of asthma and chronic obstructive pulmonary disease 
(COPD) has increased continuously, especially in the industrialized Western countries. 
Although genetic predisposition is a fundamental factor underlying both diseases, the 
observed increase in prevalence has occurred too rapidly to be explained by genetic 
variations alone, implicating a role for environmental factors 1.  
To unravel the impact of environmental insults on the induction, progression or aggravation 
of asthma and COPD, we moved towards a new generation of animal models, with combined 
exposures to natural and man-made environmental stimuli.  
 
In the first part of the thesis we focused on allergic asthma. Epidemiological studies have 
demonstrated that cigarette smoke (CS) exposure is a considerable risk factor in the 
development or aggravation of asthma, predominantly early in life 2. To better understand 
the impact of CS exposure on immunological responses towards allergens, Chapter 6.1, 6.2 
and 6.3 of the thesis focused on the role of CS as a risk factor for allergic sensitization and 
asthma development in mice.  
In Chapter 6.1 we studied the impact of CS inhalation on key aspects of airway dendritic cell 
(DC) biology. Airway DCs are generally accepted to drive mucosal sensitization towards 
inhaled aeroallergens 3. In vivo depletion of lung CD11c+ DCs abrogates Th2 sensitization in 
response to allergen exposure 4, whereas transfer of allergen-primed DCs into naïve mice 
induces Th2 immunity and features of asthma upon allergen rechallenge 5. Using the 
previously established mouse model of Moerloose et al. – in which CS breaks inhalation 
tolerance to aerosolized ovalbumin (OVA) 6 – we demonstrated increased recruitment and 
activation of airway DCs in mice concomitantly exposed to OVA and CS. Moreover, 
prolonged CS inhalation markedly amplified the DC-mediated transport of OVA to the 
draining lymph nodes, probably in response to CS-induced up-regulation of the homing 
receptor CCR7 on airway DCs 7. Although our data are consistent with previous results in CS-
exposed mice 7-10, some groups rather suggest impaired DC maturation and migration in 
response to CS inhalation 11,12. This discrepancy may be explained due to dose-dependent 
adjuvant or anti-inflammatory properties of CS 13,14 and differences in exposure protocol. To 
explain the mechanistic pathway through which CS affects DC biology and disrupts normal 
tolerogenic immunity against OVA, we hypothesized a role for the contaminating endotoxin 
(or LPS) content in CS 15. Eisenbarth et al. reported that low doses of endotoxin, in 
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combination with OVA, are sufficient to break inhalation tolerance in a TLR4-MyD88 
dependent way 16,17. Unexpectedly, we showed Th2-oriented immunity in both TLR4 
deficient mice and MyD88 knockout mice upon concomitant OVA/CS exposure, suggesting 
that other pathways are responsible for the enhanced sensitization towards OVA antigens.  
 
In contrast to the “surrogate” allergen OVA, most clinically relevant allergens (e.g. house 
dust mite (HDM), ragweed or animal dander) possess intrinsic proteolytic adjuvant activity, 
directly activating DCs or epithelial cells to break inhalation tolerance and promote Th2 
immunity 18. Biochemical and immunogenic differences between real-life allergens and OVA 
may have a profound impact on the nature of the allergen exposure and may even affect the 
mechanisms behind the elicited allergic response. Moreover, as the stimulatory effect of CS 
on asthma development probably results from a fine interplay between CS compounds, 
environmental allergens, and innate and adaptive immune cells, the use of real-life allergens 
(e.g. HDM) to obtain relevant mechanistic insights, is therefore crucial. 
 
In Chapter 6.2, we established a clinically relevant mouse model, using low doses of HDM as 
real-life allergen, together with CS as indoor pollutant. In conformity with epidemiological 
data, we provided biological proof that CS indeed favours HDM-driven asthma development, 
as illustrated by massive inflammatory cell recruitment, elevated Th2 cytokine production 
and increased airway hyperresponsiveness. In addition, we demonstrated that CS inhalation 
during the sensitization phase is sufficient to induce asthma development in mice. We found 
that only a few days of CS inhalation during the initial allergen contact already enhanced DC 
recruitment, activation and HDM-driven DC migration to the lymph nodes, supporting the 
local induction of HDM-specific Th2 immunity.  
From a medical point of view, these findings are of great clinical relevance. As allergic 
sensitization mainly occurs during early life, young children may become more vulnerable for 
future asthma development due to (short) CS inhalation. 
 
As HDM is a complex mixture of various proteolytic enzymes, together with a number of 
non-protein compounds (endotoxins, β-glucans, chitin, … ), these elements may act synergis-
tically, or at least in combination with CS constituents (LPS, aluminium, ...), to modulate the 
disease phenotype. In Chapter 6.3 we obtained preliminary mechanistic insights regarding 
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the role of CS during asthma development. HDM allergens have been reported to posses 
auto-adjuvant activity, in a protease dependent (e.g. Der p 1) 19 or independent 20 way and 
together with CS 21,22, these allergens may act synergistically to further decrease the 
epithelial barrier function and to increase transepithelial delivery to antigen-presenting cells. 
In our model of CS-induced facilitated early Th2 sensitization, we observed no significant 
difference in E-cadherin expression – a marker of epithelial integrity – between all 4 groups, 
although the individual values of the PBS/air control mice seemed to be higher. However, 
combined exposure to HDM and CS did result in elevated levels of the endogenous danger 
signal uric acid (UA) compared to HDM or CS alone. UA may act as a Th2 prone adjuvant 23 
and may be released upon tissue injury 24, oxidative stress 25 or alum 26, which is present a 
high concentrations in CS 27. Furthermore, UA may amplify the production of innate pro-Th2 
cytokines, such as IL-1β 23. In fact, acute HDM/CS exposure for 3 days induced additionally 
more IL-1β compared to control mice, suggesting a putative role for the IL-1β – IL1RI 
signalling pathway during facilitated allergic sensitization upon CS inhalation. Using IL1RI 
knockout mice, we confirmed the IL1RI pathway to be necessary to prime local Th2 
immunity in the draining lymph nodes. To our knowledge, only one study already 
demonstrated the role of the IL1RI signalling during allergic sensitization, however in the 
absence of any environmental pollutant 28.  
Moreover, many HDM components possess Toll-like receptor (TLR) agonist activity 29-31. 
HDM can induce the release of endogenous danger signals or pro-allergic cytokines from 
airway epithelial cells, in a TLR4-dependent way 23,28,29,32. Although the role of TLR4 in our 
combination model has not been investigated yet, prolonged HDM/CS exposure further 
increased UA and IL-1β, as well as IL-25 and IL-33, illustrating the immunostimulatory effect 
of CS on airway epithelial cells. Figure 14 summarizes our findings from the HDM/CS 
exposure model and illustrates potential mechanisms. 
 
Albeit our findings suggest a role for CS as an adjuvant during allergic sensitization and 
subsequent asthma development, additional experiments are needed to further unravel the 
mechanisms behind the facilitated allergic response. To further elucidate the role of the 
airway epithelium, we should focus on the expression profile of other tight junction and 
adherens junction molecules. Together with UA, the role of other danger molecules (e.g. 
ATP, hsp70, S100 proteins) and innate pro-allergic cytokines can be unravelled, using 
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Figure 14: Summary of the immunostimulatory effect of CS on house dust mite-driven allergic inflammation 
and an illustration of potential mechanisms (e.g. E-cadherin, uric acid, IL-1β – IL1RI pathway). 
Figure by Lanckacker EA 
degradation enzymes, neutralization antibodies or knockout mice. Moreover, it may be 
interesting to analyse the long-term effect of HDM/CS exposure on the induction of 
epithelial-to-mesenchymal (EMT) transition and the development of airway wall remodeling. 
Mast cells are key effector cells of allergic inflammation, located in close proximity to 
sensory nerves 33. Within this regard, the role of mast cells and their mediators, neurogenic 
inflammation and the involvement of transient receptor potential channels may be 
interesting to examine in HDM/CS exposed mice. Our model also offers the opportunity to 
investigate the role of epigenetic changes (miRNA expression 34, histone modifications and 
DNA-methylation 35), during CS-induced asthma development. As oxidative stress originating 
from HDM or CS, may compromise the protein folding capacity of the endoplasmic reticulum 
(ER) 36, it may be significant to unravel the role of ER stress during enhanced CS-induced 
HDM sensitization. Finally, it will be interesting to examine whether promising asthma 
genes, identified from genome wide association studies (GWAS) (e.g. ORMDL3 37, TLSP 38, 
PCDH1 39) are upregulated in our mouse model, as well as to examine their role in asthma 
development. Conversely, we need to check whether data obtained from mice can be 
confirmed in patients with allergic asthma. 
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In the second part of the thesis, we focused on environmental aggravating factors in the 
pathogenesis of smoking-related diseases, such as COPD. More specifically, in Chapter 6.4 
we investigated the disease-modifying role of bacterial superantigens. Staphylococcus 
aureus (S. aureus) has been identified as one of the main pathogenic bacteria, capable of 
producing a variety of bacterial toxins with superantigenic capacity. Although bacterial S. 
aureus is often associated with asymptomatic colonization of the respiratory tract, repeated 
CS exposure may compromise the mucosal barrier function, thus providing the opportunity 
for the pathogen to break through. Moreover, the discovery of specific IgE antibodies 
directed against Staphylococcus aureus (S. aureus) enterotoxins in patients with COPD 40, 
provides indications that these antigens may act as potential aggravating factors of COPD 
pathophysiology. In order to identify whether S. aureus superantigens may alter the 
pulmonary inflammatory response upon CS, we designed a novel mouse model of 
concomitant S. aureus enterotoxin B (SEB) and CS inhalation. Interestingly, simultaneous 
exposure to both stimuli resulted in a significant aggravation of hallmark features of CS-
induced pulmonary inflammation, such as a marked increase in CD8+ T lymphocytes and 
neutrophils, associated with the increased release of IL-17A, and not KC, as neutrophil-
attracting chemokine. Furthermore, combined SEB/CS exposure enhanced goblet cell 
hyperplasia, IL-13 mRNA expression and the formation of dense lymphoid aggregates in the 
lung, in an experimental protocol of 4 weeks. In COPD patients, the presence of pulmonary 
lymphoid follicles correlates with the progression and severity of the disease 41. Similarly, 
using the standard murine COPD model within our lab, lymphoid follicle formation occurs 
after a chronic CS exposure period for 24 weeks 42. The observed increase in lymphocytes 
and their organization into follicles after only 4 weeks of concomitant SEB/CS exposure, 
illustrates the disease-aggravating role of SEB in COPD pathology. SEB exposure also 
enhanced tissue-local production of IgM and protective mucosal IgA, which may offer local 
protection against the invading pathogens.  
As we postulated to design clinically relevant mouse models, using complex environmental 
stimuli, the use of SEB within our combination model, instead of S. aureus itself, may be 
considered as a weakness of the study. However, because of its proven relevance in other 
respiratory diseases, the use of SEB solely may be justified 43,44. Another limitation of the 
study may be the fact that SEB on itself already induced stimulatory effects, probably in a 
dose-dependent way. 
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Little is known about the mechanisms underlying the aggravating effect of SEB on immune 
activation and further research is needed to obtain mechanistic insights. Considering the 
stimulatory effect of SEB, it may be interesting to down-titrate the SEB dosage, in order to 
further emphasize the immunomodulatory effect of SEB in combination with CS-induced 
inflammation. It may be interesting to focus on the airway epithelium and to identify 
pathogen recognition receptors on epithelial cells, DCs or other innate and adaptive immune 
cells which may be activated upon SEB and CS constituents. Moreover, the role of danger 
molecules and innate cytokines in response to SEB/CS exposure deserves further attention. 
As the enhanced production of lymphoid chemokines CXCL13 and CCL19 upon CS exposure 
are lymphotoxin (LT)α1β2-LTβR dependent, the role of this pathway may be significant in our 
model 45. Finally, chronic SEB/CS exposure for 24 weeks may reveal additional information 
on the immunostimulatory effect of SEB on key aspects of COPD pathophysiology, such as 
emphysema or lung function.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As a general conclusion, preclinical mouse models may be very useful to provide biological 
mechanistic data, supporting the hypothesis that environmental factors may be responsible 
for the increased prevalence and aggravation of asthma and COPD. 
 
Figure 15: Summary of the disease-modifying role of S. aureus enterotoxin B on CS-induced  
pulmonary inflammation. Figure by Lanckacker EA 
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